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Pain 
For many years pain was conceptualized, managed, and studied as a sensory experi-
ence and a symptom of pathology or injury. However, the conscious perception of 
pain does not always directly reflect incoming signals from primary sensory neurons 
(Melzack & Wall, 1994; Petrovic & Ingvar, 2002). At a higher level, cognitive process 
seems to modulate the perception of pain. As incoming sensory input becomes 
incorporated into the texture of cognition, it undergoes extensive associative elabo-
ration and modulation (Mesulam, 1998). Pain is a multidimensional experience, 
which includes both sensory components (e.g. intensity, quality and spatiotemporal 
characteristics of the sensation), and affective-motivational components (i.e. the 
unpleasantness and aversiveness of the sensation) and which has no one-to-one 
relationship with the amount of tissue damage. For example, low back pain research 
has shown that the extent of disc herniation rarely relates to the pain experienced 
(e.g. Jensen et al, 1994). However, the ratio of the amount of injury to the amount 
of pain swings the other way too. For example, a paper cut creates a rather small 
incision, but hurts for most people attending to it. Other times, the pain system 
actually fails. Some life-threatening diseases, like cancer, are not painful, which is 
the reason they can affect the organism unnoticeably. Pain is not just a symptom; it 
can persist and become a patho-physiologic condition in itself. Functional disability 
and movement dysfunction are not just a consequence of anticipating and minimiz-
ing pain, but are one element of a much broader complex pain problem. There are 
many factors that are important in determining what hurts for whom and when, for 
example context, meaning, and the presence of competitive stimuli. One example 
to illustrate this: exactly the same minor finger injury will cause more pain in a pro-
fessional violinist than in a professional ballerina because finger damage poses a 
greater treat to the violist. The event plays a greater role in the violinist’s life goals 
and identity. There are different dimensions of a noxious stimulus context that may 
influence how it is experienced. Experimental studies showed that meaning (per-
ceived tissue damaging properties) affects pain experience, a noxious stimulus 
evokes pain, and that warning and visual attention moderate the effects of meaning 
when the meaning is associated with tissue-damage (e.g. Arntz & Claassens, 2004; 
Moseley & Arntz, 2007). Different dimensions of the stimulus’ context can have 
differential effects on sensory-discriminative and affective-emotional components 
of pain. 
Neurocognitive aspects of pain 
A fundamental principle of the complexity is that pain is produced by the brain 
when it perceives that danger to body tissue exists and that action is required (Mer-
skey & Bogduk, 1994). Imaging studies demonstrate that there is no single ‘pain 
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centre’. Many cortical areas can be activated during pain and wide variability exists 
within and between individuals (e.g. Ingvar, 1999). However, some cortical areas are 
involved more often than others. Most studies identify a network of primary and 
secondary somatosensory, insular, anterior cingulate, and prefrontal cortices and 
thalamus receiving parallel inputs from multiple nociceptive pathways (e.g. Ingvar, 
1999; Creac’h et al., 2000; Apkarian et al., 2001; Bantick et al., 2002). In contrast to 
pain in normal subjects, decreased incidence of activity across these brain areas has 
been observed in patients (e.g. Apkarian et al., 2005). The anterior cingulated cortex 
(ACC) can be considered as the action centre (Craig, 2002). It is considered to serve 
to establish an emotional valence of pain, and coordinate the selection and planning 
of an appropriate behavioral response strategy (Price, 2000). Similar ACC activity 
has been reported during non-nociceptive but biologically threatening events such 
as anticipated pain (Sawamoto et al., 2000) and anxiety (Osuch et al., 2000) and the 
ACC is chronically active in chronic pain patients (Hsieh et al., 1995). Further, in 
chronic pain conditions, including cancer pain, headache, visceral pain and neuro-
pathic pain, there seems a preferential activation of the prefrontal cortex (PFC) (e.g. 
Apkarian et al., 2005). The PFC has different subdivisions that are thought to play 
specific roles in various cognitive, emotional and memory functions. The preferen-
tial activation of then PFC underscores the conjecture that chronic pain states have 
stronger cognitive, emotional and introspective components than acute pain condi-
tions, and that chronic pain conditions may be a reflection of decreased sensory 
processing and enhanced emotional and cognitive processing. 
 
Another critical and as well complex component is that pain is experienced in the 
body image that is held by the brain, the so-called ‘virtual body’ in the primary so-
matosensory cortex (e.g. Melzack et al., 1997). This part of the brain is organized in 
‘maps’ that represent a point-to-point connection between well-defined parts of 
the body and their respective anatomical location in the cortex. It is found that 
these maps change in response to (behavioral) experience and injury (e.g. Flor, 
2002). Research has shown that chronic pain leads to an expansion of the cortical 
representation zone related to nociceptive input similar to the expansions observed 
with other types of behaviorally relevant stimulation (e.g. Flor, 2002). Katz and Mel-
zack (1990) suggested that somatosensory memories play an important role in es-
tablishing cortex reorganization and chronic pain. According to their hypothesis, this 
means that experience of pain leads to a memory trace in the brain. In addition, it 
should be emphasized that this is a type of implicit memory that leads to behavioral 
and perceptual changes, such as hyperalgesia and allodynia, of which the patient is 
not aware. If pain experience is stored in memory, there is a possibility that the 
patient experiences pain even after the disease has been cured or the injury has 
healed. Research has shown that somatosensory pain memories manifest them-
selves in alterations in the S1 cortex, which means that they may contribute to hy-
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persensitivity even in the absence of peripheral stimulation (e.g. Flor, 2002). In addi-
tion, memories can be further established or enhanced by psychological processes, 
such as conditioning or attention (e.g. Flor, 2002). Furthermore, chronic states of 
pain are also associated with increased cortical excitation that may significantly 
contribute to reorganization. 
Summary 
In sum, pain experiences are normal responses to perceived threat to the integrity 
of the body. However, the level of pain does not necessarily reflect the amount of 
body tissue damage. The construction of the pain experience relies on many sensory 
and affective cues which are involved simultaneously. Although consistent patterns 
can be seen during pain experiences, the exact parts and amount of activity vary 
between people and even between several occasions in the same person (e.g. Pey-
ron et al., 2000). Moreover, when pain persists and becomes chronic, the affective 
response system seems to be more involved and may increasingly contribute to the 
pain problem, while sensory processing may play a lesser role to pain experience. 
For example, pain-related fear or the anticipation of pain may be enough to predis-
pose to pain experience if maintained long term (e.g. Vlaeyen & Linton, 2000). 
Pain-related fear 
Fear is described as a present-oriented state that is designed to protect the individ-
ual from a perceived immediate state (e.g. Izard, 1998). It is the emotional manifes-
tation of the fight or flight response (Cannon, 1992). In contrast to fear, anxiety is a 
seen as a future-oriented cognitive-affective state which occurs in response to an-
ticipated threats that are often vague or uncertain in nature (e.g. Barlow, 2002). 
Research studies focusing on the explanation of chronic pain and its associated 
disability showed that pain-related fear plays an important role in the domain of 
pain (e.g. Vlaeyen & Linton, 2000; Leeuw et al., 2007a). Pain-related fear can best be 
defined as the fear that emerges when stimuli that are related to the pain problem 
are perceived as a main threat. Pain-related fear is not a unitary construct and 
probably encompasses several forms of fear. For example, pain patients may fear 
the causes and consequences they assume to be associated with their pain. De-
pending on the current concerns, different stimuli are attended to and possibly 
misinterpreted. Patients suffering pain report fear of ‘interoceptive stimuli’ (e.g. 
mild pain, physiological sensations like feeling a ‘crack’, sudomotor activity, changes 
in skin blood flow) which often are interpreted as sign of (re)injury, ‘proprioceptive 
stimuli’ (e.g. activities, movements) which are perceived as harmful and may cause 
(re)injury, and ‘exteroceptive stimuli’ (e.g. doctors information, CT-scan, other pa-
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tients who now sitting in a wheelchair) which are related to patients fear to be or 
become (e.g. work-loss, wheelchair-bounded). 
 
Kori et al. (1990) introduced the term ‘kinesiophobia’ (kinesis = movement) for the 
condition in which a patient has ‘an excessive, irrational, and debilitating fear of 
physical movement and activity resulting from a feeling of vulnerability to painful 
injury or reinjury’. Research revealed that during confrontation with feared move-
ments, pain patients who reported pain-related fear typically show a fear response 
comprising of psycho-physiological (e.g. muscle reactivity), behavioral (e.g. escape 
and avoidance behavior) as well as cognitive (e.g. think in catastrophes) elements. 
This supports the idea that chronic pain and chronic fear share important character-
istics (e.g. Vlaeyen & Linton, 2000). Indeed, when comparing the major features of 
specific phobia according to the criteria of the Diagnostic and Statistical Manual of 
Mental Disorders 4th edition (DSM-IV: American Psychiatric Association, 1994) and 
pain-related fear in chronic pain patients, there is much similarity between the two 
conditions (table 1) (Kori et al., 1990). One point on which the two conditions differ 
is that people with a phobia are aware that the fear is excessive and irrational, whe-
reas most pain patients reporting pain-related fear are convinced of the fact that 
avoidance has a protective function. 
 
Table 1 Differences and similarities between specific phobia (according to DSM-IV) and pain-related fear 
(Kori et al., 1990) 
Specific phobia Pain-related fear 
1. Marked and persistent fear that is excessive 
or unreasonable cued by the presence or an-
ticipation of a specific object or situation.  
1. Marked and persistent fear that is (often) excessive 
and unreasonable, cued by the presence or antici-
pation of a pain-eliciting situation. 
2.  Exposure to the phobic stimulus almost 
invariably provokes an immediate anxiety 
response, which may take the form of a situ-
ational predisposed panic attack. 
2.  Exposure to the pain-eliciting stimulus almost 
invariable provokes an immediate anxiety response, 
including avoidance/escape/safety-seeking behav-
iors, increased arousal levels, and hypervigilance. 
3.  The person recognizes that the fear is exces-
sive or unreasonable. 
3.  The person often does not recognize that the fear is 
excessive or unreasonable. 
4.  The phobic situation is avoided or else is 
endured with intense anxiety or distress. 
4.  The phobic situation is avoided or else is endured 
with intense anxiety or distress. 
5.  The avoidance, anxious anticipation, or 
distress in the feared situation(s) interferes 
significantly with the person’s normal rou-
tine, occupational (or academic) functioning, 
or social activities or relationships, or there 
is marked distress about having the phobia. 
5.  The avoidance, anxious anticipation, or distress in 
the feared situation(s) interferes significantly with 
person’s normal routine, occupational (or academic) 
functioning, or social activities or relationships, ore 
there is marked distress about having the pain prob-
lem. 
6.  In individuals under age 18 years, the dura-
tion is at least 6 months.  
6.  Not considered relevant. 
7.  The anxiety, panic attacks, or phobic avoid-
ance associated with the specific object or 
situation are not better accounted for by an-
other mental disorder. 
7.  The anxiety, panic attacks, or phobic avoidance 
associated with the specific object or situation are 
not better accounted for by another mental or 
physical disorder. 
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Safety-seeking behaviors 
It has repeatedly shown that pain-related fear is associated with safety-seeking 
behaviors. Recently, Tang et al. (2007) identified in chronic back pain patients with 
high health anxiety a wide range of safety-seeking-behaviors (SSBs). SSBs are de-
fined as behaviors performed as a strategy intended to prevent or minimize a 
feared catastrophe (e.g. Salkovskis & Bass, 1997). SSBs refers not only to total 
avoidance of a feared situation (e.g. “I don’t lift anything heavy because that would 
damage my back”) but also to escape behaviors which are performed to terminate 
exposure to a feared situation (e.g. “I will stop garden at the first sign of pain in case 
I damage my back”) and subtle avoidance behaviors which are performed to pre-
vent the feared catastrophe while remaining in the feared situation (e.g. “I take care 
that I don’t lean forward when I’m holding something heavy because that might 
break my spine”). Health anxiety is different from pain-related fear in that individu-
als with health anxiety are afraid to compromise their health, whereas pain-related 
fear is focused on pain and injury, it seems, given the similarity of both concepts, 
that SSBs may have relevance for pain-related fear. In the study of Tang et al. the 
SSBs had the common goal of protecting from further pain, injury or danger. Some 
of the SSBs were similar to an overt pain behavior (e.g. ‘holding the back’), while 
some others were very subtle (e.g. ‘continually testing the stomach muscles’) and 
creative (e.g. ‘constantly rocking, shifting the weight between the legs’). Most SSBs 
continued throughout the time the patient remained in a feared situation. The au-
thors suggested that the use of SSBs could have two unintended effects: firstly, to 
exacerbate pain (e.g. “using the strength of the arm instead of the strength of my 
body”) and, secondly, to prevent the disconfirmation of catastrophizing beliefs (e.g. 
“something drastic will happen unless I do this”), thus potentially maintaining the 
anxiety and disability in the long term, and maintaining pain itself. Furthermore, by 
using physical performance tests some studies even reported that behavioral per-
formance appeared to be more strongly associated with pain-related fear than with 
pain severity (Crombez et al., 1999; Vlaeyen et al., 1995). In addition, Waddell et al. 
(1993) demonstrated that fear-avoidance beliefs about work are strongly related to 
overall functional disability, and more so than pain, and concluded that ‘fear of pain 
and what we do about it may be more disabling than pain itself’. 
 
In line with the cognitive theory of anxiety, a number of studies have also shown 
that pain-related fear is associated with heightened vigilance to pain and noxious 
body stimuli and increased body awareness (Crombez et al., 2004; Goubert et al., 
2004; Roelofs et al., 2003). Hyper-vigilance refers to an increased attention and 
scanning of the environment for a feared stimulus and it emerges when pain is ap-
praised as threatening and a patient’s current goal is to escape or to avoid pain 
(Crombez et al., 2005). In such cases, hyper-vigilance to pain is driven by top-down 
instead of bottom-up variables. Because hyper-vigilance is largely the result of au-
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tomatic processes, this may undermine the efficacy of attentional coping strategies, 
in particular distraction (Crombez et al., 2005). For precise conclusions about which 
processes underlie hypervigilance, specific components of attention have been 
proposed (e.g. Posner & Petersen, 1990): 1) initial orienting of attention (shift com-
ponent), 2) focusing of attention (engagement component), and 3) directing atten-
tion away (disengagement component). Van Damme et al. (2006) showed that hy-
pervigilance to pain signals does not emerge as rapid initial shifting to the pain sig-
nal but rather as enhanced processing once it is detected. 
Fear-avoidance model of pain 
The fear-avoidance model of chronic musculoskeletal pain (e.g. Lethem et al., 1983; 
Vlaeyen et al., 1995; Asmundson et al 1999, Vlaeyen & Linton, 2000; Leeuw et al., 
2007a) assigns a prominent role to catastrophic (mis)interpretation of pain and the 
associated pain-related fear in the development and maintenance of chronic pain. 
This model is primarily developed as an explanation of why chronic low back pain 
problems and associated disability develop in a minority of patients who experience 
acute low back pain. Pain-related fear has shown to be associated with increased 
disability levels, not just in back pain but also in cervical pain (e.g. Turk et al., 2008), 
Complex Regional Pain Syndrome (formerly Reflex Sympathetic Dystrophy: Rose et 
al., 1992), non-traumatic arm pain (Feleus et al., 2007), burn pain (Sgroi et al., 
2005), Post-Herpetic neuralgia (Rose et al., 1992), chronic headache (e.g. Nash et 
al., 2006), fibromyalgia (e.g. Turk et al., 2004), knee injury (Kvist et al., 2005) and 
osteoarthritis (Heuts et al., 2004). So, it seems that the fear-avoidance model may 
be useful as an heuristic framework for the explanation of why some individuals 
develop a chronic pain condition, independent of the medical diagnosis. 
 
The basic tenet of the fear-avoidance model is the way in which pain is interpreted. 
Acute pain patients who perceive their pain as non-threatening, and are likely to 
maintain engagement in daily activities promote functional recovery. In contrast, 
when pain is catastrophically (mis)interpreted this gives rise to pain-related fear, 
and associated safety seeking behaviors such as avoidance and/or escape and hy-
per-vigilance, that can be adaptive in the acute pain stage, but paradoxically worsen 
the problem in the case of long-lasting pain. Specifically, continuous avoidance of 
activities and/or certain movements may result in disability (problems executing 
daily life tasks and activities), altered central processing (preventing or reversing 
some of the more subtle, higher central changes associated with the pain syn-
drome), neglect (Galer & Jensen, 1999; Moseley et al., 2004), motor abnormalities 
(e.g. weakness, muscle spasm, lack of coordination, dystonia: Galer & Jensen, 1999; 
Jänig & Baron, 2004) and depressed mood, which in turn may perpetuate the pain 
problem. 
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Although changes in cognitive factors (fear-avoidance beliefs, catastrophizing) are 
not always found to be significantly associated with changes in pain intensity (Woby 
et al., 2004), their relationship with disability has been repeatedly shown. Crombez 
et al. (2002) showed that patients scoring high on pain-related fear over-predict the 
intensity of pain they will experience during physical examinations. In addition, 
compared to patients who report low levels of pain-related fear, fearful patients 
perform poorly on physical tasks (Vlaeyen et al., 1995). For low back pain patients, 
pain-related fear is a risk factor for the development of chronic low back pain 
through diminished participation in activities of daily life, greater perceived disabil-
ity, greater work loss, and more frequent sick leave (Leeuw, Goossens, Linton, et al., 
2007a), as well as poorer treatment performance (Asmundson, Norton, & Norton, 
1999). Furthermore, pain-related fear is a maintaining factor of pain-related disabil-
ity due to its associations with escape/avoidance behavior already during the acute 
pain phase. Several prospective studies have demonstrated that fear avoidance 
beliefs influence the transition to chronic low back pain and associated outcomes, 
such as disability and sick leave (Waddell, 2004). 
 
Most evidence concerning the validity of the fear avoidance model stems from 
cross-sectional studies, making it impossible to determine whether pain catastro-
phizing leads to poorer adjustment or vice versa (Keefe et al., 2004). However, using 
a cross-lagged correlational panel design, Burns et al. (2003) showed that early-
treatment reductions in pain catastrophizing and pain-related anxiety predicted 
late-treatment changes in pain severity, disability, and distress. Further, by the use 
of structural equation modelling, Goubert et al. (2004) showed that pain catastro-
phizing led to increased fear of movement, consequently leading to increased vigi-
lance to pain and, finally, increased pain severity. In addition, using the same model, 
Cook et al. (2006) replicated the mediating role of pain-related fear between catas-
trophizing and pain severity. Further, Leeuw et al. (2007a) performed a large-scale 
population-based prospective study. Within a sample of low back pain patients 
these authors were not able to show that pain-related fear mediated the relation-
ship between pain catastrophizing and functional disability as pain catastrophizing 
and disability were not related. However, pain catastrophizing was related to a 
measure of pain-related fear that patients completed six months later. In turn, pain-
related fear predicted pain intensity and disability. Finally, Nieto et al. (2008) tested 
in sub-acute whiplash patients whether fear of movement is a mediator in the rela-
tion between catastrophizing and pain-related disability/depression as has been 
suggested by the fear-avoidance model. After controlling for descriptive variables 
and pain characteristics, pain catastrophizing and fear of movement were found to 
be predictors of disability and depression. Pain intensity was a predictor of disability 
but not of depression. The mediation effect of fear of movement in the relation-
 15 
ships between catastrophizing and disability, and between catastrophizing and 
depression was also supported. The authors concluded that the results of this study 
are in accordance with the fear-avoidance model, and support a biopsychosocial 
perspective for whiplash disorders. 
Fear learning: Classical conditioning 
Classical or Pavlovian conditioning has traditionally been considered as model for 
the acquisition of pathological states of fear and anxiety. Anxiety disorders are con-
sidered having their origins in the acquired linking of an originally neutral stimulus 
with a biological relevant and threatening stimulus or situation. Unfortunately, 
there has been little research into the role of classical conditioning in the develop-
ment of pain-related fear. However, it is likely that during an acute pain episode 
severe pain or another physical sensations as a sign of injury (unconditioned stimu-
lus: US) and a harmless activity or movement (conditioned stimulus: CS) are causally 
associated. The result of this learning process is propositional knowledge about the 
relationship between the two stimuli (the movement with the increased pain as sign 
for injury) is stored in memory. In later phases, when the subject is exposed to the 
same kind of movement, the movement will activate the association with the in-
creased pain, resulting in the elicitation of a conditioned response (CR). Even more 
than evoking a memory, this process results in a movement activating the active 
expectation of a threatening event. Because of its repeating (contingent) occur-
rence, the movement has also become a good predictor of the increased pain as 
sign for injury: ‘When I lift up my four-year-old child, increase pain will follow which 
is a sign of irreparable damage of the intervertebral discs’ and ‘When I don’t lift up 
my four-year-old child, pain will not increase, which means that the intervertebral 
discs will not be frayed’. The subject not only links two events (associative learning) 
but also learns that one event predicts another (expectancy learning). This expec-
tancy learning will lead to the generalization of fear towards activities, movements 
and/or situations somewhat similar to the harmless movement that provoked 
and/or increased the pain. This new and threatening meaning of the originally neu-
tral movement will change the subject’s behavior. More and more activities, move-
ments and/or situations are avoided. 
 
Pain-related fear can develop in at least three different ways: direct experiences 
(e.g., a specific movement increases the pain or the swelling of the limb used); ver-
bal information (e.g., a doctor indicates that arthrosis or an injury is involved); or 
observing others (e.g., a friend sitting in a wheel chair because of the same pain 
complaints or being unable to work). The way in which this association has come 
about is not important, since the outcome is always the same: an originally neutral 
stimulus provokes a pain-related fear because this stimulus was earlier causally 
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associated with an aversive stimulus. Although fear conditioning is generally an 
adaptive and self-preserving form of learning, such conditioning may become a 
source of pathology when prolonged protective responses are elicited by an extend-
ing number of CSs in the absence of a US. 
The extinction of pain-related fear 
Based on the aforementioned findings one may conclude that pain-related fear 
could be an important target for intervention in pain syndromes. It is not clear 
whether fearful patients can benefit optimally from traditional health care. For 
example, regardless of the treatment message, fearful patients may sustain their 
avoidance behavior when the disadvantageous consequences of avoidance behavior 
are neither explicitly addressed, nor managed. Especially in traditional health care, 
in which pain is approached from a more biomedical orientation, the message that 
activity is beneficial is often accompanied by a note of caution, certainly when the 
pain increases. Consequently, it is not surprising if fearful patients may respond with 
more avoidance and safety behaviors to these biomedical treatments. One of the 
questions is how these treatments have been delivered, and whether pain-related 
fear and the associated safety behaviors were adequately addressed (Leeuw et al., 
2007a). 
In line with the idea of matching treatment to specific treatment characteristics 
(Vlaeyen & Morley, 2005) several cognitive behavioral programs, comprising various 
treatment techniques directed at changing cognitions and improving behavioral 
participation in activities, have currently been developed (see Leeuw et al., 2007a). 
The results of these treatments suggest that such programs, and even brief educa-
tional sessions, can effectively decrease functional disability, which might be due to 
reducing fear-avoidance beliefs and catastrophically thoughts about pain-related 
stimuli. Pain-related fear might therefore be an essential target for successful inter-
ventions, and it can be suggested that methodically addressing and diminishing 
pain-related fear might even been more powerful. An example of a treatment that 
is designed for those reporting high levels of fear is exposure. Therefore, it may be 
the most suitable treatment to achieve the most significant reduction of pain-
related fear. 
Summary 
In sum, there is accumulating support for the role of pain-related fear as explana-
tion of why patients experience acute pain develops chronic pain problems and 
associated disability. Pain-related fear is associated with catastrophic 
(mis)interpretations of pain, hyper-vigilance, increased escape and avoidance be-
haviors, as well as intensified pain experience and functional disability, central 
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change, motor abnormalities and depression. Exposure seems to be a suitable 
treatment. 
Exposure therapy 
One of the most effective strategies for treating anxiety disorders undoubtedly is 
exposure therapy with or without cognitive strategies and pharmacotherapy (e.g. 
Barlow, 2002). Exposure therapy is rooted in behaviorism and learning theories. In 
particular, Mowrer (1939) was one of the first who hypothesized that fears are 
acquired through repeated presentations of a neutral stimulus (conditioned stimu-
lus: CS) and a pain-producing or fear-eliciting stimulus (unconditioned stimulus: US). 
In a series of rat studies he observed that the strength of the fear response is de-
termined by the number of repetitions of association between the CS and US, and 
the intensity of the unconditioned response. Further, Mowrer (1939) also gave the 
initial impetus to exposure therapy in humans. He noted that the repeated presen-
tation of the CS in the absence of the US leads to extinction, the gradual decrease of 
the conditioned response. Currently, exposure is seen as the process in which the 
patient is repeatedly exposed for prolonged periods to a feared object or situation 
in the company of a supported therapist and in the absence of aversive conse-
quences; also named extinction training (e.g. Bouton et al., 2001; Davis et al., 2006; 
Quirk, 2006). Extinction is a well-known and important behavioral process that al-
lows the organism to adapt its behavior to a changing environment. Animal research 
suggests that extinction is a form of acquired inhibition that suppresses a fear re-
sponse and that extinguished conditioned responses can be recovered (e.g. Bouton, 
2002; 2004; Rescorla, 2001). Examples of such conditions are the mere passage of 
time (spontaneous recovery) (e.g. Rescorla, 2004), context change after extinction 
(renewal) (e.g. Bouton & Ricker, 1994), or the presentation of postextinction US-
only trials (reinstatement) (e.g. Rescorla & Herth, 1975). These phenomena support 
the view that extinction is not simply unlearning or forgetting but rather a new form 
of learning that changes the CS-US contingency in such a way that the CS no longer 
signals an aversive event and thereby inhibits the expression of the fear response 
(e.g. Bouton, 1993; 2004; Myers & Davis, 2002; Rescorla, 1996; 2001). Given the 
often highly specialized functions of specific brain regions and the cognitive system 
of humans that is capable of a symbolic and propositional analysis of conditioning 
experiences (see De Houwer et al., 2005), there are no a priori reasons to assume 
that similar processes are not involved in extinction in humans. 
 
Knowledge about the conditions that facilitate or hamper extinction learning may 
help to sharpen exposure treatments in such a way that treatment outcome can be 
maximized in the short run (therapy efficacy) as well as in the long run (relapse 
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prevention). Hence, before describing graded exposure in vivo as therapy for pain-
related fear, the most important findings from human fear extinction are reviewed 
briefly. The focus will be on the extinction principles to exposure therapy protocols 
in clinical groups with established fears. 
Extinction procedures in human phobic samples 
With regard to animal studies and laboratory studies in humans the experimental 
investigation of extinction procedures in human phobic samples is immediately 
disadvantaged by starting from the stage of fear reduction rather than fear acquisi-
tion. This means that the circumstances of acquisition are often unknown and there 
is usually no opportunity to test the original context. Nevertheless, experimental 
clinical studies are of great importance because of their potential relevance for 
enhancing treatments for anxiety disorders. Moreover, replicable effects have been 
observed. 
Safety signals and protection from extinction 
Consistent with the idea that avoidance responses may share some functional prop-
erties with Pavlovian safety signals (see Mineka & Henderson, 1985), Salkovskis et 
al. (1991) have provided evidence that ‘within-situation safety behaviors’, equiva-
lent to avoidance responses, interfere with the benefits of exposure therapy. Spe-
cifically, these authors showed that teaching anxious clients to refrain from these 
behaviors leads to greater fear reduction after an exposure session. They argued 
that clients attribute the absence of harm to their safety behaviors, rather than 
reducing their appraisal of the threatening stimulus. An alternative interpretation of 
these results derives from a protection from extinction perspective. Exposure to a 
phobic stimulus while using safety signals (avoidance responses or conditioned 
inhibitors) partially protects the phobic stimulus from extinction. 
Contextual effects on return of fear 
The majority of research has focused on context renewal effects, wherein contexts 
associated with successful exposure treatment are assumed to activate non-fearful 
memories and non-treatment contexts are assumed to elicit fearful memories and 
return of fear. Using graduated exposure therapy with live spiders by means of 
participant modeling in individuals who are highly fearful of spiders, context re-
newal effects have been observed when participants are retested 1 to 2 weeks later 
in a context that differs from the treatment context (e.g. Mineka et al., 1999). The 
effects became stronger with more distinctly different contexts and with various 
other improvements to methodology (Mystkowski et al., 2002). Context-based re-
newal also has been demonstrated via use of videotape exposure to a spider in a 
specific location of a house (Vansteenwegen et al., 2007). Not only did videotaped 
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exposure lead to decreased electrodermal responding and disgust ratings compared 
with the control group (single context exposure), but both indices subsequently 
increased when tested with a videotape showing the same spider in a new context 
(e.g. a location in the house that was not previously seen) relative to the original 
exposure context. 
Evidence for internal context specificity of extinction was demonstrated in a study 
of Mystkowski et al. (2003) in which drug state through caffeine versus placebo 
ingestion for individuals fearful of spiders was manipulated. Participants received 
one session of exposure therapy under the influence of a randomly chosen drug 
condition (placebo or caffeine) and were reassessed one week later after ingesting a 
drink mixture that was either the same or different than the drink ingested during 
the previous treatment session. The results showed that participants experiencing 
incongruent drug states exhibited significantly greater self-reported return of fear, 
measured during a behavioral approach task, from post-treatment to follow-up than 
those participants experiencing congruent drug states. Remarkable, the effects 
were comparable whether the shift was from caffeine to placebo or vice versa. 
However, the effect sizes were smaller than those achieved via the inside/outside 
context shifts. 
An obvious implication of the above mentioned studies on the effects of contextual 
change on enhancing return of fear seems to be to apply exposure therapy in multi-
ple contexts so that extinction memories can be cued by multiple contexts. 
Reinstatement effects 
Follow-up studies of exposure often report return of fear. Models of classical condi-
tioning often focus on reinstatement as an explanation of relapse. Reinstatement is 
the return of avoidance, escape or safety-seeking behavior (conditioned responses) 
to a previously extinguished CS as a result of the confrontation with an unpredicted 
US-presentation. The US-only presentation reactivates the memorized CS-US asso-
ciation that is still present after successful exposure. Reinstatement studies in hu-
mans are rare and as far as known only documented in three experimental labora-
tory studies. The first two studies of Dirikx et al. (2004) and Hermans et al. (2005), in 
which a series of differential fear conditioning experiments were conducted, sho-
wed whenever CSs were tested after reinstatement there was a selective partial 
return of US-expectancy for the CS+ in a reinstatement group. In addition, selective 
reinstatement was observed in fear ratings as well. Van Damme et al. (2004), who 
used an emotional modification of a spatial cueing paradigm, demonstrated also 
successful reinstatement of attentional bias, resulting in facilitated engagement to 
threat signals, and in retarded disengagement from threat signals. Because one or a 
few unpredicted US experiences were capable of reinstalling conditioned responses, 
these authors assumed that this finding implicates that extinction does not result in 
simple unlearning of the association between a CS+ and a US. Further, the findings 
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of this third study indicate that reinstatement is not limited to expectancy and 
arousal, but also extends to attentional processing. Finally, the study showed that 
attentional bias to threat can be extinguished by CS+ presentations without US 
reinforcement, suggesting that exposure may be an effective intervention to reduce 
hypervigilance as well. However, it should be mentioned that a simple reappearance 
of the object of threat may be sufficient to reinstate biased attentional processing 
of signals previously predicting threat. Contrary, clinical anecdotes about return of 
fear (Jacobs & Nadel, 1985) and also theoretical accounts of classical condition 
(Wagner & Brandon, 1989) indicate that an identical US-only experience is not nee-
ded to have reinstatement effects. Van Damme et al. (2004) suggested that it may 
be sufficient that the new US has similar affective attributes as the previous one. 
 
A clinical example of reinstatement in relation to pain-related fear is when someone 
develops pain-related fear after experiencing a shooting pain in the lower back 
during his work. After a successful exposure treatment, this person has enough 
confidence to return to work. A few months after treatment, however, the person 
experiences a shooting pain in the lower back while playing with his/her children. 
This shooting pain could lead to a re-emergence of the expectancy of a shooting 
pain at work. The finding of reinstatement is intriguing, and has potential implica-
tions for pain-related fear. The example shows that exposure does not result in 
unlearning of the association between a US (pain) and a CS (activity), as one unpre-
dicted shooting pain experience in the lower back is capable of reinstalling condi-
tioned responses (e.g. avoiding work). It seems likely that pain-related fear can be 
easily reactivated. To clarify the specific mechanisms of and the situations in which 
reinstatement can occur, more research into pain-related fear is needed. For exam-
ple, clinical experiences about return of pain-related fear, shows that an identical 
pain experience is not needed to have reinstatement effects. Van Damme et al. 
(2006) suggested that US experiences do not need to share sensory characteristics, 
but that it may be sufficient that they have the same affective attributes. Further-
more, it is also important that experimental and clinical research focuses on preven-
tion of reinstatement in order to further increase the effectivity of exposure ther-
apy. 
Cognitive processes in exposure therapy 
In cognitive therapy, dysfunctional beliefs about the dangerousness of the feared 
stimulus are assumed to play a crucial role in the maintenance and development of 
the fear response (e.g. Beck & Emery, 1985; Clark, 1989; Salkovskis & Clark, 1991; 
Hofmann, 2007). During treatment, the patient is provided with an opportunity to 
challenge these beliefs by rejecting hypotheses by exposing himself to situations 
that are likely associated with the expected harmful consequences. The fact that the 
 21 
patient is encouraged to re-evaluate harm expectancy appears to be the commonal-
ity between extinction learning and exposure therapy. 
 
For a variety of chronic pain problems cognitive-behavioral therapies (CBT) have 
been demonstrated to be effective (e.g. Spinhoven et al., 2004; Smeets et al., 2006; 
Turner et al., 2007). In these studies changes in patient-related beliefs (e.g. catas-
trophic misinterpretation of increased pain) were shown to mediate the effects of 
CBT. Although cognitive-behavioral treatments share certain fundamental charac-
teristics, they vary in goals and techniques (Jensen et al., 2001). Empirical evidence 
suggests that exposure procedures without explicit cognitive intervention strategies 
have very similar effects than comprehensive cognitive-behavioral treatments (e.g. 
Hofmann, 2004). Moreover, it has been shown that that treatment changes during 
exposure therapy are also mediated via changes in patient-related beliefs (Hof-
mann, 2004). These results are consistent with previous studies suggesting that 
simple exposure procedures lead to significant improvements in negative self-
perception (Hofmann, 2000) and negative beliefs about social interactions (New-
man et al., 1994). 
 
By using exposure in vivo or behavioral experiments Arntz et al. (1994) investigated 
in anxiety patients the overprediction of anxiety phenomenon and its relationship 
with fear, dysfunctional beliefs, and emotional experiences during confrontations 
with feared stimuli. Independent of the executed treatment the study showed, 
clearly ad odds with the cognitive views, that expectations of anxiety have an addi-
tional influence on fear to that of dysfunctional beliefs. According to these authors 
it appears that the influence of change in dysfunctional beliefs on change in fear is 
exerted only via the change in anxiety prediction. This indicates that reduction of 
dysfunctional beliefs have an independent influence on reduction of fear. Further, 
Arntz et al. (1994) found strong evidence for the view that experienced unpleasant-
ness of the (potentially) disconfirmatory experience negatively influences reduction 
of fear. 
Summary 
Exposure is seen as the process in which the patient is repeatedly exposed for pro-
longed periods to a feared object or situation and hence in the absence of aversive 
consequences; also named extinction. As a procedure, extinction refers to the re-
peated presentation of a CS in the absence of the US with which it was previously 
paired. Studies of fear extinction in human samples support the view that that ex-
tinction does not entail unlearning and that the addition of context changes and one 
or a few unpredicted US experiences after extinction can lead to a partial recovery 
of the apparently extinguished fear responses. The work on extinction in multiple 
 22 
contexts and use of reminder cues seems to be important in this respect. Further-
more, it appears that exposure therapy involves cognitive processes that influence 
dysfunctional beliefs. 
Graded exposure in vivo in chronic pain 
Because of many remarkable similarities between pain-related fear and fear in gen-
eral, a graded exposure in vivo treatment protocol (GEXP) is developed for applica-
tion in fearful pain patients. By the use of studies with replicated single-case ex-
perimental methodology Vlaeyen et al. (2001, 2002a, 2002b) were the first who 
illustrated that GEXP is a promising treatment in fearful chronic back pain patients. 
Hereafter, more single-case studies and randomized clinical trials have examined 
the effectiveness of exposure in vivo in (sub) acute and chronic low back pain pa-
tients. Besides effectiveness also generalization of exposure in chronic low back 
pain patients is investigated. Before reviewing the outcome studies on exposure in 
vivo for reducing pain-related fear and examining generalization, the clinical appli-
cation of GEXP as developed by Vlaeyen and colleagues is described first. 
Clinical application 
The GEXP that was developed for patients with chronic pain who report substantial 
pain-related fear, and fear of movement/(re)injury in particular, is highly structured, 
protocolized, individually tailored, and aim to restore a normal pattern of daily func-
tion, including complete return to work (see Vlaeyen et al. 2002c, 2004). Due to 
gradual and repeated encounters with feared activities, the goal of GEXP is to pro-
vide patients with the most convincing evidence that expected detrimental conse-
quences of these feared activities are in fact a catastrophic overestimation. Pain 
reduction and decrease of observed and reported physiological signs, such as ede-
ma, changes in skin blood flow or abnormal motor and sudomotor activity is not the 
primary goal. Usually, a therapist team consisting of a behavioral therapist and a 
paramedic (occupational therapist or physiotherapist) both experienced in the cog-
nitive-behavioral rehabilitation of patients with chronic pain provides GEXP. Appro-
priate instruments to indicate the presence of pain-related fear are for example the 
Tampa Scale for Kinesiophobia (TSK: Miller et al., 1991) and the Photograph-series 
Of Daily Activities (PHODA: Dubbers et al., 2003; Jelinek et al., 2003; Kugler et al, 
1999; Leeuw et al., 2007a). Following the suggestions of Philips (1987), who was the 
first suggesting to gradually expose pain patients to activities they feared and avoid 
during long time due to the belief that these cause damage and/or (re)injury, GEXP 
consists of several components: behavioral analysis, goal identification, education, 
graded hierarchies, exposure in vivo, and generalization. 
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Behavioral analysis 
The GEXP starts with an intake by the psychologist or behavioral therapist. The aim 
is to complete a behavioral, cognitive and psycho-physiological analysis of the pain 
problem with special attention to patient’s catastrophic interpretations and to as-
sess the role of pain-related fear in the context of the pain problem. It also includes 
information about the antecedents (situational or internal) of the pain-related fear 
and about the direct and indirect consequences. This screening might also include 
other areas of life stress, as they might increase arousal levels and indirectly also 
fuel pain-related fear. Phobic thoughts are often formed as conditional assump-
tions: ‘If P, then Q’ (P is the predictor and Q is the consequence): “I’m in pain so 
there must be something harmful happening to my body”, Further, because pa-
tients do not see their complaints as a fear problem, the term harmfulness can bet-
ter be used in the communication about there avoidance of physical activity. Some-
times, patients find it also hard to really estimate the harmfulness of a particular 
activity when they have avoided it extensively. In such cases, behavioral tests can be 
introduced. Finally, patients seem to search their conviction with regard to the sen-
sitivity for (re)injury in the results of diagnostics tests. Therefore, it is preferable to 
have these tests available. 
Goal identification 
Besides the behavioral analysis, patients are also invited to formulate their own 
treatment goals. Chronic pain or frequent recurrent episodic pain may have any 
profound effects on a patient’s life. The repeated interference with tasks that are 
essential to achieving various life goals and maintaining a patient’s role in society 
will impact on their sense of self, both their current self and perhaps more impor-
tantly their plans and ideas about who they might become (Morley, 2008). Patients 
may experience a sense of ‘suspended identity’ in which they consider that the real 
them is suspended at an earlier time point, usually before the onset of chronicity 
(Risdon et al., 2003). One implication of this is that they use this point of time as a 
reference for setting goals of recovery (Morley, 2008). As a consequence of this the 
therapist makes clear that GEXP does not primarily aim at reducing pain but at the 
restoration of functional abilities through which patients’ capacity to live according 
to their life values can be restored. Subsequently, the patient and therapist agree 
on one or more realistic and specific goals that are formulated in positive terms. 
Activities (e.g. lifting weights) that are in line with these goals (e.g. return to work) 
are those that will be included in GEXP. 
Education 
An educational session is provided by the therapist team explaining the treatment 
rationale. Patients are given a careful explanation of the fear-avoidance model 
(Vlaeyen et al., 1995) using their own individual symptoms, beliefs and behaviors in 
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relation to their pain complaints. The therapist team illustrates the paradoxical and 
dysfunctional effects of avoidance as safety behavior, and offers the patient a new 
view on pain as a common condition that can be self-managed, rather than as a 
serious disease or a condition that needs careful protection. One of the major goals 
of the educational component is to help the patient understand that the conse-
quences of pain are catastrophically overestimated. 
Graded hierarchies 
Direct after the explanation of the treatment rationale a hierarchy of fear-eliciting 
activities are made using the Photograph-series Of Daily Activities (PHODA; Leeuw 
et al. 2007b). This is a standardised method during which patients are requested to 
judge the harmfulness of diverse physical daily life activities represented by photo-
graphs. Using a (fear) thermometer, each picture is given a rating between zero 
(representing the situation which is not harmful for the upper extremity) to 100 
(representing the situation which is absolutely damaging the upper extremity). Ba-
sed on the graded hierarchy of the PHODA individually tailored practice tasks can be 
developed. 
Exposure in vivo 
Subsequently, during the next sessions patients are gradually and systematically 
exposed to the tailored and fear-provoking activities. During each exposure session 
patients are encouraged to engage in these fearful activities as much as possible 
until disconfirmation has occurred and anxiety levels have decreased. To demon-
strate that the concerning activity is harmless and not extraordinary it is modelled 
first by one member of the therapist team. The exposure has the form of a series of 
behavioral experiments in which dysfunctional beliefs are explicitly being chal-
lenged. The essence of the behavioral experiment is that the patient performs an 
activity to challenge the validity of his catastrophic assumptions and misinterpreta-
tions. These assumptions take the form of “If . . . , then . . .” statements (e.g. “If I lift 
up my child, then pain increases which is a sign of nerve rupture and my muscles 
will get blocked”) and are empirically tested during a behavioral experiment. Be-
sides the dysfunctional proposition, a realistic alternative belief is formulated. Be-
fore and after each exposure trial, then credibility of both propositions is rated on a 
0 to 100 numerical rating scale. For example, a back pain patient may expect that 
jumping down from a stair will inevitably cause nerve damage and results in an 
acute paralysis of the legs [credibility = 75%]. Alternatively, the patient might expect 
that after jumping down, he or she will be able to continue walking without any 
problem [credibility = 25%]. The behavioral experiment is designed and described as 
specific and concrete as possible. For example, if the patient is convinced that jump-
ing down is harmful, the therapist team can further inquire about the minimal 
height that is needed to cause nerve injury. Before the experiment is carried out the 
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therapist team asked the patient what he expects will happen during the experi-
ment whenever the original and alternative belief is true. Afterwards the patient is 
requested to reflect on what he did learn from the experience. If subjective distress 
is significantly decreased, the patient and therapist team can consider moving on to 
the next item of the fear hierarchy. In order to facilitate independence and to pro-
mote more exposures, the therapists gradually withdraw their presence, as they 
may serve as initial safety signals. 
Effectiveness of graded exposure in vivo 
In the past years, the effectiveness of exposure in vivo has only been examined in 
studies with back pain patients. A summary of the outcome studies reviewed is 
presented in Table 2 and 3. First, studies using single-case designs will be discussed 
followed by a discussion of randomized clinical trials. 
Single-case studies 
In two studies of Vlaeyen et al. (2001, 2002a), a replicated single-case cross-over 
design was applied with four and six chronic back pain patients respectively. After a 
no-treatment baseline measurement period, the patients were randomly assigned 
to either GEXP first followed by an operant graded activity program (GA) or to a 
situation in which the treatment modules were reversed. GEXP as well as GA were 
imbedded in a rehabilitation program. Daily measures of pain-related cognitions, 
fears and disabilities were recorded with visual analogue scales. Before and after 
each treatment and at 6-month follow-up standardized measures of pain-related 
fear, pain catastrophizing, pain control and pain disability were taken. The results 
provided preliminary evidence showing that GEXP, compared with GA, was superior 
in decreasing pain-related cognitions and fears, pain control and pain disability. Not 
only were improvements found on self-report measures, but GEXP also generalized 
to increas of daily life activities as measured with ambulatory activity monitors. 
Although GEXP was provided during a period of 4 weeks, the reduction of pain-
related fear was achieved within fewer than 3 exposure sessions of 1 hour. In these 
studies, the presentation of the rationale at the start of GEXP might have contrib-
uted to these abrupt changes. The third study of Vlaeyen et al. (2002b) revealed 
similar effects in two low back pain patients. In this study GEXP was delivered as the 
only treatment, and without a background rehabilitation program, which seems to 
suggest that it is GEXP that is responsible for the success. Without using ambulatory 
activity monitors Linton et al. (2002) replicated the results of Vlaeyen et al. (2001, 
2002a, 2002b) in a primary care facility of which two low back pain patients were 
recruited via a general practitioner. 
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Finally, the external validity of the exposure treatment is also supported by a study 
of Boersma et al. (2004). A multiple baseline design was employed with six back 
pain patients who filled out daily and weekly measures during a 10-week period. 
The results demonstrated clear decreases in pain-rated fear and avoidance beliefs 
while function increased substantially. In contrast to the previous studies the im-
provements were not as large and changes did not occur as rapidly. The authors 
suggest that this could be due the relative inexperience of the current therapist 
team and the assessment methods used. Furthermore, there were no follow-up 
data by which the authors were unable to pronounce generalization effects. 
Randomized clinical trials 
Besides the above mentioned single-case studies also three randomized controlled 
trials (RCT) have corroborated the effectiveness of exposure in vivo for chronic low 
back pain patients. Linton et al. (2008) evaluated the effects of exposure in vivo in 
46 patients who were randomized into an exposure plus usual treatment or waiting 
list control plus usual treatment (contact with a general practitioner, analgesics, and 
physical therapy). A particular feature of this study was that the exposure was ai-
med at fear of work-related activities. After the waiting period the control group 
crossed over and received the exposure treatment. The exposure group demon-
strated a significantly larger improvement on function. Overall exposure had mod-
erate effects on function, fear and pain intensity. However, according to the authors 
the results are quite valuable since they address generalization to a larger sample 
and since patients have been randomized thus reducing the obvious risk of patient 
selection in case studies. 
 
Woods & Asmundson (2008) randomized 46 patients to graded exposure in vivo, 
graded activity, or a wait-list condition. Despite the lack of a statistically significant 
improvement in daily functioning, patients who were randomized to the exposure 
group demonstrated also improvements in fear, both statistically and clinically, 
when compared to graded activity and the wait-list control condition. According to 
these authors the success of the exposure treatment can in particular be explained 
by the combination of the education component (illustration and explanation of the 
fear-avoidance model), the successful performance of graded exposure tasks, re-
sumption of enjoyable activities, and increased comfort with and independence 
when performing tasks. This, in turn may have contributed to increasing the likeli-
hood that treatment gains would be maintained. 
 
Finally, Leeuw et al. (2008) examined the effectiveness as well as specific mediating 
mechanisms of GEXP versus operant graded activity (OGA) in 85 patients with chro-
nic low back pain. Contrary to the study of Linton et al (2008) it was demonstrated 
that GEXP, despite excelling in diminishing pain catastrophizing and perceived harm-
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fulness of activities, was equally effective as OGA in improving functional disability 
and main complaints directly and six months after treatment, although the group 
difference almost reached statistical significance favouring GEXP. Although this 
study may suffer from a lack of statistical power, the authors discussed some other 
possible explanations for these findings. First, it was suggested that OGA and GEXP 
share components that may have strong therapeutic effects. Foremost, OGA may 
have included some form of exposure in vivo, since patients performed various 
activities, including those that were fear eliciting. In addition, OGA also included the 
explicit assurance that all activities were safe and allowed, as was communicated 
during the educational session, which may have resulted in modifications of patient 
pain-related beliefs. Finally, because therapists participated in both treatment con-
ditions and therefore also were trained in GEXP, their attitude towards activities 
may have changed accordingly in the sense that they were less careful and worried 
about possible activity restrictions for their patients (Coudeyre et al., 2006). Second, 
OGA consisted of more treatment sessions than GEXP, and patients selected and 
performed activities that were of high importance during GA, whereas patients had 
to perform activities that were selected based on their threat value during GEXP. 
Furthermore, since the therapists were already accustomed to carrying out OGA, 
and had no experience with GEXP, it may be that specific treatment competence 
was superior in OGA. Fourth, outcome studies on psychotherapy showed that spe-
cific treatment ingredients only contribute marginally and that common treatment 
factors, such as therapeutic competence or patient’s and therapist’s belief, mainly 
explain the outcome (e.g. Wampold, 2000). The fact that in the study of Leeuw et al. 
(2008) GEXP and OGA may have shared more common features than that they 
comprised unique treatment ingredients might explain the borderline significant 
differences in reducing disability levels between GEXP and OGA. Despite decreased 
pain-related fear the patients in this study still reported pain after GEXP which also 
may contribute to the experience of discomfort in daily life. The latter is different 
from the single-case studies in which the daily measures showed that during GEXP a 
reduction in pain-related fear was followed by a decrease in pain experience. 
Generalization of exposure in vivo 
As already mentioned in greater detail, there is growing evidence that exposure 
cannot simply be equated with unlearning. Studies demonstrated that a competi-
tion occurs between the original threatening (excitatory) meaning of the stimuli and 
a new (inhibitory) meaning. In other words, during successful exposure, exceptions 
to the rule are learned rather than a fundamental change of that rule. Using behav-
ioral tests several experimental studies investigated generalization of exposure to 
movements in chronic low back pain patients. Table 4 displays the most important 
characteristics and results of these studies. 
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ne
d 
un
ch
an
ge
d.
 A
 h
ig
h 
pa
in
 
ex
pe
ct
an
cy
 c
o-
oc
cu
rr
ed
 w
ith
 a
 m
ar
gi
na
lly
 si
gn
ifi
ca
nt
 
fe
ar
 o
f (
re
)in
ju
ry
, a
nd
 a
 si
gn
ifi
ca
nt
 lo
w
er
 p
ea
k 
to
rq
ue
 
of
 th
e 
kn
ee
 fl
ex
or
s.
 
Th
e 
au
th
or
s a
rg
ue
 th
at
 th
e 
re
su
lts
 c
on
cl
us
iv
el
y 
su
pp
or
t t
he
 
le
ar
ni
ng
 m
od
el
s w
hi
ch
 st
at
e 
th
at
 p
ai
n 
ex
pe
ct
an
ci
es
 a
re
 a
ss
oc
i-
at
ed
 w
ith
 a
 fe
ar
 re
sp
on
se
 a
nd
 a
n 
ur
ge
 to
 a
vo
id
 th
e 
pa
in
. T
he
 
un
fa
m
ili
ar
ity
 w
ith
 a
 p
ot
en
tia
lly
 b
ac
k 
st
re
ss
in
g 
ex
er
ci
se
, m
ak
es
 
ch
ro
ni
c 
lo
w
 b
ac
k 
pa
in
 p
at
ie
nt
s c
au
tio
us
 a
nd
 a
nx
io
us
: 1
) a
n 
in
cr
ea
se
 in
 p
ai
n 
in
te
ns
ity
 is
 a
nt
ic
ip
at
ed
, 2
) a
 h
ig
he
r f
ea
r o
f 
(r
e)
in
ju
rin
g 
th
ei
r b
ac
k 
is 
re
po
rt
ed
, a
nd
 3
) a
n 
av
oi
da
nc
e 
of
 a
 
m
ax
im
al
 p
er
fo
rm
an
ce
 is
 o
bs
er
ve
d.
 T
he
 te
st
, o
rig
in
al
ly
 d
e-
sig
ne
d 
to
 o
bj
ec
tiv
el
y 
m
ea
su
re
 p
hy
sic
al
 a
ct
iv
ity
, a
re
 p
ro
fo
un
dl
y 
co
nt
am
in
at
ed
 b
y 
th
e 
ef
fe
ct
s o
f p
ai
n 
an
tic
ip
at
io
n 
an
d 
fe
ar
 o
f 
(r
e)
in
ju
ry
.  
Cr
om
be
z e
t 
al
. (
20
02
) 
 P
at
ie
nt
s (
N
=3
7)
 e
xe
cu
te
d 
tw
o 
m
ov
em
en
ts
: b
en
di
ng
 fo
rw
ar
d 
w
hi
le
 st
an
di
ng
 a
nd
 li
ft
in
g 
1 
le
g 
w
hi
le
 ly
in
g 
do
w
n.
 
Th
e 
ba
se
lin
e 
pa
in
, 
ex
pe
ct
ed
 p
ai
n,
 a
nd
 
ex
pe
rie
nc
ed
 p
ai
n.
 
Si
m
ila
r r
at
in
gs
 fo
r 
pe
rc
ei
ve
d 
ha
rm
. 
In
iti
al
 o
ve
rp
re
di
ct
io
ns
 o
f p
ai
n 
w
er
e 
re
ad
ily
 c
or
re
ct
ed
 
w
he
n 
th
e 
sa
m
e 
m
ov
em
en
t w
as
 re
pe
at
ed
. T
he
 e
xp
o-
su
re
 e
ffe
ct
 d
id
 n
ot
 g
en
er
al
ize
 to
w
ar
d 
an
ot
he
r d
iss
im
i-
la
r m
ov
em
en
t. 
Th
es
e 
re
su
lts
 w
er
e 
on
ly
 c
ha
ra
ct
er
ist
ic
 
fo
r p
at
ie
nt
s w
ith
 c
at
as
tr
op
hi
c 
th
in
ki
ng
 a
bo
ut
 p
ai
n.
 
Lo
w
 c
at
as
tr
op
hi
ze
rs
 d
id
 n
ot
 o
ve
rp
re
di
ct
 p
ai
n.
 T
he
re
 
w
er
e 
no
 e
ffe
ct
s o
f e
xp
os
ur
e 
on
 p
er
ce
iv
ed
 h
ar
m
. 
Th
e 
re
su
lts
 su
gg
es
te
d 
th
at
 p
ai
n-
re
la
te
d 
fe
ar
 is
 n
ot
 a
 u
ni
ta
ry
 
co
ns
tr
uc
t a
nd
 p
ro
ba
bl
y 
en
co
m
pa
ss
es
 se
ve
ra
l p
ar
tly
 u
nr
el
at
ed
 
fo
rm
s p
ai
n-
re
la
te
d 
fe
ar
 (e
.g
. f
ea
r o
f p
ai
n,
 fe
ar
 o
f b
lo
od
, f
ea
r o
f 
[r
e]
in
ju
ry
, f
ea
r o
f f
la
re
-u
ps
, a
nd
 fe
ar
 o
f l
on
g-
te
rm
 c
on
se
-
qu
en
ce
s o
f p
ai
n)
. I
t i
s p
la
us
ib
le
 th
at
 g
en
er
al
iza
tio
n 
of
 e
xp
os
ur
e 
ef
fe
ct
s i
s f
ac
ili
ta
te
d 
on
ce
 p
at
ie
nt
s h
av
e 
be
en
 su
cc
es
sf
ul
ly
 
ex
po
se
d 
to
 e
ss
en
tia
l s
tim
ul
i. 
It 
se
em
s t
ha
t, 
in
 c
om
bi
na
tio
n 
w
ith
 e
xp
os
ur
e,
 c
og
ni
tiv
e 
te
ch
ni
qu
es
 su
ch
 a
s t
he
 e
lic
iti
ng
 o
f 
ne
ga
tiv
e 
th
ou
gh
ts
 a
nd
 th
e 
ex
pl
ic
it 
te
st
in
g 
of
 p
re
di
ct
io
ns
 c
on
-
ce
rn
in
g 
pa
in
 a
nd
 in
ju
ry
 is
 n
ec
es
sa
ry
 to
 d
ire
ct
ly
 c
ha
lle
ng
e 
th
e 
va
lid
ity
 o
f c
at
as
tr
op
hi
c 
as
su
m
pt
io
ns
 a
nd
 m
isi
nt
er
pr
et
at
io
ns
.  
Go
ub
er
t e
t 
al
. (
20
02
) 
Pa
tie
nt
s (
N
=3
9)
 p
er
fo
rm
ed
 
tw
o 
m
ov
em
en
ts
 tw
ic
e,
 b
en
d-
in
g 
fo
rw
ar
d 
an
d 
st
ra
ig
ht
 le
g 
ra
isi
ng
. 
Th
e 
ba
se
lin
e 
pa
in
, 
ex
pe
ct
ed
 p
ai
n 
an
d 
ex
pe
rie
nc
ed
 p
ai
n.
 
In
iti
al
 o
ve
rp
re
di
ct
io
ns
 o
f p
ai
n 
w
er
e 
re
ad
ily
 c
or
re
ct
ed
 
w
he
n 
th
e 
sa
m
e 
m
ov
em
en
t w
as
 re
pe
at
ed
. T
he
 e
xp
o-
su
re
 e
ffe
ct
 d
id
 n
ot
 g
en
er
al
ize
 to
w
ar
ds
 a
no
th
er
 d
is-
sim
ila
r m
ov
em
en
t. 
Th
es
e 
re
su
lts
 w
er
e 
on
ly
 c
ha
ra
ct
er
-
ist
ic
 fo
r p
at
ie
nt
s w
ith
 c
at
as
tr
op
hi
c 
th
in
ki
ng
 a
bo
ut
 
pa
in
. L
ow
 c
at
as
tr
op
hi
ze
rs
 d
id
 n
ot
 o
ve
rp
re
di
ct
 p
ai
n.
   
To
 in
cr
ea
se
 g
en
er
al
iza
bi
lit
y 
of
 e
xp
os
ur
e 
th
e 
au
th
or
s s
ug
ge
st
: 
1)
 c
on
du
ct
in
g 
ex
po
su
re
 th
er
ap
y 
in
 se
ve
ra
l d
iff
er
en
t c
on
te
xt
s,
 
su
ch
 a
s i
n 
a 
cl
in
ic
, i
n 
th
e 
ho
m
e 
sit
ua
tio
n,
 e
tc
., 
2)
 v
ar
yi
ng
 th
e 
st
im
ul
us
 b
y 
th
e 
us
e 
of
 se
ve
ra
l m
ov
em
en
ts
 d
ur
in
g 
ex
po
su
re
, 
an
d 
3)
 d
ist
rib
ut
in
g 
ex
po
su
re
 se
ss
io
ns
 ra
th
er
 w
id
el
y 
ov
er
 ti
m
e.
 
  
Be
ha
vi
or
al
 te
st
s 
M
ea
su
re
m
en
ts
 
Re
su
lts
 
Di
sc
us
sio
n 
Go
ub
er
t e
t 
al
. (
20
05
) 
Pa
tie
nt
s (
N
=8
4)
 p
er
fo
rm
ed
 
fo
ur
 b
eh
av
io
ra
l t
es
ts
 o
f w
hi
ch
 
th
e 
fin
al
 te
st
 w
as
 th
e 
sa
m
e 
fo
r 
al
l p
at
ie
nt
s.
  
Co
nd
iti
on
 I:
 th
re
e 
di
ffe
re
nt
 
m
ov
em
en
ts
. 
Co
nd
iti
on
 II
: t
hr
ee
 ti
m
es
 th
e 
sa
m
e 
m
ov
em
en
t. 
Fi
na
l t
es
t: 
tr
un
k 
ex
te
ns
io
n-
fle
xi
on
 te
st
 (C
yb
ex
 6
00
0 
sy
st
em
). 
O
th
er
 te
st
s:
 to
rs
o 
ro
ta
tio
n 
te
st
 (C
yb
ex
 3
50
 sy
st
em
), 
kn
ee
-e
xt
en
sio
n-
fle
xi
on
 te
st
 
(C
yb
ex
 3
50
 sy
st
em
), 
an
d 
Bi
er
in
g-
Sö
re
ns
en
1  t
es
t. 
 
Th
e 
ba
se
lin
e 
pa
in
, 
ex
pe
ct
ed
 p
ai
n 
an
d 
ex
pe
rie
nc
ed
 p
ai
n.
 T
he
 
pe
ak
 to
rq
ue
 a
nd
 th
e 
va
ria
bi
lit
y 
of
 th
e 
pr
o-
du
ce
d 
m
us
cl
e 
st
re
ng
th
 
du
rin
g 
th
e 
fin
al
 b
eh
av
-
io
ra
l t
es
t. 
Al
l p
at
ie
nt
s o
ve
rp
re
di
ct
ed
 p
ai
n 
du
rin
g 
th
e 
fin
al
 b
eh
av
-
io
ra
l t
es
t, 
in
cl
ud
in
g 
th
e 
pa
tie
nt
s f
or
 w
ho
m
 th
e 
fir
st
 
th
re
e 
be
ha
vi
or
al
 te
st
s c
on
sis
te
d 
of
 th
re
e 
di
ffe
re
nt
 
m
ov
em
en
ts
. N
o 
di
ffe
re
nc
es
 b
et
w
ee
n 
th
e 
tw
o 
co
nd
i-
tio
ns
 in
 p
ea
k 
to
rq
ue
 a
nd
 v
ar
ia
bi
lit
y 
in
 p
er
fo
rm
an
ce
 o
n 
th
e 
fin
al
 b
eh
av
io
ra
l t
es
t. 
Al
l p
at
ie
nt
s t
en
de
d 
to
 o
ve
r-
pr
ed
ic
t p
ai
n 
du
rin
g 
th
e 
fir
st
 th
re
e 
be
ha
vi
or
al
 te
st
s.
 
Hi
gh
 c
at
as
tr
op
hi
ze
rs
 sh
ow
ed
 m
or
e 
ov
er
pr
ed
ic
tio
ns
 o
f 
pa
in
 d
ur
in
g 
th
e 
fir
st
 th
re
e 
be
ha
vi
or
al
 te
st
s c
om
pa
re
d 
w
ith
 lo
w
 c
at
as
tr
op
hi
ze
rs
.  
Si
nc
e 
th
e 
m
ov
em
en
ts
 w
er
e 
no
t i
nd
iv
id
ua
lly
 se
le
ct
ed
, i
t c
an
 b
e 
as
su
m
ed
 th
at
 fo
r s
om
e 
pa
tie
nt
s t
he
 m
ov
em
en
ts
 w
er
e 
no
t 
th
re
at
en
in
g.
 T
o 
fa
ci
lit
at
e 
ge
ne
ra
liz
at
io
n,
 e
xp
os
ur
e 
th
er
ap
y 
sh
ou
ld
 c
on
sis
t o
f r
ep
ea
te
d 
ex
po
su
re
 to
 e
ss
en
tia
l a
nd
 in
di
vi
du
-
al
ly
 id
en
tif
ie
d 
st
im
ul
i. 
Ex
po
su
re
 to
 m
or
e 
th
an
 th
re
e 
di
ffe
re
nt
 
m
ov
em
en
ts
 m
ay
 b
e 
ne
ce
ss
ar
y 
to
 b
en
ef
it 
ge
ne
ra
liz
at
io
n.
 
Ex
po
su
re
 sh
ou
ld
 b
e 
su
pp
le
m
en
te
d 
w
ith
 c
og
ni
tiv
e 
te
ch
ni
qu
es
. 
Be
ha
vi
or
al
 te
st
s s
ho
ul
d 
be
 c
on
sis
ts
 o
f d
ai
ly
 li
fe
 a
ct
iv
iti
es
 th
at
 
ar
e 
co
nn
ec
te
d 
to
 li
fe
 g
oa
ls.
 P
ai
n 
m
ay
 n
ot
 h
av
e 
be
en
 th
e 
cr
uc
ia
l 
va
ria
bl
e,
 b
ut
 in
st
ea
d 
th
e 
po
ss
ib
ili
ty
 o
f (
re
)in
ju
ry
. F
ut
ur
e 
re
-
se
ar
ch
 sh
ou
ld
 in
cl
ud
e 
a 
fo
llo
w
-u
p 
as
se
ss
m
en
t, 
be
ca
us
e 
it 
is 
po
ss
ib
le
 th
at
 th
e 
be
ne
fit
s o
f e
xp
os
ur
e 
on
ly
 a
pp
ea
re
d 
af
te
r a
 
fe
w
 w
ee
ks
. 
Tr
os
t e
t a
l. 
(2
00
7)
 
Pa
tie
nt
s (
N
=6
0)
 p
er
fo
rm
ed
 
fo
ur
 a
da
pt
at
io
ns
 o
f a
 re
ac
hi
ng
 
ta
sk
, e
ac
h 
in
tr
od
uc
in
g 
an
 
el
em
en
t o
f i
nc
re
as
ed
 in
te
n-
sit
y.
  
Ex
pe
ct
ed
 a
nd
 e
xp
er
i-
en
ce
d 
pa
in
 a
nd
 h
ar
m
 
ra
tin
gs
 w
er
e 
co
lle
ct
ed
 
du
rin
g 
th
e 
tw
o 
tr
ia
ls 
co
m
pr
isi
ng
 e
ac
h 
m
ov
e-
m
en
t. 
 
Pa
tie
nt
s w
ith
 h
ig
h 
le
ve
ls 
of
 k
in
es
io
ph
ob
ia
 re
po
rt
ed
 
gr
ea
te
r p
ai
n 
an
d 
ha
rm
 ra
tin
gs
 d
ur
in
g 
th
e 
m
ov
em
en
ts
. 
Hi
gh
ly
 k
in
es
io
ph
ob
ic
 fe
m
al
e,
 b
ut
 n
ot
 m
al
e,
 p
at
ie
nt
s 
de
m
on
st
ra
te
d 
gr
ea
te
r o
ve
rp
re
di
ct
io
n 
of
 h
ar
m
 re
la
tiv
e 
to
 lo
w
 k
in
es
io
ph
ob
ic
 c
ou
nt
er
pa
rt
s d
ur
in
g 
th
e 
fir
st
 
re
ac
hi
ng
 tr
ia
l. 
Hi
gh
ly
 k
in
es
io
ph
ob
ic
 p
at
ie
nt
s s
ho
w
ed
 
su
cc
es
sf
ul
 g
en
er
al
iza
tio
n 
of
 p
ai
n 
ex
pe
ct
an
cy
 c
or
re
c-
tio
ns
 a
cr
os
s m
ov
em
en
t t
as
ks
.  
W
hi
le
 p
ai
n 
ov
er
pr
ed
ic
tio
n 
is 
co
nt
in
ua
lly
 p
re
se
nt
 o
n 
th
e 
fir
st
 
tr
ia
l, 
th
e 
m
ag
ni
tu
de
 o
f o
ve
rp
re
di
ct
io
n 
de
cl
in
es
 a
cr
os
s m
ov
e-
m
en
ts
. I
n 
co
nt
ra
st
 to
 C
ro
m
be
z e
t a
l. 
an
d 
Go
ub
er
t e
t a
l.,
 th
is 
st
ud
y 
in
cl
ud
ed
 g
ra
de
d 
ex
po
su
re
 e
le
m
en
ts
 b
y 
w
hi
ch
 a
 g
ra
du
al
 
ex
tin
ct
io
n 
of
 th
e 
ov
er
pr
ed
ic
tio
n 
re
sp
on
se
 is
 o
bs
er
ve
d.
 T
he
 
slo
w
 d
ec
lin
e 
in
 o
ve
rp
re
di
ct
io
n 
ob
se
rv
ed
 a
m
on
g 
ki
ne
sio
ph
ob
ic
 
pa
tie
nt
s d
ur
in
g 
a 
sin
gl
e 
re
ac
hi
ng
 m
ov
em
en
t c
an
 li
ke
w
ise
 
ill
um
in
at
e 
th
e 
ch
al
le
ng
e 
to
 g
en
er
al
iza
tio
n 
ac
ro
ss
 tw
o 
ra
di
ca
lly
 
di
ss
im
ila
r p
hy
sic
al
 ta
sk
s.
 In
 m
od
ify
in
g 
ra
tin
gs
 o
f o
ve
rp
re
di
ct
io
n 
am
on
g 
ch
ro
ni
c 
ba
ck
 p
ai
n 
pa
tie
nt
s a
dd
iti
on
al
 b
en
ef
it 
m
ay
 b
e 
ga
in
ed
 fr
om
 g
ra
de
d 
ex
po
su
re
 to
 v
ar
ia
tio
ns
 o
f a
 sp
ec
ifi
c 
fe
ar
ed
 
m
ov
em
en
t r
el
ev
an
t t
o 
ev
er
yd
ay
 ro
ut
in
e.
  
1 
M
ea
su
re
s h
ow
 m
an
y 
se
co
nd
s t
he
 p
at
ie
nt
 is
 a
bl
e 
to
 k
ee
p 
th
e 
un
su
pp
or
te
d 
up
pe
r p
ar
t o
f t
he
 b
od
y 
in
 a
 h
or
izo
nt
al
 p
os
iti
on
 (s
ee
 K
el
le
r e
t a
l.,
 2
00
1)
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By the use of four exercise bouts (two with each leg), each consisting of flexing and 
extending the knee three times at maximal force, Crombez et al. (1996) investigated 
whether pain expectancies cause pain. During each exercise bout the baseline pain, 
the expected pain and experienced pain were recorded. Patients also rated their 
experienced fear of further injury to the back. Although patients did expect a back 
pain increase during the first exercise bout with each leg, no evidence was found for 
the hypothesis that pain expectancies generate increases in subjective pain experi-
ences. Instead, the reported pain expectancy was readily corrected during the next 
exercise bout, whereas the experienced pain remained unchanged. This corrective 
experience generalized, but not completely, to the exercise bouts with the other 
leg. A small but significant increase in the pain expectancy re-emerged during the 
first exercise bout with the second leg. A sub-maximal performance was observed in 
parallel with these pain expectancies. Overall, the results suggest that the unfamili-
arity with a potentially back stressing exercise, makes chronic low back pain patients 
cautious and anxious. First, an increase in pain intensity was anticipated. Second, a 
marginally significant higher fear of injuring their back was reported. Finally, an 
avoidance of a maximal performance as indicated by the lesser peak force of the 
knee flexors, is observed. This pattern of results was present especially during the 
very first experience with the exercise. Bases on the results it seems that low back 
pain patients initially tend to over-predict how much pain they will experience, but 
after some exposures the predictions of pain intensity tend to match with the actual 
experience. 
 
Crombez et al. (2002) and Goubert et al. (2002) investigated whether the effects of 
exposure to one movement generalize towards another dissimilar movement. In 
both studies patients were requested to perform two movements twice, i.e. bend-
ing forward and straight leg raising. During each of the four trials baseline pain, 
expected pain and experienced pain were recorded. Similar ratings for perceived 
harm were obtained in the study of Crombez et al. (2002). In line with Crombez et 
al. (1996), analyses of both studies revealed that patients initially over-predicted 
pain, but after exposure the over-prediction was readily corrected. Thus, it seems 
reasonable to assume that avoidance behaviors of chronic back pain patients can be 
limited through defying the harm and danger beliefs about pain and the resulting 
inaccurate pain expectancies. Given the results it can be assumed that exposure 
could be an effective method to correct maladaptive beliefs about pain. However, 
of particular interest to the studies of Crombez et al. (2002) and Goubert et al. 
(2002) was that although patients readily corrected over-predictions of pain, this 
correction of over-prediction of pain did not extend across different movements. 
This means that generalization was not present. Another finding was that the pat-
tern of results was only characteristic for patients reporting a high frequency of 
catastrophic thinking about pain. Low catastrophizers did not over-predict pain. 
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Furthermore, the results of Crombez et al. (2002) seem to indicate that over-
predictions of harm were not corrected by exposure. 
One explanation of the lack of generalization in the above-mentioned studies might 
be that patients do not easily change their belief that many movements hurt or 
harm. Research has shown that such beliefs are widespread in the general popula-
tion (Goubert et al. 2004). Furthermore, conditioning research has shown that con-
ditioned fear may generalize well across contexts and stimuli, but fear extinction 
does not (e.g. Bouton & Swartzentruber, 1991). Thus, the belief that many move-
ments are harmful and painful when you have back pain may be confirmed through 
exposure to certain pain-provoking activities, which then easily generalizes to other 
movements. In contrast, extinction of pain-related fear and fear-avoidance beliefs 
may not easily generalize. Based on the findings that exposure will result in learning 
an exception of the rule, rather than in a fundamental change of the rule itself, it is 
thus reasonable to assume that exposure to physical activities and movements in 
patients with back pain will not result in a fundamental change of the belief that 
movements are painful and dangerous as predicted, but that other movements are 
still hazardous and painful. In their attempt to facilitate generalization of the effects 
of exposure Goubert et al. (2005) investigated the benefits of exposure to a variety 
of movements versus exposure to the same movements on over-prediction of pain 
and behavioral performance on a final behavioral test which was the same for all 
patients. In condition I the first three behavioral tests consisted of three different 
movements and of three times the same movement in condition II. Replicating and 
extending previous research, the results showed that patients over-predicted pain 
during a threatening behavioral test. Furthermore, pain-related fear and pain catas-
trophizing were unique predictors of the peak torque of the final behavioral test. 
The study failed to find an advantageous effect of varied-stimulus exposure. This 
failure may be due to several reasons. First, since the movements were not indi-
vidually selected, it can be assumed that for some patients the movements were 
not threatening. To facilitate generalization, it seems that exposure therapy should 
consist of repeated exposure to essential and individually identified stimuli and 
more than three different movements. Second, the movements that were chosen 
for the behavioral tests were highly standardized, by which the tests were some-
what artificial. Finally, pain may not have been the crucial variable which patients 
over-predicted, but instead the possibility of injury. Although fear of injury was not 
assessed it is plausible to assume that not fear of pain but fear of injury was af-
fected by exposure to a variety of movements. Patients in condition I may have 
learned that injury was not very likely since it did not occur during the first three 
behavioral tests, whereas patients in condition II did not have this opportunity. 
 
Contrary to the previous studies, Trost et al. (2007) showed successful generaliza-
tion of pain expectancy corrections across movement tasks. In this study the main-
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tenance of corrective experiences were determined across identical movements of 
increasing intensity in chronic low back pain patients with high versus low levels of 
pain-related fear. Rather than the series of artificial movements used by Goubert et 
al., four reaching movements were selected that approximate activities encoun-
tered in everyday life. Results indicated that individuals with high versus low levels 
of pain-related fear reported greater pain and harm, greater over-prediction of 
harm among female participants, and last but not least an unexpected trend of 
successful generalization across movements of corrected pain over-predictions. The 
trend of declining over-prediction was, however, not apparent for harm ratings. 
Harm over-prediction ratings remained notably stable across movements in partici-
pants who reported highly pain-related fear. This finding is not consistent with the 
assumption of Goubert et al. (2005) who suggested that not fear of pain but fear of 
injury is affected by exposure. In order to explain for the success of the gradual 
extinction of the over-prediction of pain, Trost et al. (2007) suggested that the 
graded exposure elements played an important part. 
Summary 
GEXP is developed for application in fearful pain patients. The treatment is highly 
structured, protocolized, individually tailored, and aims to restore a normal pattern 
of daily functioning, including complete return to work. Both experimental single-
case studies and randomized controlled trials showed that exposure in vivo is effec-
tive in improving functional disability in patients with chronic low back pain. How-
ever, in two RCT’s this improvement was statistically not significantly better than 
the control group, who were offered wait-list, usual treatment (contact with a gen-
eral practitioner, analgesics, and physical therapy) or an operant graded activity. 
Overall, one of the most striking characteristic in these studies is the discussed im-
portance of the educational component which illustrates and explains the fear-
avoidance model. Also, the importance of including various fear eliciting activities 
during exposure and therapeutic competence are described. Finally, the results of 
the single-case studies as well as those of the RCT’s are hopeful with regard to gen-
eralization of extinction. 
Conclusion and discussion 
Pain is a normal response of the organism when exposed to bodily threat. However, 
the level of pain someone experience does not necessarily relate to the amount of 
tissue damage. When pain persists, the danger alarm system in the brain becomes 
more sensitive. It seems that response systems and thoughts and beliefs become 
more involved and start contributing to the pain problem. Extremely negative 
 37 
thoughts (pain catastrophizing) arouse pain-related fear; fears of interoceptive (e.g. 
pain), proprioceptive (e.g. movement) and exteroceptive (e.g. physical context) 
stimuli. Pain-related fear is a strong negative reinforcement for the persistence of 
avoidance behavior and the functional disability. 
 
The treatment of choice for a number of anxiety disorders is exposure therapy. 
Experimental studies in psychology showed that extinction of fear is a highly com-
plex process which is probably multiply determined. This complexity is mainly clari-
fied by the observation that extinction is sometimes followed by a (partial) return of 
fear with the passage of time. Not only is it important to know how exposure treat-
ment can be optimized to reduce the risk of relapse, but from a theoretical perspec-
tive it is also crucial to understand the mechanisms by which previously reduced 
fears reappear. 
Exposure can be conceptualized as a clinical analogue of extinction (CS-only presen-
tations after acquisition). Although an extinction procedure results in a decrease of 
conditioned responses, it does not destroy the underlying CS-US association. What 
happens is that new associations are added to the existing one. These second-
learned associations are inhibitory, and can be viewed as ‘exceptions to the rule’ 
and are likely to be context-dependent. Post-extinction events that might reactivate 
the original CS-US association are spontaneous recovery, renewal, reinstatement 
and reacquisition. Moreover, it appears that exposure therapy involve higher-order 
cognitive processes which are associated with changes in CS-US expectancy. Expo-
sure therapy is also seen as a form of cognitive intervention that specifically changes 
the expectancy of harm. 
Because of the substantial contribution of pain-related fear in the maintenance of 
chronic pain, it seems to be an important target for intervention. Indeed, a devel-
oped exposure program (GEXP) is examined in different exposure studies as an 
effective treatment in chronic low back pain patients who report high levels of pain-
related fear. However, on the basis of the results of these studies and the overall 
complexity of exposure there are still several questions that need to be worked out, 
for example, which treatment characteristics makes the GEXP successful or unsuc-
cessful in pain-related fear, what is actually learned during GEXP in pain-related 
fear, does GEXP in pain-related fear generalize to daily functioning, is GEXP usable in 
other pain disorders like neuropathic pain? In short, enough questions to answer in 
the process of optimizing GEXP in pain-related fear. 
Outline of this dissertation 
The general theme of this dissertation is to further explore the utility of GEXP in 
pain-related fear. For this purpose we will examine whether the effects of GEXP 
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generalize from chronic low back pain to other pain problems such as complex re-
gional pain syndrome and posttraumatic neck pain. Additionally, the contribution of 
specific treatment components to outcome will be examined. Finally, the question 
whether exposure to multiple stimuli enhances generalization after treatment will 
be addressed. This dissertation comprises five studies and a summary with a general 
discussion that are organized into the following sections: 
 
First, we will focuses on the role of pain-related fear in neuropathic pain. Pain-
related fear recently has received much attention in the pain literature. Numerous 
studies have shown that pain-related fear is one of the strongest predictors of pain 
disability, and some have argued that ‘pain-related fear is more disabling than pain 
itself’. However, these studies have mainly been carried out in patients with chronic 
low back pain, and empirical studies focussing on other chronic pain conditions, 
such as neuropathic pain are lacking. Recently the International Association for the 
Study of Pain (IASP, 2005) suggested that the fear-avoidance model may be very 
relevant in a subset of CRPS patients. Chapter 2 presents two studies, each with a 
cross-sectional design, in which the role of pain-related fear in Complex Regional 
Pain Syndrome type I (CRPS-I) is investigated. Study I includes CRPS-I patients visit-
ing an outpatient pain clinic. In study II, members of the Dutch association for CRPS-
I Patients were invited to complete a number of questionnaires. Besides the role of 
pain-related fear in predicting disability also various assessments methods of pain-
related fear in neuropathic pain are discussed. 
 
Several studies already demonstrated the effectiveness of GEXP in chronic low back 
pain patients reporting substantial pain-related fear, but its effectiveness was never 
tested in other musculosketal and neuropathic pain complaints. For patients with 
acute posttraumatic neck pain (PTNP), pain-related fear has been identified as a 
potential predictor of chronic disability. If such is the case, fear reduction should 
enhance the prevention of further pain disability and distress after traumatic neck 
pain disability. In chapter 3, a study with a replicated single-case crossover phase 
design with multiple measurements is presented that examines the effectiveness of 
GEXP as compared to GA directly and six months after treatment in eight chronic 
and fearful PTNP patients. Besides the use of a diary and standardized question-
naires of pain-related fears and pain disability also an ambulatory activity monitor 
was used to quantify daily physical activity level. The results are discussed in the 
context of the search for customized treatments for PTNP. 
 
The IASP has proposed to test the contribution of pain-related fear in CRPS, and also 
to examine the effects of an exposure treatment applied in then context of func-
tional restoration in CRPS (IASP, 2005). Following these suggestions, chapter 4, de-
scribes a study that examined whether the reduction of pain-related fear through 
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GEXP also resulted in a decrease of disability in a subgroup of patients with CRPS-I 
who report substantial pain-related fear. A single-case experimental ABCD-design 
was used with random determination of the start of the intervention. Eight patients 
with CRPS-I were included in the study. To assess daily changes in pain intensity, 
pain-related fear, pain catastrophizing, and activity goal achievement, a diary was 
used. Standardized questionnaires of pain-related fear, pain disability, and self-
reported signs and symptoms of CRPS-I were administered before and after each 
intervention, and at 6-month follow-up. Possible theories and elements of GEXP 
that may explain the results of the study are discussed in view of insights from neu-
roscience. 
The results of the first single-case experimental studies examining the effectiveness 
of GEXP in patients with chronic low back pain conducted by Vlaeyen et al. (2001, 
2002a, 2002b) showed abrupt changes in self-reported pain-related fears and cogni-
tions. These changes seem to be more characteristics of insight learning rather than 
the usual gradual progression of trial and error learning. The educational session at 
the start of GEXP might have contributed to this insight. In addition, also in the lit-
erature about exposure it is suggested that, in order to be effective, exposure must 
have a convincing rationale (e.g. Barlow, 2004). Chapter 5 presents a study which 
examined the contribution of education and GEXP versus GA in the reduction of 
pain-related fear and associated disability and physical activity. Six consecutive 
patients with chronic low back pain who reported substantial fear of move-
ment/(re)injury were included in the study. After a no-treatment baseline meas-
urement period, all the patients received a single educational session at which an 
individualized and tailored fear-avoidance model was presented, followed again by 
a no-treatment period. Patients were then randomly assigned to either GEXP or GA. 
Besides the use of a diary and standardized questionnaires of pain-related fears and 
pain disability also an ambulatory activity monitor was used to quantify daily physi-
cal activity level. The influence of the education on patients’ beliefs and behavior 
are discussed. 
 
Despite the success of GEXP in chronic low back pain it is still the question whether 
extinction generalizes to new threatening activities. Research into the return of fear 
has revealed that extinction does not mean unlearning (e.g. Craske et al., 2008). It 
appears that the extinguished fear response can arise spontaneously after a while 
(spontaneous recovery), or reoccur when confronted with a new CS-US event (rapid 
reacquisition) or an unpredicted US (reinstatement). In addition, it also appears that 
extinction is very context-sensitive (e.g. Craske et al., 2008). It has been established 
that what has been learned during the process of extinction will not necessarily 
generalize towards other situations; not even when the extinction process takes 
place during the original process of acquisition. In chapter 6, a study is described in 
which the primary objective was to replicate the finding that exposure to multiple 
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stimuli (or contexts) can enhance the generalization process of extinction. Using a 
randomized replicated single case experimental design, this study examined 
whether the effects GEXP in fearful CRPS-I patients generalized to threatening ac-
tivities which were not addressed during GEXP. Two exposure conditions of 15 ses-
sions were tested: Condition I (N = 4) in which GEXP consists of ≥ 15 activities to 
which patients were exposed once and Condition II (N = 4) of 3 activities to which 
patients were exposed five times. In both conditions generalization of extinction 
was tested by exposing patients to a new activity after successful exposure treat-
ment. It was hypothesized that generalization of extinction is facilitated in the con-
dition with exposure to multiple stimuli. Possible mechanisms of GEXP in relation to 
generalization are discussed. 
Finally, in chapter 7, a summary of the main findings is presented together with a 
general discussion. The findings are positioned within the available literature of 
extinction, and pain-related fear. Furthermore, the methods and the procedures of 
the studies are critically appraised, and clinical implications of GEXP as well as rec-
ommendations for future research are outlined. 
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Chapter 2 
Pain-related fear, perceived 
harmfulness of activities and 
functional limitations in Complex 
Regional Pain Syndrome type I 
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perceived harmfulness of activities and functional limitations in Complex Regional Pain Syn-
drome type I. Submitted for publication 
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Abstract 
Numerous studies have shown that in patients with chronic musculoskeletal pain, 
pain-related fear is one of the strongest predictors of pain disability, and the reduc-
tion of pain-related fear through an exposure treatment is associated with restora-
tion of functional abilities in patients with low back pain (LBP) and complex regional 
pain syndrome, type I (CRPS-I). These latter findings suggest that pain-related fear 
may be associated with functional limitations in neuropathic pain as well. The aim of 
the current study was to test whether the debilitating role of pain-related fear gen-
eralizes to patients with CRPS-I. Two studies are presented. Study I includes a sam-
ple of patients with early CRPS-I referred to an outpatient pain clinic. In study II, 
patients with chronic CRPS and who are members of patients association were in-
vited to participate. The results show that pain severity but not fear of move-
ment/(re)injury as measured with Tampa Scale for Kinesiophobia was related to 
functional limitations in early CRPS-I. In patients with chronic CRPS-I, however, per-
ceived harmfulness of activities as measured with the pictorial assessment method 
PHODA significantly predicted functional limitations, together with pain severity. 
This study supports the idea that pain-related fear in chronic CRPS-I patients is a 
promising research direction in the understanding of pain disability in CRPS, but that 
not general fear of movement/(re)injury, but the perceived harmfulness is a key 
factor that might be addressed more systematically in the assessment of patients 
with CRPS-I. 
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Introduction 
There is general consensus that the pathophysiology of Complex Regional Pain Syn-
drome type I is still unknown, and that the contribution of bio-psychological interac-
tions to the development and maintenance of CRPS-I symptoms is unclear (Wilson 
et al., 2005). During the last decennium, biopsychosocial models have been intro-
duced and successfully applied in chronic pain research (e.g. Turk & Okifuji, 2002; 
Vlaeyen & Morley, 2005). One particular model that has gained wide interest among 
pain researchers and clinicians alike is the fear-avoidance model. (Vlaeyen & Linton, 
2000; Leeuw et al., 2007c). Patients who (mis)interpret pain catastrophically are 
likely to become fearful about their pain and its consequences, and engage in pro-
tective avoidance behaviours that are adaptive in acute pain, but paradoxically 
worsen the pain problem in the long run. Although it has repeatedly been shown 
that in musculoskeletal conditions pain-related fear is associated with ongoing pain 
and more severe functional limitations, the role of pain-related fear in CRPS-I was 
never tested systematically. In one study, however, CRPS-I patients responded suc-
cessfully to an exposure in vivo treatment aimed at the reduction of pain-related 
fear. This study which employed a replicated single case experimental design, sho-
wed that as compared to baseline and education, patients reported not only less 
pain-related fear but also less pain and increased functional abilities after the 
treatment (De Jong et al., 2005). These findings are in line with other studies sug-
gesting that differences between nociceptive and neuropathic pain conditions main-
ly lie in factors that increase pain and beliefs about causes of pain, rather than 
mood, cognition, and physical function (Daniel et al., 2008). Taken together, these 
findings suggest that the impact of pain-related fear on functioning is not restricted 
to patients with nociceptive pain, but is also relevant in patients with neuropathic 
pain, and CRPS in particular (e.g. Haythornthwaite et al 2003). 
Therefore, the aim of the current studies was to test whether the debilitating role of 
pain-related fear generalizes to patients with CRPS-I. We predicted that pain-related 
fear is significantly associated with functional limitations, over and beyond the ef-
fects of pain severity. 
Materials and Methods 
The role of pain-related fear in CRPS-I was investigated in two independent cross-
sectional studies. Study I used data collected by the pain clinic of the University 
Hospital Maastricht, pain-related fear was measured with the Tampa Scale for Kine-
siophobia (TSK; Miller et al., 1991; Roelofs et al. 2007), a self-report measure fo-
cused on the general fear that painful movement might be a sign of (further) injury. 
In Study II, where data was collected from chronic CRPS-I patients who were mem-
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bers of the Dutch association for patients with CRPS, a pictorial measure of per-
ceived harmfulness of activities (PHODA; Leeuw et al, 2007b) was used in addition 
to TSK. Methods and results are described in detail below. The Medical Ethics 
Committee of the Maastricht University approved both studies. 
Study I 
Participants 
In this study, 79 CRPS-I patients were included who visited the outpatient clinic of 
the Pain Management and Research Center (PKC) of the University Hospital Maas-
tricht for the first time from 2004 to 2006. The diagnosis of CRPS-I was made ac-
cording to the criteria formulated by Veldman et al. (1993), and based on physician 
evaluation of objective symptoms. Veldman et al.’s criteria were initially developed 
for the description of CRPS I in the acute phase of the disease and are formulated as 
follows: 1) At least four out of five signs or symptoms: pain, difference in skin color, 
oedema, difference in skin temperature and active range of motion. (2) Signs and 
symptoms present in an area larger than might be expected of the initial trauma. (3) 
Increase of signs and/or symptoms during or after exercise. 
Procedure 
Once the first appointment at the pain clinic of the University Hospital Maastricht 
was scheduled, patients were sent a booklet with a series of questionnaires at ho-
me. Patients were asked to complete and return the questionnaires a few days 
before the first meeting with the anaesthesiologist. These data serve as additional 
diagnostic information which was added to the case history and physical examina-
tion. At this point, patients gave their informed consent for using the questionnaire 
data for research purposes. 
Measures 
Sociodemographics 
By means of the above-mentioned booklet, data were available on age, gender and 
pain duration. 
Functional limitations 
One of the most widely used generic health status measures is the Short Form Heal-
th Survey (SF-36: Ware & Sherbourne, 1992). The SF-36 is developed in the late 
1980, and is translated and validated for use among Dutch-speaking residents of the 
Netherlands (Aaronson et al., 1998). SF-36 is composed of thirty-six questions and 
standardized response choices, organized into eight multi-item scales (Ware & 
Sherbourne, 1992). For this study we used the scale limitations in physical activities 
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because of health problems. The raw scale scores were linearly converted to a 0 to 
100 scale, with higher scores indicating higher levels of functioning or well-being. 
The SF-36 has proven to be a reliable and valid instrument, with a mean Cronbach’s 
alpha of 0.84 across scales and samples (Van der Zee & Sanderman, 1993). Cron-
bach’s alpha of the subscales in our sample of CRPS-I patients was 0.73. 
Pain-related fear 
The Dutch language version of the Tampa Scale for Kinesiophobia (TSK-DV: Goubert 
et al., 2000) was used. . The TSK-DV measures one’s belief that activities which in-
crease pain indicate serious body damage and should be avoided (Goubert et al., 
2004; Roelofs et al., 2007). The TSK-DV consists of 17 statements that are rated on a 
four-point scale (1 = strongly agree, 4 = strongly disagree) (Miller et al. 1991). Sam-
ple items are “Pain always means I have injured my body” and “If I were to try to 
overcome it, my pain would increase”. The total score was calculated after inversion 
of items 4, 8, 12, and 16 which were phrased in reversed key. The total score varies 
between 17 and 68. The Dutch version of the TSK has been shown to be sufficiently 
reliable and valid (Goubert et al., 2000). Cronbach’s alpha of the total score in our 
sample of CRPS-I patients was 0.94. 
Pain severity 
Four visual analogue scales (VAS), consisting of 10 cm horizontal lines anchored at 
the left and the right with the words “no pain at all” and “worst pain experienced” 
were used (Melzack, 1975). The VAS referred to the present pain, experienced aver-
age pain of the last week and the lowest and highest experienced pain. Because the 
statistical analyses showed the same results for these different VAS, pain severity 
was described as the result of the experienced average pain (VAS-average pain). 
Statistical analyses 
The obtained data were analyzed with the SPSS version 15.0 (SPSS Inc., Chicago, IL). 
The analyses included pain-related fear and pain severity in predicting functional 
and role limitations. Multiple regression analyses were carried out with functional 
limitations as dependent variable. Gender and age were entered into the first step 
to control for sociodemographic variables. Next, pain-related fear was entered, and 
pain severity in the third step. 
Results Study I 
Sociodemographics 
A summary of the sociodemographics is displayed in table 1. Seventy-nine patients 
with CRPS-I with an average age of 43.9 years (SD = 13.5, range 16-80) were in-
cluded in the analyses. CRPS-I involved the upper extremities in 39% (4 men and 27 
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women), the lower extremities in 44% (12 men and 23 women), and both the upper 
as the lower extremities in 16% (1 man and 12 women) of the patients. In total 78% 
is female. In 48.1% of the patients the duration of the CRPS-I symptoms was less 
than one month, and in 30.5% the pain duration was between one and six months. 
The remaining 21.4% of the patients had pain for longer than 6 months (range 7 
months-26 years). 
 
Table 1 The sociodemographics for the patients in Study I and II 
 Study I 
(N = 79) 
Study II 
(N = 107) 
 
Age (years) 
mean 
standard deviation 
range 
 
Gender (% female) 
 
CRPS-I upper extremities (%) 
CRPS-I lower extremities (%) 
CRPS-I both extremities (%) 
 
Pain duration 
< 1 month (%) 
1-6 months (%) 
> 6 months (%) 
 
43.9 
13.5 
16-80 
 
78% 
 
39% 
44% 
16% 
 
 
48.1% 
30.5% 
21.4% 
 
48.5 
11.3 
23-65 
 
89% 
 
24% 
39% 
37% 
 
 
1% 
0% 
99% 
 
 
Variable information 
The mean TSK-score, as measure for pain-related fear, was 43.68 (SD = 8.70, range 
20.0-63.0). Compared with normative data about the TSK in chronic low back pain 
(CLBP) patients (Vlaeyen et al., 1995b) or a mixed group of patients with chronic 
pain (Nicholas et al., 2008), 52.7% scored below or on the same level, as the re-
ported median. This suggests that the level of pain-related fear, or more specific 
fear of movement/(re)injury, of the CRPS-I group in Study I is comparable with the 
average chronic pain population. The mean group-score of the experienced average 
pain, as measure for pain severity, was 7.34 (SD = 1.73, range 1.4-10.0). In addition, 
patients reported for present pain 6.91 (SD = 2.12, range 0-10.0), highest experi-
enced pain 8.87 (SD = 1.07, range 5.9-10.0), and lowest experienced pain 4.94 (SD = 
2.12, range 0.1-10.0). 
Regression analyses 
The results of the multiple regression analysis are displayed in table 2. Adding pain-
related fear to the model in which age and gender were already included explained 
additional 19% of the variance. When pain severity was added to these predictors, 
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they accounted for 51% of the total variance. Step 3 (F (change) = 18.87, p < .01) in 
the regression model did improve our ability to predict general physical health. Pain 
severity (β = -.479, p < .01) but not pain-related fear (TSK) contributed significantly 
to the prediction of functional limitations. 
 
Table 2 The results of the multiple regression analysis of Study I (N=79) with functional limitations as 
outcome measure 
 SE B β  
Step 1 
Gender 
Age 
 
6.945 
.226 
 
.150 
-.087 
 
Step 2 
Gender 
Age 
Pain-related fear (TSK) 
 
7.426 
.228 
.347 
 
.184 
-.081 
.096 
 
Step 2 
Gender 
Age 
Pain related fear (TSK) 
Pain severity (VAS-average pain) 
 
6.716 
.202 
.308 
1.556 
 
.080 
-.082 
.091 
  -.479** 
 
** p < .01 
 
Conclusion 
In contrast to what was expected, pain-related fear was not a predictor of func-
tional imitations in this sample of early diagnosed CRPS-I patients admitted to the 
University Hospital. However, fear was measured with the TSK, which might be a 
too global measure of pain-related fear. A novel measure of pain-related fear is the 
Photograph Series of Daily Activities (PHODA: Leeuw et al., 2007b; Trost et al., 
2009), which more specifically measures the perceived harmfulness of a series of 
movements and activities presented by photographs. Another explanation could be 
that the measure of functional disability was too generic and not CRPS-I specific 
enough. Further, the group of patients who were referred to the pain clinic of the 
Hospital, might be a highly selected group of CRPS-I patients with early symptoms, 
and in whom avoidance behaviour might still have adaptive function. Therefore, to 
examine the role of more CRPS-specific variables for disability and pain-related fear 
with a different cohort of patients with CRPS-I, Study II was set up. 
Study II 
Study II was carried out among members of the Dutch association for Patients of 
Post-Traumatic Dystrophy (Nederlandse Vereniging van Posttraumatische Dystrofie 
Patienten: NVPDP). Contrary to study I, this study used more specific measurement 
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tools to test the role of pain-related fear and pain severity on functional limitations 
in chronic CRPS-I patients. 
Procedure 
A sample of 400 NVPDP members was randomly selected using the computer pro-
gram PEPI 3.0 (Abramson & Gahlinger, 1999), and contacted by mail. A package 
including patient information, informed consent form, a body pain chart, a letter of 
recommendation by the patients association and stamped addressed envelopes 
were sent to them. Body pain charts, developed by A.J. Kresch (http://www.kickas-
.org/painmap.shtml), were used to indicate the body location where participants 
felt most severe pain. The instruction was to mark with a cross (x) the body location 
where the pain was felt as most intense. This information was used to decide which 
questionnaire(s) should be send to the participants (upper versus lower extremities) 
to measure functional and role limitations. Depending on the affected limb, differ-
ent versions of disability instruments were completed. 
The participants returned their informed consent forms and the body pain chart in 
the pre-addressed envelopes to the Maastricht University. The participants also 
indicated their preference for the online version or the mailed version of the ques-
tionnaires. Participants who were able to use the Internet received the online ver-
sion of the questionnaires by e-mail. The answers were registered and transformed 
to the computer program Statistical Package for the Social Sciences (SPSS) by the 
computer program EMIUM (Janssen, 2005). A printed version of the questionnaires 
was sent by regular mail to the participants who had no access to the internet. 
Participants 
Four of the randomly selected NVPDP members lived in foreign countries and were 
excluded from participation. In total, 396 members were contacted, of which 121 
(30.6%) gave their informed consent to participate. Four of these respondents gave 
their informed consent too late, one participant was not able to fill in the online 
version of the questionnaires, another person had filled in the questionnaire, but 
the sex of this person remained unanswered. Eight participants did not fill in the 
questionnaires, resulting in a final sample of 107 (27%) respondents for the purpose 
of the current analyses. 
Measures 
Functional limitations 
The functional limitations were measured by two questionnaires. The first one is the 
Radboud Skills Questionnaire (RASQ: Oerlemans et al., 2000b), which was com-
pleted by CRPS-I patients with upper extremity pain. The RASQ was used to score 
the patient’s ability to perform activities of daily living in the normal manner. The 
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activities are described in forty-five items which are divided into six domains: 1) 
personal care 2) household activities; 3) recreational activities; 4) social activities; 5) 
remaining; and 6) work. Each of the items can be scored on a five-point Likert scale 
(1 = normal, 5 = ‘I do not perform the activity anymore as a result of CRPS-I’). There 
is an extra score of ’9’ for ‘not applicable’. The patient indicates the effort perform-
ing the activity by choosing a number. Different scores are computed by summing 
up relevant items, divided over the number of items of the relevant scale, minus the 
number of items in which the category ‘not applicable’ was chosen. A total score 
can be computed, along with the six domain scores. For this study the total score 
was converted into a 0-10 score. The questionnaire has been found reliable in CRPS-
patients, with good agreement between the outcomes for test-retest and inter 
observer reliability studies as established with the method of Bland and Altman 
(1986) (Oerlemans et al., 2000b). 
For patients with CRPS-I lower extremity pain, the Dutch questionnaire ‘Walking 
Ability Questionnaire’ (WAQ: Roorda et al., 1996a) was used. The three domains 
that were used in this study are: 1) walking inside the house; 2) walking outside; and 
3) rising and sitting down. The questionnaire is a combination of the original form of 
the Walking Stairs Questionnaire (WSQ: Roorda et al., 1996b) and a shortened ver-
sion of the Questionnaire Rising and Sitting Down (QR&S: Roorda, et al. 1996b). 
Response options are presented in a dichotomous fashion (yes or no). Following 
Perez et al. (2002), the score of each of the domains was calculated by adding up 
the total number of affirmative responses. These scores were converted into a 0–10 
total score for each scale, by dividing the score of each scale by the total number of 
items of that scale, and subsequently multiplying the outcome by 10. In the case 
that a patient had marked: ‘I do not walk inside/outside due to my dystrophy’ the 
total score of 10 was included for the relevant domain. Items that suggest difficul-
ties with walking due to other reasons than CRPS were excluded from the total 
score calculation. In terms of test-retest reliability as expressed by Spearmans’s r 
(range 0.79-0.90 and 0.85-0.89 respectively) and the intraclass correlation coeffi-
cient (ICC: range 0.78-0.84 and 0.84-0.87 respectively) the WSQ and the QR&S form 
a reliable tool for measuring activity limitation of patients with CRPS-I of a lower 
extremity. Patients who had lower as well as upper extremity CRPS-I (37%) filled in 
both the RASQ and the WAQ. 
Pain-related fear 
The Tampa Scale for Kinesiophobia (TSK; Miller et al., 1991), is a brief questionnaire 
that measures fear of movement/(re)injury. Although psychometric studies have 
supported the reliability and validity of the TSK (Goubert et al., 2004, Roelofs et al., 
2007), limitations are that it does not provide information about other feared stim-
uli than fear of movement/(re)injury and which specific movements or activities a 
patient fears or avoids. Therefore, the Photograph Series of Daily Activities (PHODA: 
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Kugler et al., 1999; Dubbers et al., 2003; Jelinek et al., 2003) was included as well. 
The PHODA is an instrument that includes photographs of various daily activities. 
Patients have to indicate to what extent they perceive these daily activities to be 
harmful and/or threatening. Support has been found for both the reliability and 
validity of a computer version of PHODA (Leeuw et al., 2007b). 
Two parallel forms of PHODA were used. PHODA-UE (Dubbers et al., 2003) was used 
for the upper extremities and PHODA-LE (Jelinek et al., 2003) for the lower extremi-
ties. For this study a shortened computer version of PHODA-UE and PHODA-LE was 
developed, consisting of 40 selected pictures. For every basic movement category, 
activities were selected with variable degrees of rated harmfulness. Participants 
were instructed to watch each photograph carefully and to try to imagine perform-
ing the same activity. To determine the expected harmfulness of these activities a 
visual analogue scale (VAS), consisting of a 100 mm horizontal line was used an-
chored at the left and right by the words ‘not harmful’ and ‘very harmful’, was used. 
Each photograph is given a rating according to its position on the VAS. A mean total 
score ranging from 0 to 100 is calculated as the sum of each rating divided by 40. To 
test the predictive value of the PHODA in the hierarchical regression analyses PHO-
DA-UE or PHODA-LE were used depending on the affected limb. 
Pain 
The Dutch translation of the Neuropathic Pain Scale (NPS: Galer & Jensen, 1997) 
was used to assess the distinct pain qualities associated with neuropathic pain. The 
NPS consisted of ten items. Two items assessed the global dimensions of pain inten-
sity and pain unpleasantness. Seven items contained the words: intense; sharp; hot; 
dull; cold; and itchy to characterize the patient’s pain and the word sensitive to 
describe the patient’s pain reaction to light touch or clothing. In addition, each of 
these items included a description and other similar descriptive words for that item. 
One item described the temporal sequence of pain as constant with ‘intermittent 
increases’, ‘intermittent’, or ‘constant with fluctuation’. Each item was rated on a 0 
to 10 numerical rating scale. Galer & Jensen (1997) provided preliminary support for 
the discriminant and predictive validity of the NPS items. 
Statistical analyses 
The obtained data were analyzed with the SPSS version 15.0. Because functional 
limitations were measured differently in patients with CRPS-I in the lower and upper 
extremities, analyses were performed in two groups: lower extremity group and 
upper extremity group, by which patients who had CRPS-I in the lower as well as the 
upper extremity were added to both groups. Pearson correlation showed that the 
RASQ and the WAQ were highly correlated in the sample of patients who had CRPS-I 
in both the lower and upper extremity (Pearson r = .62, p < .01). Descriptive statis-
tics of each questionnaire were generated to evaluate the completeness of the data 
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and to characterize the score distributions, including scale ranges, means and stan-
dard deviations. In the case of missing data, means replacement methods were 
used if 90% of relevant data was present. 
Multiple regression analyses were carried out with functional and role limitations as 
dependent variable. Gender and age were entered into the first step to control for 
sociodemographic variables. Next, pain-related fear was entered and in the third 
step pain severity. Regression analyses were repeated in each group separately with 
the TSK or PHODA as a measure for pain-related fear. 
Results Study II 
Sociodemographics 
The sociodemographics for the patients in Study II are displayed in table 1. Hun-
dred-seven members of the Dutch association for patients with CRPS-I (89% 
women) with an average age of 48.5 years (SD = 11.3, range 23-65) were included in 
the analyses. Fifty-three respondents completed the questionnaires online, fifty-
four respondents completed paper versions of the questionnaires. CRPS-I involved 
the upper extremities in 24% (6 men and 20 women), the lower extremities in 39% 
(4 men and 38 women), and both extremities in 37% (2 men and 37 women) of the 
respondents. The average duration of the CRPS-I symptoms was estimated at 8.14 
years (SD = 4.65, range 0-22 years). In only one patient the duration of the CRPS-I 
symptoms was less than one month and no patients reported a pain duration be-
tween one and six months. The remaining patients had pain for longer than 6 
months. 
Variable information 
The mean TSK-score of the patients was 37.69 (SD = 8.20, range 19.0-59.0). Com-
pared with normative data of the TSK in a mixed group of patients with chronic 
pain, 65% scored below or on the same level, as the reported median (Nicholas et 
al., 2008). The mean PHODA-score was 48.02 (SD = 20.66, range 6.25-94.05). Com-
pared with normative data of the PHODA in CLBP patients (Leeuw et al., 2007b), 
50% scored below or on the same level, as the reported median. This suggests that 
the level of pain-related fear, as measured with the PHODA, of the CRPS-I group in 
Study II is comparable with the average CLBP population. Furthermore, the mean 
NPS-score, as measure for pain severity, was 50.16 (SD = 17.46, range 7.00-90.70). 
Regression analyses 
Lower extremity CRPS-I group 
Table 3 shows the results of the multiple regression analysis of the lower extremity 
CRPS-I group in which the TSK was used as measure for pain-related fear. The de-
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mographic variables gender and age were entered in Step 1 and explained 29% of 
the variance in functional limitations. The variable pain-related fear entered in step 
2 explained an additional 29% of the variance, and for pain severity in step 3 this 
was an addition of 44% of the variance. Inclusion of the predictor pain severity in 
the model (step 3) improved the ability to predict the outcome variable (F (change) 
= 9.87, p < .01). Of the variables age (β = .274, p < .05) and pain severity (β = .351, p 
< .01) were significantly related to the function in which the level of functional and 
role limitations was predicted. 
 
Table 3 The results of the multiple regression analysis of Study II in lower (N=79) and upper (N=65) 
extremities CRPS-I patients with functional limitations as outcome measure and the TSK as measure for 
pain-related fear 
 Lower extremities Upper extremities 
 SE B β SE B β 
Step 1 
Gender 
Age 
 
1.199 
.026 
 
.235 
.221 
 
.342 
.011 
 
.103 
-.141 
Step 2 
Gender 
Age 
Pain-related fear (TSK) 
 
1.211 
.027 
.034 
 
.234* 
.222 
-.014 
 
.344 
.011 
.014 
 
.107 
-.150 
.097 
Step 3 
Gender 
Age 
Pain-related fear (TSK) 
Pain severity (NPS) 
 
1.164 
.025 
.033 
.017 
 
.167 
.274* 
-.081 
.351** 
 
.262 
.009 
.011 
.005 
 
.023 
.114 
-.044 
.717** 
 * p < .05, ** p < .01 
 
In an additional multiple regression analysis the PHODA, as measure for pain-related 
fear, was entered in step 2 (table 4). As a consequence, this explained an additional 
48% of variance in functional limitations. For pain severity in step 3 this was 52%. 
Unlike the analysis described above, in which the TSK was used as measure for pain-
related fear, not the inclusion of pain severity but pain-related fear improved the 
ability to predict the outcome variable (F (change) = 13.54, p < .01). In addition, the 
multiple regression analysis showed that pain-related fear (β = .328, p < .01) and 
age (β = .225, p < .05), and not pain severity, were significantly related to functional 
limitations. 
Upper extremity CRPS-I group 
Table 3 shows also the results of the multiple regression analysis of the upper ex-
tremity CRPS-I group in which the TSK was used as measure for pain-related fear. 
Adding gender and age in step 1 explained 19%, pain-related fear in step 2 ex-
plained 21%, and pain severity in step 3 explained 68% of the variance in functional 
limitations. Inclusion of pain severity in the model (step 3) improved the ability to 
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predict the outcome variable (F (change) = 45.43, p < .01). Of the variables only pain 
severity (β = .717, p < .01) was significantly related to functional limitations. 
 
Table 4 The results of the multiple regression analysis of Study II in lower (N=76) and upper (N=64) 
extremities CRPS-I patients with functional limitations as outcome measure and the PHODA as measure 
for pain-related fear 
 Lower extremities Upper extremities 
 SE B β SE B β 
Step 1 
Gender 
Age 
 
1.232 
.028 
 
.233 
.209 
 
.345 
.011 
 
.099 
-.148 
Step 2 
Gender 
Age 
Pain-related fear (PHODA) 
 
1.134 
.026 
.014 
 
.206 
.192 
.395** 
 
.299 
.010 
.005 
 
.135 
-.184 
.510** 
Step 3 
Gender 
Age 
Pain-related fear (PHODA) 
Pain severity (NPS) 
 
1.127 
.026 
.015 
.018 
 
.172 
.225* 
.328** 
.221 
 
.251 
.009 
.004 
.006 
 
.058 
.022 
.267* 
.575** 
 * p < .05, ** p < .01 
 
When the PHODA, as measure for pain-related fear, was entered in step 2 of the 
regression model (table 4) this explained an additional 54% of variance in functional 
limitations. Adding pain severity in step 3 this explained 72%. Inclusion of the pre-
dictors pain-related fear (F (change) = 21.05, p < .01) and pain severity (F (change) = 
27.53, p < .01) improved the ability to predict the outcome variable. Contrary to the 
previous multiple regression analysis, not only pain severity (β = .575, p < .01), but 
also pain-related fear (β = .267, p < .05) was significantly related to functional limita-
tions. 
Conclusion 
Study II showed that the higher pain-related fear, when measured with a pictorial 
fear of activity scale (PHODA) and not with a self-report measure specifically fo-
cused on fear of movement/(re)injury (TSK), the higher impact on the experienced 
functional limitations. Contrary to Study I the role of pain severity was different in 
both CRPS-I subsamples. When the PHODA was entered in the regression model in 
patients who had lower extremity CRPS-I only pain-related fear, and not pain sever-
ity, was a significant predictor of functional limitations. 
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Discussion 
The primary aim of this study was to investigate the role of pain-related fear in 
CRPS-I patients. Two studies were carried out. In Study I data of CRPS-I patients who 
visited an outpatient clinic of Pain Management for the first time were used. Pain-
related fear was measured with a self-report measure specifically focused on fear of 
movement/(re)injury (TSK). The results of Study I showed that pain severity affected 
functional limitations more than any other variable. In Study II, members of the 
Dutch association for CRPS-I Patients completed a series of questionnaires. To mea-
sure pain-related fear a pictorial fear of activity scale (PHODA) was used. The results 
demonstrated that pain-related fear, only when measured with a pictorial fear of 
activity scale, was associated with functional limitations, above and beyond the 
contribution of pain severity. Moreover, also in Study II, pain severity was a predic-
tor for functional limitations. However, when the PHODA was used in the group of 
patients with CRPS-I in the lower extremities, only pain-related fear and not pain 
severity was a predictor of functional limitations. The current studies showed that 
pain-related fear might affect functional limitations in CRPS-I patients. 
 
To the current knowledge of the authors, both studies are the first to specifically 
examine the role of pain-related fear in relation to functional limitations in a group 
of CRPS-I patients. By using motor imagery in CRPS patients Moseley et al. (2008) 
showed that change in pain and swelling was related to pain catastrophizing and 
pain-related fear, which they interpreted in a way that pain-related fear affects 
motor processes and pain even when the individual has no intention to actually 
execute the movement. Another possible mechanism that is suggested to underlie 
CRPS-I, and as such may be linked to pain-related fear, is disuse or deconditioning, 
that develops in an effort to avoid pain (Verbunt et al., 2003). Operantly condi-
tioned disuse of the affected extremity, reinforced by avoidance of actual pain or 
reduced anxiety of anticipated worsening of pain, may prevent desensitization and 
eliminate the normal tactile and proprioceptive input from the extremity that may 
be necessary to restore normal central processing (Bruehl, 2005; Stanton-Hicks et 
al., 1998). Disuse also suggested to trigger hyperalgesia and allodynia in the affected 
extremity (Butler, 2001) and to interact with pathophysiological mechanisms that 
prevent the CRPS-I patient from ending a vicious cycle in which altered central proc-
essing leads to increased pain, which provokes catecholamine release that further 
stimulates the nociceptive input maintaining the central processing alterations 
(Bruehl, 2001). It is possible that pain-related fear is a mechanism that underlies and 
contributes to this disuse through its associated avoidance behavior, and that it may 
help maintain the primary features of CRPS-I. These, of course, are speculations that 
still await scientific scrutiny. 
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Remarkable is that both studies demonstrated that the TSK does not significantly 
predict functional limitations in patients with CRPS-I. These results are not consis-
tent with previous research among patients with musculoskeletal pain in which 
pain-related fear was shown to be associated with pain disability, and more so than 
pain itself (e.g. Crombez et al., 1999; Leeuw et al., 2007a). The TSK has been spe-
cially developed for patients with musculoskeletal pain, and back pain in particular. 
Although there is a lack of consensus among researchers, CRPS-I is thought to be a 
neuropathic pain disorder (Jänig & Baron, 2003). Therefore, TSK might not be suit-
able for measuring pain-related fear in neuropathic pain disorders such as CRPS-I. 
However, the mean score and the standard deviation of the TSK in Study I did not 
deviate that much from the scores in studies among chronic back patients, in which 
the TSK predicts the level of disabilities (e.g. Goubert, 2000). 
 
In contrast to the weak association between TSK and functional disability, pictorial 
measure of perceives harmfulness of activities (PHODA) appears to be a significant 
predictor for reported functional limitations in CRPS-I patients. It might be that 
visualisation of activities makes imagining executing the activity simpler, concrete 
and salient, as compared to general verbal statements such as the ones used in TSK. 
Because the PHODA makes performing activities better imaginable, its pictures may 
elicit more elevated fear levels as compared to the verbal items of the TSK. There is 
evidence that exposure to pictures with a negative valence elicit fear responses 
such as increase startle potentiation and also to lower pain tolerance (De Wied and 
Verbaten, 2002). As PHODA was not included in Study I, we do not know whether 
perceived harmfulness of activities is also a predictor of disability in patients with 
early CRPS-I who are admitted to a specialized pain clinic of the University Hospital. 
 
Finally, several limitations of both studies should be mentioned. First, the present 
studies are limited by there cross-sectional design. Positive correlations or regres-
sion weights may not be confused with causal effects. Second, the results are based 
on a relatively small number of CRPS-I patients. Third, because only 27% of the ini-
tially recruited sample actually participated in the study, there may be any potential 
impact of selection bias. However, non-response can cause a significant bias even 
with a high participation rate if the non-responders are a relatively homogeneous 
group that differs markedly from the responders (Bergstrand et al., 1983). Unfortu-
nately, and due to the study logistics, we do not have information about the charac-
teristics of the non-responders in our study. Fourth, the studies are impeded by the 
use of self-report measures only, which are subject to bias. Fifth, the two CRPS-I 
samples differed in duration of the condition. Study I consisted primarily of acute 
CRPS-I patients and Study II of chronic CRPS-I patients. There is good evidence that 
pain-related fear is associated with disability in patients with chronic musculoskele-
tal pain (Vlaeyen & Linton, 2000). However, also in (sub)acute pain disorders re-
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search showed very clearly that pain-related fear is related to pain and disability, 
and is a essential factor in the development of chronicity and long-term disability 
(e.g. Linton, 2000b; Fritz and George, 2002; Swinkels et al, 2003; Heneweer et al., 
2007; Vangronsveld et al., 2008). In fact, pain-related fear during the early pain 
condition seems to be the best predictors of future problems (e.g. Gheldof et al, 
2010). Therefore, we do not think that differences in pain duration between both 
samples may have affected our results adversely. Finally, a further point of consid-
eration is the fact that no gold standard for the diagnosis of CRPS-I has been estab-
lished, because a single pathophysiological mechanism explaining the variety of 
features observed in CRPS-I is lacking. Only the criteria set by the International As-
sociation for the Study of Pain (IASP) is officially recognized by the IASP to be used 
for formal diagnosis of CRPS-I (Harden & Bruehl, 2005). Other sets of diagnostic 
criteria are from Veldman et al. (1993) and Bruehl et al. (1999). Perez et al. (2007) 
found that there is a lack of agreement between the different diagnostics sets for 
CRPS-I and difference in clinical appearance between patients meeting the different 
criteria which may have profound consequences for the clinical profile of a study 
population. In study I, the diagnose CRPS-I is made based on the criteria of Veldman 
and in Study II, the participants declared themselves to be diagnosed with CRPS-I. 
Despite the choice for any of the criteria sets used in a study remains arbitrary 
(Perez et al. 2007), the current research results could be better translated if the 
diagnostic criteria for both studies were uniform. 
 
In summary, the current studies show that pain-related fear, when measured with a 
pictorial fear of activity scale (PHODA), is a predictor of functional limitations among 
CRPS-I patients with longstanding pain who are not seeking care in a specialized 
university pain clinic. Also, it appears that pain severity affects functional limitations 
in CRPS-I patients. The results indicate that the pain-related fear measures TSK and 
PHODA assess unique constructs of fear. However, it is not clear what CRPS-I pa-
tients with a high pain-related fear score, actually fear. Study I and II provide data to 
start a qualitative study to address the current concerns of CRPS-I patients. Despite 
the need replication in a larger CRPS-I sample, this study supports the idea that 
pain-related fear in CRPS-I patients is a promising research direction to get more 
insight in a poorly understood painful and disabling disorder (Nelson, 2002). 
 
What are the clinical implications of the current studies? If pain-related fear is in-
deed such a relevant factor it could be a treatment target in CRPS-I. Treatments that 
are based on the fear-avoidance model of pain do not primarily aim at pain relief, 
but at extinguishing pain-related fear and the presumed associations patient may 
have learned between certain activities and/or movements and potential body 
harm. Because of remarkable similarities between pain-related fear and 
fear/phobias in general, and the success of exposure-based treatments in patients 
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with anxiety disorders, a similar treatment was developed for application in fearful 
chronic pain patients (Vlaeyen et al., 2004). A preliminary experimental study of de 
Jong et al., (2005) supported the effectiveness of a graded exposure in vivo ap-
proach to chronic CRPS-I. The most essential step in this approach consisted of gra-
ded exposure to the situations the patients has identified as ‘dangerous’ or ‘threat-
ening’. Thus, in chronic CRPS-I patients it seems appropriate to assess not only pain 
severity, but also pain-related fear for which a treatment approach is available that 
shows promising results for this disabling chronic pain condition (see Baily et al., 
2010 for a review). 
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Chapter 3 
Reduction of pain-related fear and 
disability in posttraumatic neck pain: 
a replicated single case experimental 
study of exposure in vivo 
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Abstract 
For patients with acute post-traumatic neck pain (PTNP), pain-related fear has been 
identified as a potential predictor of chronic disability. If such is the case, fear reduc-
tion should enhance the prevention of further pain disability and distress after 
traumatic neck pain disability. However, exposure-based treatments have not been 
tested in patients with PTNP. Using a replicated single-case crossover phase design 
with multiple measurements, this study examined whether the validity of a graded 
exposure in vivo, as compared with usual graded activity, extends to PTNP. Eight 
patients who reported substantial pain-related fear were included in the study. 
Daily changes in pain intensity, pain-related fear, pain catastrophizing, and activity 
goal achievement were assessed. Before and after each intervention, and at 6-
month follow-up, standardized questionnaires of pain-related fear and pain disabil-
ity were administered, and, to quantify daily physical activity level, patients carried 
an ambulatory activity monitor. The results showed decreasing levels of self-
reported pain-related fear, pain intensity, disability, and improvements in physical 
activity level only when graded exposure in vivo was introduced, and not in the 
graded activity condition. The results are discussed in the context of the search for 
customized treatments for PTNP. 
Perspective 
This is the first study showing that the effects of graded exposure in vivo generalize 
to patients with chronic PTNP reporting elevated levels of pain-related fear. This 
could help clinicians to customize treatments for PTNP. 
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Introduction 
An increasing number of both experimental and clinical studies, mainly performed 
in patients with chronic low back pain (CLBP), have shown that pain-related fear is 
one of the most potent predictors of observable physical performance, self-
reported disability levels in daily life situations, and work loss (Buer & Linton, 2002; 
Fritz et al., 2001; Leeuw et al., 2007a; Vlaeyen & Linton, 2000). The basic tenet of 
the fear-avoidance model of pain is that the way in which pain is interpreted may 
lead to 2 different pathways. When dysfunctional beliefs about pain exist, a number 
of safety behaviors are initiated that may be adaptive in acute pain but paradoxi-
cally worsen the problem in the case of long-lasting pain. Typical safety behaviors 
are avoidance/escape behaviors and hypervigilance and the prolonged use of them 
maintains the fear level rather than reduces it. Fearful patients have a risk of getting 
mired in a downward cycle of pain, fear, avoidance, and increased disability. In con-
trast, when acute pain is perceived as less threatening, patients are likely to main-
tain their engagement in daily activities, through which functional recovery is pro-
moted (Asmundson et al., 1999; Vlaeyen & Linton, 2000). The fear-avoidance model 
has been successfully tested in patients with back pain (Picavet et al., 2002; Swin-
kels et al., 2006; Turner et al., 2006), osteoarthritis (Heuts et al., 2004), and burn 
injuries (Sgroi et al., 2005). 
 
If pain-related fear is indeed one of the important mechanisms responsible for the 
development and maintenance of chronic pain disability, fear reduction should 
enhance the prevention of further pain-disability and distress. Well-designed proce-
dures exist for the treatment of specific fears and phobias and usually these involve 
repeated and systematic exposure to fear-provoking stimuli, often presented in the 
context of behavioral experiments (Barlow, 2002; Butler et al., 2006; Clark, 1986). 
Although Philips (1987) argued for the application of exposure techniques to chronic 
pain some time ago, the first systematic experimental studies and randomized, 
controlled clinical trials in patients with chronic back pain were carried out more 
recently (Boersma et al., 2004; De Jong et al., 2005; Leeuw et al., 2008; Linton et al., 
2008; Vlaeyen et al., 2001; Vlaeyen et al., 2002a; 2002b; Woods & Asmundson, 
2008). 
 
In patients with post-traumatic neck pain (PTNP) pain-related fear is also found to 
be an important predictor for chronic disability (Nederhand et al., 2004; 2006). 
Given the beneficial effects of cognitive behavioral interventions for chronic pain 
(Morley et al., 1999), cognitive behavioral therapy programs have been developed 
for patients with PTNP disability as well (Foster et al., 2003; Jaspers, 1998; Linton & 
Andersson, 2000a; Linton & Ryberg, 2001; Soderlund & Lindberg, 2001; Sterner et 
al., 2001), of which those promoting physical activity have proven to be the most 
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effective (Crawford et al., 2004; Provinciali et al., 1996; Rosenfeld et al., 2003; So-
derlund & Lindberg, 2001; Vassiliou et al., 2006; Vendrig et al., 2000). Although 
these studies suggest that activity increase is associated with faster return to work 
and a decrease in pain and disability levels, there is evidence showing that these 
changes are mediated by the reduction of the catastrophic (mis)interpretations of 
pain (Mannion et al., 1999; Smeets et al., 2006a; Spinhoven et al., 2004). Therefore, 
we decided to test the effectiveness of an intervention that has catastrophic inter-
pretations and associated pain-related fear as its primary target. Given the benefi-
cial results of graded exposure in vivo (GEXP) in patients with CLBP, and since pain-
related fear has shown to be associated with neck pain injury (Nederhand et al., 
2004), there are good reasons to believe that an GEXP treatment would be benefi-
cial for the PTNP population as well. 
 
Using a replicated crossover, single-case, experimental phase design with multiple 
measurements, we examined whether the validity of a GEXP, as compared with a 
usual operant graded activity program (GA), extends to patients with chronic PTNP 
disability. We expected that GEXP would be superior to GA in patients reporting 
elevated levels of pain-related fear. 
Materials and Methods 
Study Design 
A sequential replicated crossover, single-case, experimental phase design was used. 
This design contains both direct and systematic replication elements to examine the 
effectiveness of GEXP as compared with GA. Direct replication is replication of the 
same experiment with another patient. Patients were randomly assigned to 1 of the 
2 conditions. Randomization occurred after the 14 baseline days (BAS) and was 
done by a computer system, providing allocations in a file that could be assessed 
only by an independent research administrator. In condition I, patients received 
GEXP first, followed by GA. In condition II, the sequence of treatment modules was 
reversed. 
Participants 
Eight consecutive patients who had chronic neck pain (>12 weeks) after a motor 
vehicle accident were included in the study. All patients were diagnosed as having 
whiplash-associated disorder (WAD), resulting from an acceleration-deceleration 
mechanism of energy transfer on the cervical spine. On the basis of these prede-
termined inclusion and exclusion criteria, the present study focused on patients 
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with grades I (neck pain but no physical findings) and II (pain and musculoskeletal 
findings such as reduced cervical range of motion) as decreed by the grading system 
of the Quebec Task Force on WADs associated with motor vehicle collisions (Spitzer 
et al., 1995). Patients with signs of a concussion, retrograde, or post-traumatic am-
nesia, serious injuries (eg, fractures, traumatic internal organic pathology), and any 
neurological signs were excluded. Two of the 8 participants reported memory prob-
lems, 3 reported problems concentrating, and 4 reported neither problems in 
memory or concentration. Besides the above-mentioned other exclusion criteria 
were illiteracy, pregnancy, alcohol or drug abuse, non–Dutch-speaking, and serious 
psychopathology. To check the latter, preset criteria based on Dutch norms were 
applied on the Symptom Checklist (SCL-90: Arrindell & Ettema, 1986). Because of 
post-traumatic amnesia and non–Dutch-speaking, 2 potential participants were 
excluded from the study. With regard to psychopathology none of the potential 
participants were excluded. The sample consisted of 5 male and 3 female patients, 
with a mean age of 45 ± 10.30 (SD) years and a mean duration of pain disability of 
44.4 months (range, 27.6–67.2 months). The patients were referred for outpatient 
behavioral rehabilitation at the department of rehabilitation of the Maastricht Uni-
versity Hospital or the Hoensbroek Rehabilitation Center and reported substantial 
fear of movement/(re)injury (Tampa Scale for Kinesophobia [TSK: Kori et al., 1990] 
score ≥40). 
The Medical Ethics Committee of the Rehabilitation Foundation Limburg–Institute 
for Rehabilitation Research Hoensbroeck approved the research protocol in addition 
to the institutional committee of the University Hospital Maastricht. 
Procedure and Program Overview 
Patients were first evaluated by the rehabilitation physician, who conducted a full 
physical examination, evaluated previous diagnostic tests, and who informed par-
ticipants about the study. When patients agreed to participate, the researcher sent 
additional written information, along with an informed consent form, TSK, and SCL-
90. If patients scored ≥40 on the TSK and fulfilled the preset SCL-90 criteria, they 
were invited for an intake procedure. 
During the intake procedure, information was gathered to complete a behavioral 
analysis of the pain problem with special attention to the patient’s catastrophic 
interpretations of his/her pain problem. At the end of the interview, the therapist 
encouraged the patient to formulate specific treatment goals, preferably in terms of 
activities that had been avoided such as household chores, leisure, or work activi-
ties. A hierarchy of fear-eliciting movements and activities was made using the Pho-
tograph series of Daily Activities for the upper extremities (PHODA: Dubbers et al., 
2003), a standardized method during which patients are requested to judge the 
harmfulness of 125 diverse physical movements from daily life activities repre-
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sented by photographs. Using a (fear) thermometer, each picture is given a rating 
between zero (representing the situation which is not harmful for the neck) to 100 
(representing the situation that is absolutely damaging the neck). Various forms of 
PHODA have been used successfully in previous studies (De Jong et al., 2005; Leeuw 
et al., 2008; Vlaeyen et al., 2001; 2002a; 2002b). 
 
After this assessment, patients started with a no-treatment 2-week BAS. During the 
second week of BAS, patients wore ambulatory accelerometry-based activity moni-
tors to register daily activity levels. After this first period, the 8 patients were ran-
domly allocated to 1 of 2 intervention sequences, GEXP followed by GA or vice ver-
sa. GA consisted of 20 sessions of 1 hour during 10 weeks. GEXP consisted of 12 
sessions of 1 hour during 6 weeks. After termination of GEXP and GA, patients car-
ried the activity monitor for 1 week with the instruction to resume their daily activi-
ties as much as possible. The fourth period was a 6-month follow-up (follow-up) at 
the end of which patients once more carried the accelerometry-based activity moni-
tor for 1 week. During BAS, GEXP, GA, and follow-up, patients completed daily mea-
sures at home. Questionnaires were completed before and after BAS, after GEXP, 
after GA, and at follow-up. 
Interventions 
Two different outpatient therapist teams provided GA and GEXP. Both teams con-
sisted of a behavioral therapist and an occupational or physical therapist experi-
enced in the cognitive-behavioral rehabilitation of patients with chronic pain. GEXP 
and GA are highly structured, protocolized, and individually tailored and aim to 
restore a normal pattern of daily function, including complete return to work. Pain 
reduction is not a direct goal of either intervention. 
Graded Exposure In Vivo 
The GEXP consists of several components: Goal identification, education, exposure 
in vivo, and generalization. 
Goal Identification 
First, the patient is invited to formulate his or her own treatment goals. The thera-
pist makes clear that GEXP does not primarily aim at reducing pain but at the resto-
ration of functional abilities despite pain. Subsequently, the patient and therapist 
agree on one or more realistic and specific goals that are formulated in positive 
terms. Activities (e.g., lifting weights) that are in line with these goals (e.g., return to 
work) are those that will be included in the graded exposure sessions. 
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Education 
Patients are given a careful explanation of the fear-avoidance model (Vlaeyen 
1995a; 1995b), using their own individual symptoms, beliefs, and behaviors in rela-
tion to their pain complaints. The therapist illustrates the paradoxical and dysfunc-
tional effects of avoidance as safety behavior and offers the patient a new view on 
pain as a common condition that can be self-managed rather than as a serious dis-
ease or a condition that needs careful protection. One of the major goals of the 
educational component is to help the patient understand that the consequences of 
pain are catastrophically overestimated. 
Exposure In Vivo 
Individually tailored practice tasks are developed based on the graded hierarchy of 
fear eliciting activities and/or movements. The exposure takes the form of a series 
of behavioral experiments in which dysfunctional beliefs are explicitly being chal-
lenged. These assumptions take the form of “If . . . , then . . .” statements (eg, “If I 
lift up my child, then nerves in the neck region will rupture and my muscles will get 
blocked”) and are empirically tested during a behavioral experiment. 
Generalization 
To enhance generalization and maintenance exposure is provided to the full spec-
trum of contexts and natural settings in which fear has been experienced, and the 
stimuli are varied. For example, bicycling can be done on a city bike and/or moun-
tain bike, uphill as well as downhill, on rough as well as even terrain, and so on. The 
exposure procedure included activities from PHODA and other activities. A more 
detailed description of GEXP can be found in Vlaeyen et al. (2002; 2004). 
Graded Activity 
The GA is based on the programs originally described by Fordyce (1976) and up-
dated by Sanders (2002). The main goal of GA is the systematic removal of the con-
tingent relationship between overt pain behavior and its positive consequences. 
This implies that GA is guided by the patient’s functional abilities and a time-
contingent rather than a pain-contingent regimen. In this study, GA consisted of the 
following components: Education, identification of goals, establishment of a base-
line, successive approximation, and generalization. 
Education 
The educational session is similar to the one in GEXP, except that the focus is on the 
detrimental effects of inactivity and not on dysfunctional beliefs. 
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Identification of Goals 
Similar to GEXP, realistic and functional treatment goals are formulated based on 
the patient’s main complaints. Goals are split up into separate activities in the quota 
system. 
Establishing Baseline Levels 
For each of these activities, a baseline level is determined based on a pain-
contingent principle (“go on with this activity until your pain makes you feel like 
discontinuing”). Afterward, time-contingent treatment quotas for each activity are 
developed, always starting below the mean baseline value. 
Successive Approximation 
During the treatment phase, the patient systematically increases the time-
contingent quotas to enable him/her to reach his/her personal goals within the 
preset therapy time period. The patient practices at home and documents every 
activity or exercise on a performance chart. These charts are discussed in each 
treatment session, and all team members positively reinforce the individual pro-
gress and successive approximations towards predefined (sub)goals. 
Generalization 
At the end of the treatment, activities are planned outside the hospital, preferably 
in the home and work setting to enhance response generalization. A more detailed 
description of GA can be found in Sanders (2002). 
Outcome Measures 
The primary outcome measures are self-reported achievement of functional goals, 
and pain disability. Secondary outcome measures are pain catastrophizing, pain-
related fear, physical activity levels in the home situation, and pain intensity. 
Daily Diary Measures 
To check whether the GEXP and/or GA indeed modified activity goal achievement, 
pain-related fear, and pain intensity, a brief diary was used consisting of 14 items 
with visual analog scales (VAS). The first 11 items (Table 1) represented the main 
factors of existing questionnaires for fear of movement/(re)injury (TSK: Goubert et 
al., 2004; Kori et al., 1990; Roelofs et al., 2004), fear of pain (Pain Anxiety Symptoms 
Scale; PASS: McCracken et al., 1992; 1999), and pain catastrophizing (Pain Catastro-
phizing Scale; PCS: Sullivan et al., 1995; Van Damme et al., 2002). All items were 
scored on 10-cm VAS, anchored “totally disagree” to “totally agree.” Three main 
scores were derived, consisting of the mean scores (range, 0–10) of the items from 
the TSK, PASS, and PCS. Pain intensity was measured with an additional VAS an-
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chored with “no pain at all” at one extreme and “worst pain experienced” at the 
other. The last 2 VAS referred to the performance of personally relevant activities 
that represented 2 main functional goals. Each scale was preceded by the same 
question: “How difficult was it to perform this activity today?” The scale was an-
chored with “no problem at all” at one extreme and “impossible” at the other. The 
diary was completed during the whole duration of the study, and the follow-up 
period of 1 week. The patients were requested to complete the diary each evening 
and to send the package by mail to the researchers the next day. The diary has been 
shown to be sensitive to GEXP in previous studies (De Jong et al., 2005; Vlaeyen et 
al., 2001; 2002a; 2002b). 
Functional Disability 
The Neck Disability Index (NDI) is a 10-item self-reporting instrument for the as-
sessment of physical disability of subjects with neck pain, particularly from whip-
lash-type injuries (Vernon & Mior, 1991). Each item is scored from 0 to 5. The NDI 
has been shown to have a high degree of test-retest reliability, internal consistency, 
and acceptable level of validity being sensitive to severity levels and to changes in 
severity over time (Riddle & Stratford, 1998; Vernon & Mior, 1991. Disability catego-
ries for the NDI are: 0 to 4 = no disability, 5 to 14 = mild disability, 15 to 24 = moder-
ate disability, 25 to 34 = severe disability, and above 34 = complete disability. We 
used a Dutch version, which has shown to be a reliable and responsive instrument in 
patients with acute neck pain in general practice (Köke et al., 1999; Vos et al., 2006). 
 
Table 1 Items of the Shortened and Adapted Versions of the TSK, PASS, and PCS That Are Completed on a 
Daily Basis 
Fear of movement/(re)injury (adapted and modified from TSK) 
1. If I exercise I might be in danger of reinjuring myself (Harm) 
2. My body is telling me I have something dangerously wrong (Fear) 
3. My pain complaints would decrease if I were to exercise (Exercise) 
4. I can’t do everything because it’s too easy for me to get injured (Avoidance) 
 
Fear of pain (adapted and modified from PASS) 
1. I become sweaty when in pain (Somatic anxiety) 
2. I feel confused when I hurt (Cognitive anxiety) 
3. When I feel pain, I think that something dreadful may happen (Fear) 
4. When I feel pain I try to stay quite as possible (Escape/Avoidance) 
 
Pain catastrophizing (adapted and modified from PCS) 
1. When I am in pain I keep thinking about how badly I want the pain to stop (Rumination) 
2. When I am in pain I wonder whether something serious may happen (Magnification) 
3. When I am in pain I feel I can’t go on with my daily activities (Helplessness) 
Abbreviations: PASS, Pain Anxiety Symptoms Scale; PCS, Pain Catastrophizing Scale; TSK, Tampa Scale for 
Kinesophobia. 
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Pain-Related Fear 
The complete Dutch version of the TSK was used. This questionnaire consists of 17 
items, measuring fear of (re)injury due to movement, scored on a 4-point scale. The 
TSK has been found reliable and valid and was capable to predict chronic disability 
in neck pain (Nederhand et al., 2004; 2006). 
Physical Activity Level 
To objectively assess physical activity level (PAL) in the home situation of the pa-
tients, patients carried a CSA/MTI uniaxial accelerometry-based electronic activity 
monitor (Computer Science and Applications, now Manufacturing Technology In-
corporated, Fort Walton Beach, FL). The monitor is attached to a belt dorsally, at 
the height of the thoracic vertebras and uses a built-in single axis accelerometer 
designed to detect normal human motion. The monitor outputs movement counts, 
which reflect the summation of vertical accelerations from 0.05 to 2.1 G. Data was 
stored for 1 week. The subjects wore the accelerometer during the daytime except 
during water-based activities. The data were downloaded to a computer via an 
infrared interface for data processing. Raw data were exported in 1-minute intervals 
and saved in separate files for each subject. Patients kept a notebook daily in which 
they registered the time carrying the activity monitor and the kind of activities per-
formed. Total physical activity was expressed as total counts divided by registered 
time; counts · min−1 · d−1 (counts per minute of days registered). The activity moni-
tor used in our study appeared to have acceptable reliability for most research ap-
plications (Welk et al., 2004). 
Manipulation Check 
To check whether the threat value of physical activities was diminished as a result of 
GEXP, the PHODA for upper extremities was repeated after baseline, GA, and GEXP. 
Each photograph is given a rating according to the position on the fear thermome-
ter. A total score ranging from 0 to 100 is calculated as the sum of each rating, di-
vided by 125 (the maximum total score). 
Validity Checks 
To avoid contamination the GEXP and the GA were given by different experienced 
therapists. In addition and to avoid contamination as a result of patient interactions, 
patients randomly assigned to the different conditions received their treatments at 
different days. Finally, records of activity performances, according to graded hierar-
chies or preset quota, were kept to enhance the compliance of the patients. 
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Statistical Analyses 
Besides graphical interpretations for analyzing the data of the daily measures, a 
randomization test for single-case experimental phase designs, based on the ran-
dom determination of the moments of phase change or intervention points, was 
carried out (Edgington, 1975; 1980; Ferron & Onghena, 1996; Onghena, 1992; Ong-
hena & Edgington, 2005). With respect to Student t tests, analysis of variance F 
tests, or other inferential procedures from within the general linear model frame-
work, randomization tests have the advantage of being valid for single-case experi-
ments without making distributional assumptions (Edgington, 1980; Edgington & 
Onghena, 2007; Onghena & Edgington, 2005), of being easy to apply (Edgington, 
1980; Onghena & Edgington, 2005), and of being extremely versatile for even the 
most complex single-case designs (Onghena & Van Damme, 1994; Persons & Silber-
schatz, 1998). A randomization test is a permutation test based on random assign-
ment to test a null hypothesis about treatment effects in a randomized experiment 
(Edgington, 1975; 1980; 1992; Edgington & Onghena, 2007). The randomization 
tests for the different single-case designs all make use of a directional test statistic 
(a difference between means). Replicated single-case experiments may be consid-
ered as multiple studies that can be combined using meta-analytical procedures. In 
the current study we used P value combining, which has the advantages that it is 
broadly applicable and that it is distribution-free without converting the scores to 
ranks or signs (Edgington, 1992; Onghena & Edgington, 2005). A more detailed de-
scription of the randomization tests for single-case experimental designs and se-
quential replication designs in particular can be found in Onghena and Edgington 
(2005). Because GEXP was expected to be superior to BAS and GA, the null hypothe-
sis that there is no differential effect for any of the measurement times was tested 
using a randomization test on the differences between GEXP and BAS, GA and BAS, 
and GA and GEXP. Although follow-up is expected to be superior to BAS and will not 
change in relation to GEXP, differences between follow-up and BAS, follow-up and 
GA, follow-up and GEXP were also tested using randomization tests. The analysis is 
performed using the SCRT software (Single-Case Randomization Tests, version 1.1; 
Katholieke Universiteit Leuven, Leuven, Belgium, 1994). Finally, the test is repeated, 
assuming delayed effects until the minimal P value (P < .05) is reached (Edgington, 
1992; Edgington & Onghena, 2007; Wampold & Furlong, 1981). One effect lag 
equals 1 week, or 2 treatment sessions. 
Preset Criteria for Nondaily Measures 
For the nondaily measures, the limited number of data made it impossible to use 
randomization tests. Therefore, we decided to formulate preset criteria to conclude 
whether the treatment could be considered successful. For the NDI, a 5-point 
change is required to be clinically meaningful (Stratford et al., 1999). For the TSK 
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and PHODA, we considered a 50% decrease would give enough support that the 
threat value of the activities had decreased. This decision was based on the results 
of exposure studies of patients with CLBP who show at least a comparable decrease 
for these variables (De Jong et al., 2005; Vlaeyen et al., 2001; 2002a; 2002b). 
Results 
Manipulation Check 
The results of the PHODA for upper extremities, used to check whether the threat 
value of physical activities has diminished as a result of GEXP, are summarized in 
Table 2. In condition I, as compared with the start of GEXP (PHODA score = 86), a 
relevant reduction (≥50% decrease) in PHODA-scores is observed at the end of GEXP 
(PHODA score = 9), and there was no further reduction during GA (PHODA score = 7) 
and follow-up (PHODA score = 8). In condition II, the PHODA score decreased so-
mewhat from 85 at the start of GA to 68 at the end of GA. However, once again, 
when GEXP was introduced, the PHODA score decreased further to 8 (≥50% de-
crease) and remained at the same level at follow-up. 
 
Table 2 Mean Scores (Range) for Pain-Related Fear (TSK and PHODA) and Pain Disability (NDI), Deter-
mined at Baseline, Before, and After Each Treatment Module, and at the 6-Month Follow-Up for Condi-
tion I (n = 4) and Condition II (n = 4) 
Condition Interval NDI (0–50) TSK (17–68) PHODA (0–100) 
Condition I    
Baseline 37.8 47.5 83 
Start GEXP 37.8 47.5 86 
End GEXP 7.5 24 9 
Start GA 7.5 24 9 
End GA 7.5 24 7 
6-mo follow-up 8.5 25 8 
Condition II    
Baseline 35.5 48 85 
Start GA 35.5 48 85 
End GA 27 41 68 
Start GEXP 27 41 69 
End GEXP 8.5 23 8 
6-mo follow-up 8.5 23 8 
Abbreviations: TSK, Tampa Scale for Kinesophobia; PHODA, Photograph series of Daily Activities for the 
upper extremeties; NDI, Neck Disability Index; GEXP, graded exposure in vivo; GA, graded activity. 
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Daily Measures 
Because the patterns of change for fear of movement/(re)injury, fear of pain, pain 
catastrophizing, and pain experience of each patient within both conditions are 
quite similar, we decided to calculate group means of the time series for these vari-
ables. This produced more conveniently arranged graphs. Figure 1 displays the 
graphical representations for fear of movement/(re)injury, pain experience, fear of 
pain, and pain catastrophizing. Visual inspection reveals that in both conditions 
trend changes occur after the introduction of GEXP only and that these changes are 
still present during the 6-month follow-up period. By contrast, the introduction of 
GA does not lead to observable trend changes. These observations suggests that, 
for chronic neck pain patients who reported substantial pain-related fear, fear of 
movement/(re)injury, pain experience, fear of pain, and pain catastrophizing are 
reduced only by GEXP. It is also remarkable that at the onset of GEXP in both condi-
tions pain experience increased. There appears to be an increase in pain experience 
at the start of the sessions before the standard decrease observed in sessions 7 
through 9. In fact, in condition II, this increase in pain appears to return to levels 
that were experienced at the start of the GA protocol. Also, in both conditions, the 
results suggest that the decrease in pain experience temporarily follows an associa-
ted decrease in fear of movement/(re)injury. 
 
The graphical representations of personally relevant activities for both conditions 
are displayed in figure 2. Because both selected activities show the same patterns of 
change for each patient, only 1 activity per person is presented. Again, only substan-
tial trend changes are observed when GEXP is introduced. 
 
The results of the randomization tests on the raw data of the daily measures con-
firm the conclusions of the graphical display. For the variables fear of movement, 
fear of pain and pain catastrophizing the moments of phase change or intervention 
points in which significance is reached take place during the GEXP (Table 3). Because 
the above-mentioned variables show the same results (P values) for each patient 
only the variable fear of movement is presented. For all patients in condition I (BAS-
GEXP-GA-follow-up), the effect lag during GEXP, in which the minimum P values (P > 
.05) for the randomization tests was reached, is the fifth week. In condition II (BAS-
GA-GEXP-follow-up), this is the same for patient 1 and 5. Conversely, for patient 6 
and 8 the minimum P value was reached in the fourth week of GEXP. With regard to 
pain experience and the performance of personally relevant activities such as con-
structing a floor, gardening, mountain biking/jogging, working as a nurse/salesman, 
playing with the children, looking backward, and dancing, significant moments of 
phase change (P > .05) occurred only during GEXP, in both conditions in the fifth 
week (Table 3). For all variables, the measurement periods after the GEXP did not 
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provide any other significant phase changes with regard to a positive improvement 
or a possible relapse. 
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Figure 1 Means calculated from the time series of each patient within condition I (n = 4) and condition II
(n = 4) for fear of movement/(re)injury (fom), pain experience (pe), fear of pain (fop), and pain catastro-
phizing (pc) as measured with the daily diary, across baseline (BAS), graded exposure in vivo (GEXP), 
graded activity (GA), and 6-month follow-up period (FU). BAS = 14 days, GEXP= 42 days (12 sessions of 1 
hour) + 7 days of activity monitor; GA = 70 days (20 sessions of 1 hour) + 7 days of activity monitor, FU = 
7 days. VAS, visual analog scale. 
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Figure 2 Mean daily measures for each patient in condition I and condition II for 1 of the 2 selected
personally relevant activities, across baseline (BAS), graded exposure in vivo (GEXP), graded activity (GA), 
and 6-month follow-up period (FU). BAS = 14 days, GEXP= 42 days (12 sessions of 1 hour) + 7 days of
activity monitor; GA = 70 days (20 sessions of 1 hour) + 7 days of activity monitor, FU = 7 days. VAS, visual 
analog scale. 
Functional Disability 
Functional disability assessed by the NDI is shown in Table 2. In both conditions at 
the start and the end of BAS the mean score equates with “completely disabled.” 
Clinically meaningful changes (≥5-point change) are observed when GA (mean score 
of 35.5–27) as well as GEXP (mean score of 37.8–7.5) is introduced first. However, 
considering the disability categories for the NDI, patients in condition II are still 
“severely disabled” at the end of GA, whereas the patients in condition I report mild 
disability at the end of GEXP. When GEXP follows GA in condition II, the mean score 
for the NDI decreased further (mean score of 27–8.5), which means that the GEXP 
provides for a situation in which patients are “mildly disabled.” The measurement 
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periods after the GEXP did not show new clinical relevant changes in either category 
for functional disability. 
 
Table 3 The Effect Lag During the Graded Exposure In Vivo in Which the Minimum P Values for the Ran-
domization Tests With 1 Observation Per Phase Has Been Reached for Each Patient in Condition I and 
Condition II for Fear of Movement, Pain Experience, and 2 Personally Relevant Activities 
Condition Interval Fear of Movement Pain Experience Activity 1 Activity 2 
Condition I     
Patient 2 5 (P = .024) 5 (P = .029) 5a (P = .024) 5b (P = .024) 
Patient 3 5 (P = .024) 5 (P = .024) 5c (P = .024) 5d (P = .024) 
Patient 4 5 (P = .021) 5 (P = .024) 5e (P = .021) 5f (P = .021) 
Patient 7 5 (P = .029) 5 (P = .037) 5g (P = .029) 5h (P = .029) 
Condition II     
Patient 1 5 (P = .013) 5 (P = .013) 5i (P = .013) 5j (P = .016) 
Patient 5 5 (P = .016) 5 (P = .024) 5k (P = .016) 5l (P = .016) 
Patient 6 4 (P = .024) 5 (P = .024) 5m (P = .024) 5n (P = .024) 
Patient 8 4 (P = .029) 5 (P = .037) 5o (P = .029) 5p (P = .024) 
NOTE. The effect lag (1 lag is 1 week or 2 sessions of exposure therapy) during the graded exposure in 
vivo in which the minimum P values for the randomization tests with 1 observation per phase has been 
reached for each patient in condition I (baseline – graded exposure in vivo – graded activity – 6-month 
follow-up) and condition II (baseline – graded activity – graded exposure in vivo – 6-month follow-up) for 
fear of movement, pain experience, and 2 personally relevant activities.a Mountain bike; b construct a 
floor; c garden; d jogging; e lift paving stones; f play soccer; g ride; h work as nurse; i swim; j look back; 
k clean the bathroom; l cycle; m dance; n having a romp with the children; o drive a car; p work as salesman. 
Pain-Related Fear 
Clinically relevant change for pain-related fear, defined by a minimum of 50% de-
crease on the mean TSK score, is only observed when GEXP is delivered (Table 2). In 
condition I the mean TSK score decreased from 47.5 at the start of GEXP to a mean 
TSK score of 24 at the end of GEXP. This clinically relevant reduction remains after 
GA and at follow-up. In condition II, there is a slight decrease at first of the mean 
TSK score from 48 to 41 as the result of GA and a clinically relevant change to 23 at 
the end of GEXP, which remains at follow-up. 
Physical Activity 
The physical activity data obtained by accelerometry are summarized in Table 4. 
Compared with BAS, in condition I a marked increase of physical activity, expressed 
as total movement counts per minute of days registered, is observed during GEXP 
(220 ± 8.75 to 574 ± 17.75). When GA followed BAS, as prescribed for condition II, 
physical activity was also increased (217 ± 7.98 to 356 ± 6.09) but to a lesser extent 
than in condition I in which GEXP followed BAS. In condition II, physical activity in-
creased further when GEXP followed GA (356 ± 6.09 to 564 ± 23.30). In contrast, the 
degree of physical activity did not change appreciably when GA follows GEXP (condi-
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tion I). Regarding physical activity during follow-up in condition I as compared with 
GA, a slight reduction is observed (578 ± 22.43 to 543 ± 12.69), whereas in condition 
II, the degree of physical activity remains almost the same as at the end of GEXP 
(564 ± 23.30 to 561 ± 22.91). However, in both conditions, physical activity at fol-
low-up is much higher than at BAS. 
 
Table 4 Total Amount of Physical Activity, Adjusted for Time Wearing the Activity Monitor in Condition I 
and Condition II 
 Total Physical Activity (counts · min−1 · d−1) 
Condition Interval Mean Minimum Maximum SD 
Condition I (n = 4)     
Baseline 220 208 232 8.75 
GEXP 574 554 601 17.75 
GA 578 548 611 22.43 
6-mo follow-up 543 529 564 12.69 
Condition II (n = 4)     
Baseline 217 210 229 7.98 
GA 356 348 364 6.09 
GEXP 564 545 602 23.30 
6-mo follow-up 561 543 598 22.91 
Abbreviations: GEXP, graded exposure in vivo; GA, graded activity. 
NOTE. Total amount of physical activity (expressed as activity counts per minute of days registered; 
counts · min−1 · d−1) adjusted for time wearing the activity monitor in condition I (baseline – graded expo-
sure in vivo – graded activity – 6-month follow-up) and condition II (baseline – graded activity – graded 
exposure in vivo – 6-month follow-up). 
Discussion 
This is the first study showing that the effects of GEXP generalized to patients with 
chronic PTNP reporting elevated levels of pain-related fear. By using a replicated 
single-case, crossover, experimental phase design, the aim of this study was to 
examine the effectiveness of GEXP as compared with GA in reducing the threat 
value of physical activities and/or movements and to restore daily functioning in 8 
patients with chronic PTNP reporting substantial fear of movement and/or 
(re)injury. The patients were referred for outpatient behavioral rehabilitation. Both 
the randomization tests on the daily measures and the pre- and post-treatment 
phase measures showed that compared with GA, GEXP was superior in decreasing 
levels of pain-related fear, pain catastrophizing, pain disability, and pain experience, 
both after treatment and at follow-up. However, it should be mentioned that the 
results of the nondaily measures, with limited number of data points, were not 
subjected to randomization tests and for the most part based on arbitrary preset 
criteria. Improvements were found not only in the self-report measures but also in 
physical activity in the home situation, as measured with ambulatory activity moni-
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tors. Because the experimental design did not include washout periods between the 
different treatment components, it is likely that carry-over effects occurred. Indeed, 
when GA followed GEXP, the improvements remained stable, which is also consis-
tent with the favorable follow-up results. 
 
As noted in the introduction, GA showed to be helpful for chronic neck pain disabili-
ty across a number of studies. However, in the current study, change during GA was 
marginal at best when GA preceded GEXP. Both GA and GEXP were performed ac-
cording to a specific protocol. In addition, a different therapist team gave GA and 
GEXP. Because patients’ attitudes and beliefs, and thereby patients’ disability levels, 
may be derived from the projected attitudes and beliefs of health care providers 
(Rainville et al., 1995), the 2 teams were comparable in terms of experience and 
therapists’ preferences. Efforts were made to achieve the same level of enthusiasm 
in each therapist who participated in either GA or GEXP. 
Besides the superiority of GEXP over GA, there is a sudden and remarkable level of 
improvement around sessions 7 to 9 during GEXP. The content of these sessions 
mainly consisted of exposure to personally relevant activities that represented the 
main functional goals that were chosen by the patients themselves. Research into 
return of fear and contextual renewal shows that the beneficial effects of exposure 
are more or less confined to the context in which the exposure treatment was per-
formed (Bouton, 2002; Rachman & Whittal, 1989; Vansteenwegen et al., 2007). This 
means that confrontations with the (previously) fearful activity in other contexts 
could elicit a certain level of fear. However, the results in this study show that over-
all daily activity, as measured by the activity monitor, increased both in the short 
and long term. It seems likely that daily life activities not only consisted of situations 
that were part of GEXP. 
 
GEXP has successfully been applied to patients with CLBP. Besides some single-case, 
experimental studies, randomized controlled clinical trials also have shown positive 
results recently with regard to pain disability and pain-related fear (Boersma et al., 
2004; De Jong et al., 2005; Leeuw et al., 2008; Linton et al., 2008; Vlaeyen et al., 
2001; 2002a; 2002b; Woods & Asmundson, 2008). However, in comparison with the 
single-case, experimental exposure studies in patients with low back pain (De Jong 
et al., 2005; Vlaeyen et al., 2001; 2002a; 2002b), the current study shows that more 
exposure sessions are needed to demonstrate trend changes and significant effects 
in patients with PTNP. A possible explanation is that neck pain patients experience 
multiple complaints and fears, not just fear of movement. Besides neck pain, symp-
toms such as headache, visual disturbances, dizziness, weakness, paraesthesia, 
nausea, both upper and lower limb numbness and tingling, tinnitus, and cognitive 
problems (concentration and memory disturbances) are common in the acute stage 
after a traumatic event (Barnsley et al., 1994; Ferrari et al., 2005). In CLBP, patients’ 
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main concern is overall the experienced pain interfering with daily life activities. In 
addition, the concerns of the neck pain patients may be more difficult to challenge 
(eg “If I would lift heavy weights, then I do not have full control of my neck, which 
will worsen the pain complaints, with the result that I will not be able to do my job 
in the future”). 
 
It is of interest that current pain experience was also affected by GEXP. Moreover, 
the current results suggest that the decrease in pain experience temporarily follows 
an associated decrease in pain-related fear. Similar results are observed in the sin-
gle-case, experimental studies of GEXP in CLBP and are in line with the fear-
avoidance model (De Jong et al., 2005; Vlaeyen et al., 2001; 2002a; 2002b). Howe-
ver, such strong reduction in pain is not common in usual cognitive-behavioral 
treatments for chronic pain (Kole-Snijders et al., 1999; Morley et al., 1999). How can 
this unexpected result be explained? One explanation is that fear reduction is asso-
ciated with a decrease in muscle activation (Nederhand et al., 2006), which in turn 
may be associated with a reduction of pain experience (Flor et al., 1985). By avoi-
ding the use of painful muscles to prevent the amplification of pain and further 
injury, muscle activation is decreased. Alternatively, experimental studies on the 
role of attention and pain-related fear have shown that patients with elevated le-
vels of pain-related fear habitually attend to somatic sensations (Asmundson et al., 
1997; Peters et al., 2002). This finding corroborates the idea that the most impor-
tant function of anxiety is the early detection of potentially threatening situations. It 
is likely that the decrease in pain experience during GEXP was mediated by a pro-
cess in which the reduction of the threat value of previously fear-eliciting stimuli 
also produced a redirection of the attention away from pain and bodily sensations. 
Finally, pain reduction might be the direct result of the diminished threat value of 
physical activities (Arntz & Claassens, 2004). This is in line with recent imaging stu-
dies showing a relationship between catastrophizing and activity in cortical regions 
associated with affective, attention, and motor aspects of pain (Seminowicz & Davis, 
2006). 
 
Despite the overall positive influence of GEXP on pain experience, there appears to 
be an increase in pain experience at the onset of GEXP. A possible explanation may 
have to do with the natural history of the participants. They could all be characteri-
zed as not-at-fault drivers. Research has shown that the not-at-fault driver is angry 
at someone else’s actions (Ferrari et al., 2005; Mayou, 1994). They interact with the 
other driver and others with a notion of that “stupid driver” injured them and kee-
ping him/her from attaining an important goal (Berkowitz & Harmon-Jones, 2004; 
Ferrari et al., 2005). Besides, also subjectively aversive conditions which are the 
result of the injury can generate anger (Berkowitz & Harmon-Jones, 2004). An 
example of such aversive conditions could be exposure to activities and/or move-
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ments in which physical discomfort or pain will be experienced (Anderson et al., 
1998; Berkowitz & Harmon-Jones, 2004). The induction of anger, for his part, and 
also pain-evoked cardiac responses that are modulated by anger produces increa-
sed pain intensity and pain unpleasantness (Rainville et al., 2005). 
 
Finally, several limitations of the study should be mentioned. First, this study is 
limited in that it included only 8 patients. However, a replicated crossover, single-
case, experimental design was chosen with a customized randomization test to 
perform statistical analyses, which is an added value to detect idiosyncratic functio-
nal relationships and behavioral laws. Second, because in the crossover design all 
patients received both GEXP and GA, long-term differential effects could not be 
established. Replication studies in the form of randomized, controlled trials using 
larger samples are warranted. However, single-case experiments have higher practi-
cality as compared with randomized, controlled trials and therefore are more useful 
to demonstrate accountability in a clinical setting on a more regular basis (Persons 
& Silberschatz, 1998). In addition, the application of single-case experiments is an 
obvious option if the research interest is in the evaluation of individualized custom-
made therapy (Onghena & Edgington, 2005). Third, by definition, it is not possible 
within single case studies to assess generality across subjects. However, interventi-
ons that produce dramatic effects are likely to generalize more than those with 
weaker effects, and this appears to be true in this study. Using randomization tests 
as time series analysis, we have demonstrated that the changes could not be attri-
buted to chance. Besides, generalization may be derived from the fact that replica-
tions of eight different patients show consistently similar results in this study and in 
studies of patients with CLBP. So far, it seems justifiable to generalize the results to 
other patients with chronic PTNP who report substantial pain-related fear. Howe-
ver, it should be mentioned that patients who also report serious psychopathology 
did not participate in this study. Regarding limits of using GEXP to treat patients 
with fear or anxiety and significant psychopathology, the literature is not univocal. 
The same goes for the effect of psychopathology in cognitive-behavioral interventi-
ons as treatment for chronic pain. Therefore, it is quite possible that GEXP may also 
be a successful intervention for patients with PTNP who report serious psychopa-
thology. In this study, the decision about excluding patients with serious psychopa-
thology was based on criteria of earlier trials (Kole-Snijders et al., 1999; Smeets et 
al., 2006b; Hout van den et al., 2003). Fourth, this study did not check whether pain 
behavior has decreased as a result of GA. Finally, the follow-up period may not have 
been sufficient to determine the long-term effect on the treatment or long-term 
disability. 
In sum, the current study supports a GEXP approach in chronic PTNP patients repor-
ting substantial levels of pain-related fear. The GEXP was successful in decreasing 
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the level of daily life physical activity as measured with an accelerometry-based 
activity monitor. These results underscore the idea that GEXP modifies the meaning 
people attach to their neck pain complaints, and those changes also influence the 
experienced painfulness. The results need to be verified in a wider chronic PTNP 
population. However, providing patients who report pain-related fear with a struc-
tured exposure in vivo program seems a promising treatment direction. 
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Abstract 
Fear of (re)injury/movement has been identified as a potential predictor of chronic 
disability in complex regional pain syndrome type I (CRPS-I). In order to reduce pain-
related fears and pain disability, graded exposure in vivo (GEXP) is likely to be an 
appropriate treatment. Indeed, there is evidence that in chronic pain patients re-
porting substantial fear of (re)injury/movement, GEXP is successful in reducing pain 
disability. However, the efficacy of exposure-based protocols in the treatment of 
CRPS-I patients for reducing pain disability has not been tested. The main research 
question of this study was whether the reduction of pain-related fear through GEXP 
also resulted in a decrease of disability in a subgroup of patients with CRPS-I who 
report substantial pain-related fear. A single-case experimental ABCD-design was 
used with random determination of the start of the intervention. Eight patients with 
CRPS-I were included in the study. To assess daily changes in pain intensity, pain-
related fear, pain catastrophizing, and activity goal achievement, a diary was used. 
Standardized questionnaires of pain-related fear, pain disability, and self-reported 
signs and symptoms of CRPS-I were administered before and after each interventi-
on, and at 6-month follow-up. The current study supports a GEXP approach to chro-
nic CRPS-I. The GEXP was successful in decreasing levels of self-reported pain-
related fear, pain intensity, disability, and physiological signs and symptoms. These 
results support the hypothesis that the meaning people attach to a noxious stimulus 
influences its experienced painfulness, and that GEXP activates cortical networks 
and reconciles motor output and sensory feedback. 
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Introduction 
Complex regional pain syndrome type I (CRPS-I) is a poorly understood chronic pain 
disorder with regard to pathophysiology and treatment. A limited number of studies 
have focused on the psychological factors that may modulate the development of 
chronic disability in CRPS-I. One factor that has been suggested as a potential pre-
dictor of disability is fear of injury, as patients with CRPS-I are often unaware that 
their pain condition resulted from a minor trivial event (Nelson, 2002). This fear, 
combined with the increased pain sensitivity may lead to excessive guarding and 
overprotective behaviors that may worsen the pain problem. Indeed, there is evi-
dence that in other musculoskeletal pain disorders such as back and neck pain, pain-
related fear and associated avoidance behaviors contribute to the development of 
chronic pain disability (Keefe et al., 2004; Linton, 2000b; Nederhand et al., 2004; 
Vlaeyen & Linton, 2000). 
 
In the process of customization of cognitive behavioral treatments of excessive fears 
and anxiety, exposure to the feared stimuli appeared to be the most essential com-
ponent. In order to reduce fear, the bio-informational theory of fear (Lang et al., 
1998) predicts that first the fear network needs to be activated, and second, new 
information needs to be available that disconfirms the fear expectations that are 
inherent to the fear memory. On basis of these ideas and experimental support 
(Crombez et al., 1996; Goubert et al., 2002; Rachman, 1994), Boersma et al. (2004), 
De Jong et al. (2005) and Vlaeyen et al. (2001, 2002a) conducted a number of stu-
dies to examine the effectiveness of graded exposure in vivo in reducing pain-
related fears and pain disability in chronic low back pain patients reporting substan-
tial fear of movement/(re)injury. The remarkable improvements that are observed 
whenever graded exposure was initiated seem to suggest that the therapeutic po-
wer of exposure is very strong in the treatment of pain-related fear. Not only were 
improvements found on measures of pain-related fear and pain disability, but they 
were also generalized to increases in physical activity in the home situation. 
 
For the treatment of CRPS-I a few evidence-based treatment regimens are available 
so far. A limited number of treatments focusing on physiotherapeutic algorithm and 
modalities (Egle and Hoffmann, 1990; Geertzen et al., 1994; Oerlemans et al., 1999; 
Richlin et al., 1978; Schwartzman & Kerrigan, 1990) as well as cognitive-behavioral 
treatment (Geertzen et al., 1994; Lee et al., 2002) also have shown to be effective in 
patients with CRPS-I. However, the efficacy of exposure-based protocols in the 
treatment of CRPS-patients for reducing pain-related fear and pain disability has not 
been tested (Harden, 2005; Keefe et al., 2004). 
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Using a replicated single case experimental design, we decided to experimentally 
examine whether the validity of graded exposure in vivo extends to patients with 
CRPS-I. The main research question of this study was whether the reduction of pain-
related fear through graded exposure in vivo also resulted in a decrease of disability 
in a subgroup of patients with CRPS-I who report substantial pain-related fear. Besi-
des, the contribution of a psycho-educational session, as part of the exposure, was 
examined. 
Materials and methods 
Study design 
A single-case experimental ABCD-design was used with random determination of 
the start of the intervention (see also Onghena & Edgington, 2005). Measurement 
period A was a baseline (BAS) during which no new treatments where started. After 
BAS all patients received an education (EDU), followed again by a no-treatment 
period (B). Thereafter, the graded exposure in vivo (GEXP) was delivered (C). Finally, 
at 6-month there was a follow-up period of 1 week (D). To examine whether EDU, as 
particular component of GEXP, is effective in decreasing pain-related fear and/or 
disability, the ABCD-design uses control variables to demonstrate the effect of both 
interventions. These control variables are BAS and the no-treatment period after 
EDU. Experimental control is demonstrated if the changes in the patients’ behavior 
and beliefs follow the changes in treatment conditions. Besides, by varying the 
length of each intervention phase, evident changes in treatment conditions are less 
the result of coincidence (Morley, 1996). In this study, two randomizations occur-
red. 
First, the initiation of EDU was randomly assigned to the 8th or 15th day of the ex-
periment. After that, the duration of the EDU period was also randomly assigned to 
7 or 14 days. In this design, there were four possible assignments: A (7 days)–B (7 
days)–C, or A (7 days)–B (14 days)–C, or A (14 days)–B (7 days)–C, and A (14 days)–B 
(14 days)–C. Two kinds of outcome measures were included. To assess daily changes 
in pain intensity, pain-related fear, pain catastrophizing, and activity goal achieve-
ment, a diary was used. Standardized questionnaires of pain-related fear, pain disa-
bility, and self-reported signs and symptoms of CRPS-I were administered before 
and after each intervention, and at 6-month follow-up. 
Participants 
Eight patients with CRPS-I were included in the study. The sample was all female 
(100%), with a mean age of 40±10.20 (SD) years. In two patients CRPS-I was located 
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in the right lower extremity, one patient in the left lower extremity, four patients in 
the right upper extremity, and one patient in the left upper extremity. In six pa-
tients, CRPS-I occurred on the dominant side. At inclusion, the mean duration of the 
complaints was 3.0±1.11 years. The diagnosis of CRPS-I was made according to the 
criteria formulated by the IASP, and based on physician evaluation of objective 
symptoms. In order to select a subgroup of patients that also met the modifications 
that have been suggested to these criteria, the stringent criteria as formulated by 
Bruehl et al. (1999) and Veldman et al. (1993) were also assessed: altered skin color, 
altered skin temperature, edema (swelling), reduced range of motion, trophic (hair, 
nail skin). Other inclusion criteria were that the patients reported substantial fear of 
movement/(re)injury (Tampa Scale for Kinesiophobia (TSK: Miller et al., 1991) score 
>39), pain for at least 6 months and age between 18 and 65. The cut-off is based on 
the median of the TSK distribution of chronic low back pain samples reported earlier 
(Crombez et al., 1999; Vlaeyen & Linton, 2000). Exclusion criteria were illiteracy, 
pregnancy, impairment of contra lateral extremity (e.g. because of rheumatoid 
arthritis, prior sympathectomy of the affected extremity), alcohol or drug abuse, 
and serious psychopathology based on the Symptom Checklist of which Dutch 
norms are available. 
Procedure and program overview 
Patients referred to the department of Pain Management and Research, and the 
department of Rehabilitation of the University Hospital Maastricht or the Hoens-
broeck Rehabilitation Center who met the selection criteria, and who gave their 
written informed consent, were subsequently invited for an semi-structured inter-
view, during which a cognitive and behavioral analysis of their pain problem was 
made. 
A fear hierarchy was established by means of the Photograph series of Daily activi-
ties for the upper extremities (PHODA-UE: Dubbers & Vikström, 2003) or the lower 
extremities (PHODA-LE: Jelinek et al., 2003). After this assessment, patients started 
with the BAS, during which they completed daily measurements at home. This peri-
od was followed by the exposure in vivo, which consisted of two steps. In the first 
step the EDU was given, followed again by a no-treatment period. After that, the 
GEXP started and was spread over 10 weeks and consisted of 20 sessions of 1 h 
each. 
The interventions were carried out by a behavioral therapist, who is experienced in 
the field of pain, supervised by a rehabilitation specialist. 
Education (EDU) 
Patients were given a careful explanation of the fear-avoidance model, using the 
patient’s individual symptoms, beliefs and behaviors to illustrate how vicious circles 
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(pain>catastrophic thoughts>fear>avoidance>disability>pain) maintain the pain 
problem. The main goal of this part was to unambiguously educate the patient in a 
way that the patient views the various autonomic and vasomotor disturbances as a 
condition that can be self-managed, rather than a disease that needs careful protec-
tion. The aim was to correct the misinterpretations and misconceptions that have 
occurred during the development of the pain-related fear. One of the major goals of 
this educational part was to increase the willingness of the patient to finally engage 
in activities, movements and situations he has been avoiding for a long time. 
Graded exposure in vivo (GEXP) 
The most essential step consisted of graded exposure to the situations the patients 
had identified as ‘dangerous’ or ‘threatening’. Based on the graded hierarchy of 
fear-eliciting situations (PHODA), individually tailored practice tasks were develo-
ped. Further, the general principles for exposure were followed. The patient agreed 
to perform certain activities or movements or stay in situations that he or she had 
been avoiding. Patients were also encouraged to engage in these fearful activities, 
movements or situations as much as possible until anxiety levels had decreased. The 
therapist first modelled each activity or movement. Finally, the GEXP was presented 
as a start only, and the patient was encouraged to continue exposing him or herself 
to more activities in everyday life after termination of the treatment sessions. To 
facilitate independence and to promote generalization, the presence of the thera-
pist was gradually withdrawn, and contexts were created that mimicked those of 
the home situation. A detailed description of the exposure in vivo treatment can be 
found in Vlaeyen et al. (2002c). 
Outcome measures 
Functional disability 
For CRPS-I patients with upper extremity pain the Radboud Skills Questionnaire 
(RASQ: Oerlemans et al., 1999; 2000a) was used. The RASQ scored patient’s ability 
to perform activities of daily living in the normal manner. Representative items in 
the domain ‘disabilities due to a hand disease’ were measured with questions divi-
ded into 11 categories, ranging from personal hygiene to meal preparation and 
recreational activities. All questions were scored on a numerical way (1–5, with an 
extra score of ’9’ for ‘not applicable’). The questionnaire has been found reliable in 
CRPS-patients, with good agreement between the outcomes for the test-retest and 
the interobserver reliability studies as established with the method of Bland and 
Altman (1986). For patients with CRPS-I lower extremity pain, the Walking Stairs 
Questionnaire (WSQ: Roorda et al., 1996a; 2004) and Questionnaire Rising and 
Sitting Down (QRS: Roorda et al., 1996b) were used. The QRS consisted of two 
subscales. One subscale (‘QRS high chair’) focused on rising from an sitting down on 
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high seats, including lavatories and beds, and the other (‘QRS low chair’) focused on 
rising from and sitting down on low seats, such as easy chairs, car seats, and sofas. 
The questionnaire consisted of statements, which could be answered affirmatively. 
For both subscales of the QRS, the scores were converted to fit into a 0–10 range. 
The WSQ was a self-administered questionnaire consisting of 15 items, formulated 
in behavioral terms. The items referedto what a patient actually does, and not to 
what a patient thinks that he/she could do. Dichotomous response options (YES box 
marked/YES box not marked) were chosen to facilitate interpretation. Sum scores 
ranged from 0 to 15. In a group of patients living at home, with different lower-
extremity disorders, Roorda et al. (2004) found a sum score median of 7. In terms of 
test-retest reliability as expressed by Spearman’s r (range 0.79–0.90 and 0.85–0.89 
respectively) and the ICC (range 0.78–0.84 and 0.84–0.87 respectively) the WSQ and 
QRS were reliable (Perez et al., 2001; 2002). 
Fear of movement/(re)injury 
The Dutch version of the Tampa Scale for Kinesiophobia (TSK) was used. This ques-
tionnaire consisted of 17 items, measuring fear of (re)injury due to movement, 
scored on a 4-point scale. The TSK has been found reliable and valid (Roelofs et al., 
2004, Vlaeyen et al., 1995a; 1995b) and also successfully been used in patients with 
CRPS-I (Nelson, 2002). In addition to the TSK, the Photograph series of Daily activi-
ties (PHODA) for upper and lower extremities was used. The PHODA was a standar-
dized method during which patients were requested to judge the threat value of 
various physical movements from daily life activities represented by photographs. 
The patients were requested to place each photograph along a fear thermometer, 
consisting of a vertical line with 11 anchor points (ranging from 0 to 100) printed on 
a 60×40 cm hardboard. The fear-thermometer was placed on a table in front of the 
patient. The instruction was: ‘Please watch each photograph carefully, and try to 
imagine yourself performing the same movement. Place the photograph on the 
thermometer according to the extent to which you feel that this movement is harm-
ful to your affected extremity (arm/leg)’. After completion of the test, each photo-
graph is given a rating according to the position on the thermometer. A total score 
ranging from 0 to 100 is calculated as the sum of each rating, divided by 12.5 (the 
maximum total score). A similar version of the PHODA has been used successfully in 
previous studies (De Jong et al., 2005; Vlaeyen et al., 2001; Vlaeyen et al., 2002a; 
2002b). 
Disease-related signs and symptoms 
Before and after each intervention, and at 6-month follow-up, self-reported signs 
and symptoms of CRPS-I where determined. Self-reported symptoms were hyperes-
thesia, temperature asymmetry, skin color symmetry, sweating alterations and 
edema. The patients measured them in a dichotomous way (present or absent). 
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Diary 
To check whether the GEXP indeed modified the fear appraisals, pain intensity, and 
activity goal achievement, a short questionnaire was used consisting of 14 visual 
analog scales (from 0 to 10). This diary was meant as manipulation check. The first 
11 items represented main factors of existing questionnaires for pain-related fear, 
catastrophizing, and pain disability. These included the Dutch versions of the TSK, 
The Pain Anxiety Symptoms Scale (PASS: Larsen et al., 1997; McCracken et al., 1992; 
1999), and the Pain Catastrophizing Scale (PCS: Crombez et al., 1996; Sullivan et al., 
1995). Visual analogue scales (VAS) consisted of 10 cm horizontal lines followed the 
items derived from these questionnaires. These VAS’s were anchored at the left and 
right by the words ‘totally disagree’ and ‘totally agree’. Three main scores were 
derived, consisted of the mean scores (range 0–10) of the items from TSK, PASS and 
PCS, respectively. Besides daily measures of pain-related fear, pain intensity was 
measured daily with an additional visual analog scale anchored with ‘no pain at all’ 
at one extreme and ‘worst pain experienced’ at the other. The last two visual analog 
scales referred to the performance of personally relevant activities. Each scale con-
sisted of the same question: ‘How difficult was it to perform this activity today?’ The 
scale was anchored with ‘no problem at all’ at one extreme and ‘impossible’ at the 
other. This measure was administered on a daily basis during the whole duration of 
the study and the follow-up period of 1 week. The patients were instructed to com-
plete the scales each evening and to send the package the next day to the re-
searchers. This measure has been shown to be sensitive to graded exposure in vivo 
in previous studies (De Jong et al., 2005; Vlaeyen et al., 2001; 2002a; 2002b). 
Treatment expectancy and credibility 
After the rationale, and before the actual exposure, patients completed one expec-
tancy and one credibility item on visual analog scales, with ‘not at all’ and ‘very 
much’ on the extremes: ‘Do you expect that the program will help you to cope bet-
ter with your pain complaints?’ (Expectancy), ‘Do you believe that the treatment 
offered to you is a meaningful treatment for patients with CRPS-I?’ (Credibility) 
(Borkovec & Nau, 1972). 
Statistical analyses 
For analyzing the resulting data of the daily measures, a randomization test for 
single case experimental designs using the rationale of Edgington (1992) was carried 
out. Because graded exposure in vivo (C) was expected to be superior to baseline A, 
and the education (B), the null hypothesis that there is no differential effect for any 
of the measurement times was tested using a randomization test on the differences 
between B and A, C and A, C and B. While the follow-up (D) was expected to be 
superior to A and will not change in relation to C, differences between D and A, D 
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and C were also tested using randomization tests. The analyses were performed 
using the SCRT software (Single-Case Randomization Tests, version 1.1; (Onghena & 
Van Damme, 1994b)). The program also allowed the calculation of a combined P-
value of each design when the cases were considered simultaneously in a meta-
analysis according to Edgington’s additive method. Finally, the test was repeated 
assuming delayed effects (effect lags of 2 weeks or four sessions of exposure thera-
py) until the minimal P-value (P<0 05) was reached (for the general formula and 
algorithms see Edgington, 1992; Edgington, 1995; Onghena & Edgington, 1994a; 
Wampold & Furlong, 1981). 
Preset criteria for non-daily measures 
For PHODA, TSK, WSQ, QRS, and RASQ the limited number of data made it impossi-
ble to use randomization tests. Therefore, we decided to formulate pre-set criteria 
to conclude whether the treatment could be considered successful. For the TSK a 
reduction of more than 30 percentiles was considered relevant. In the absence of 
any norms for PHODA, we estimated that a 50% decrease would give us enough 
support that the threat value of the activities used in the GEXP had decreased. For 
the WSQ, QRS, and RASQ no norms were available. Because we hypothized that 
graded exposure in vivo would resulted in a decrease of disability, we estimated 
that a improvement of 50% on each subscale of these questionnaires would give 
support to this hypothesis. The physiological signs and symptoms were assessed on 
self-report, and were described in the results as such. 
Results 
Internal validity checks 
Expectancy and credibility check 
Expectancy (mean rating of 3.8±0.84 SD on a visual analog scale from 0 to 10) and 
credibility (mean rating of 4.2±0.79 SD) ratings were relative low for the GEXP. This 
implies that the participants did not expected that the program would help to cope 
better with their pain complaints, and that they did not believed that the GEXP was 
a meaningful treatment for patients with CRPS-I. 
Daily measures 
Because the patterns of change for fear of movement/(re)injury, pain catastrophi-
zing, and fear of pain were quite similar, figures 1-4 shows only the observations 
across time for fear of movement/(re)injury, pain intensity, and the performance of 
personally relevant activities for each patient. 
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Figure 1  
Mean daily measures for patient 1 and 7 of fear of movement/(re)injury (fom), pain intensity (pi), and 
two personally relevant activities, across baseline (A), psycho-education (B), graded exposure in vivo (C), 
and 6-month follow-up period (D). A=7 days, B=7 days, C=70 days (20 sessions of 1 h), D=7 days  
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Figure 2 
Mean daily measures for patient 5 and 2 of fear of movement/(re)injury (fom), pain, intensity (pi), and 
two personally relevant activities, across baseline (A), psycho-education (B), graded exposure in vivo (C), 
and 6-month follow-up period (D). A=14 days, B=7 days, C=70 days (20 sessions of 1 h), D=7 days. 
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Figure 3 Mean daily measures for patients 3 and 6 of fear of movement/(re)injury (fom), pain intensity
(pi), and two personally relevant activities, across baseline (A), psycho-education (B), graded exposure in 
vivo (C), and 6-month follow-up period (D). A=14 days, B=14 days, C=70 days (20 sessions of 1 h), D=7 
days. 
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Figure 4 Mean daily measures for patients 8 and 4 of fear of movement/(re)injury (fom), pain intensity
(pi), and two personally relevant activities, across baseline (A), psycho-education (B), graded exposure in 
vivo (C), and 6-month follow-up period (D). A=7 days, B=14 days, C=70 days (20 sessions of 1 h), D=7 
days. 
 
Visual inspection reveals that the GEXP produced substantial trend changes, in fear 
of movement/(re)injury, pain intensity and the performance of personal relevant 
activities although these changes occurred during the second part of the GEXP. 
Table 1 displays the effect lag (one lag is 2 weeks or four sessions of exposure the-
rapy) in which significance was reached for the phase design randomization tests on 
the raw data. The results appear to confirm the conclusions of the graphical display. 
For fear of movement significance was reached for patient 4 and 8 between week 3 
making love go with high-heeled shoes fom pi
drive a car play tennis fom pi
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and 4 (sessions 5–8), for patient 1–3, 5 and 7 between week 5 and 6 (sessions 9–12) 
and for patient 6 between week 7 and 8 (sessions 13–16). With regard to pain in-
tensity and personally relevant activities significance was reached either between 
week 5 and 6 (sessions 9–12) or between week 7 and 8 (sessions 13–16). When a 
combined P-value was calculated, the results for the eight P-values from table 1 of 
these four variables was in each case P<0.0001 (fear: 9.03×10−11; pain: 2.55×10−10; 
activity 1: 1.63×10−10; acƟvity 2: 2.55×10−10). 
 
Table 1 The effect lag (one lag is 2 weeks or four sessions of exposure therapy) during the graded expo-
sure in vivo in which the minimum P-values for the randomization tests with one observation per phase 
has been reached for each patient for fear of movement, pain intensity, and two personally relevant 
activities 
Patient Fear of movement/(re)injury Pain intensity Activity Activity 
1 3 (P=0.029) 3 (P=0.029) 4a (P=0.029) 3b (P=0.029) 
2 3 (P=0.024) 4 (P=0.024) 3c (P=0.024) 3d (P=0.024) 
3 3 (P=0.024) 4 (P=0.037) 3e (P=0.024) 4f (P=0.037) 
4 2 (P=0.021) 3 (P=0.029) 3g (P=0.029) 3h (P=0.029) 
5 3 (P=0.024) 3 (P=0.024) 3i (P=0.024) 3j (P=0.024) 
6 4 (P=0.037) 4 (P=0.037) 4k (P=0.037) 4l (P=0.037) 
7 3 (P=0.029) 4 (P=0.029) 3m (P=0.029) 4n (P=0.029) 
8 2 (P=0.021) 3 (P=0.029) 3o (P=0.029) 3p (P=0.029) 
a Aerobics, b Cycle, c Go shopping, d Dance, e Play the piano, f Play the violin, g Drive a car, h Play tennis, 
i Garden, j Play golf, k Model, l Work as manicurist, m Push the baby buggy, n Lift a child, o Wear high-
heeled-shoes, p Make love. 
Outcome measures 
Functional disability 
In patients 1, 2 and 8 CRPS-I was located in the lower extremity. These patients 
reported also by the use of the WSQ and QRS about their functional disabilities. To 
permit mutual comparison of scales with different numbers of items, the scores of 
the WSQ and QRS were expressed in standardized scale sum scores, i.e. scores 
(range 0–10) were calculated as the proportion of the total possible score for the 
scale at issue multiplied by ten. The standardized sum scores of patient 1, 2 and 8, 
for each category of the WSQ and QRS, revealed an improvement of more than 50% 
after the GEXP and during FU (Table 2). In fact, all the three patients reported no 
functional disability after the GEXP and during FU. The scores of the FU did not 
change regard to the GEXP. Also the mean total score of the three subgroups for 
each category of the RASQ, calculated from patients 3–7, revealed an improvement 
of more than 50% (Table 3), except for the category ‘work’. However, on closer 
inspection of the data it appeared that two patients answered ‘not applicable’ (sco-
re 9) for the question ‘performing your occupation’. Before the pain complaints of 
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these two patients started they were unemployed. Therefore, it could be that they 
had no comparison and where not able to imagine the situation. 
 
Table 2 Standardised sum score from patient 1,2 and 8, for each catagory of the walking stairs question-
naire (WSQ) and questionnaire rising and sitting down (QRS) before and after each intervention and 
during follow-up 
Questionnaire Patient BAS EDU GEXP FU 
WSQ      
Climbing stairs 1 0.63 0.63 0 0 
 2 3.13 3.13 0 0 
 8 5.00 5.00 0 0 
Walking in the house 1 6.50 6.50 0 0 
 2 6.50 6.50 0 0 
 8 6.50 6.50 0 0 
Walking outside 1 0.56 0.56 0 0 
 2 0.56 0.56 0 0 
 8 0.56 0.56 0 0 
Walking velocity 1 0 0 0 0 
 2 5.00 5.00 0 0 
 8 7.50 7.50 0 0 
QRS      
High seat 1 9.09 9.09 0 0 
 2 7.73 7.73 0 0 
 8 8.18 8.18 0 0 
Low seat 1 0 0 0 0 
 2 5.29 5.29 0 0 
 8 9.41 9.41 0 0 
BAS, baseline; EDU, education; GEXP, graded exposure in vivo; FU, follow-up. 
 
Table 3 Mean total score, calculated from patient 3–7, for each catagory of the radboud skills question-
naire (RASQ), determined at baseline, before and after each treatment module and during 6-month 
follow-up 
Group Catagory BAS EDU GEXP FU 
I. Personal care 1 Personal hygiene 25.2 25.2 8.4 8.4 
 2 Toilet hygiene 4 4 1.4 1.4 
 3 Dressing 26.2 26.2 9.8 9.8 
 4 Eating and drinking 4.4 4.4 1 1 
II. Domestic activities 5 Housekeeping 26.4 26.4 8.4 8.4 
 6 Meal preparation 35.2 35.2 13.2 13.2 
 7 Taking care of clothes 13.2 13.2 4.2 4.2 
III. Other activities 8 Recreational activities 10 10 2.8 2.8 
 9 Social activities 12.8 12.8 4.2 4.2 
 10 Other items 30.4 30.4 9.8 9.8 
 11 Work 6.6 6.6 4.4 4.4 
BAS, baseline; EDU, education; GEXP, graded exposure in vivo; FU, follow-up. 
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Fear of movement/(re)injury 
The mean TSK-score before and after each intervention was: BAS=54.75 (±5.18 SD), 
EDU=55.0 (±5.24 SD), GEXP=20.25 (±2.05 SD), FU=19.75 (±1.67 SD). For all patients a 
significant reduction was observed at the end of GEXP and during FU as compared 
to BAS and EDU. TSK scores decreased from a mean score of 55.0 (>80th percentile) 
to a mean score of 19.75 (<10th percentile). Similar results were found for PHODA: 
BAS=84.75 (±3.96 SD), EDU=85.5 (±3.82 SD), GEXP=12.86 (±3.31 SD), FU=11.63 
(±2.33 SD). Significant reductions were observed at the end of GEXP and during FU 
as compared to BAS and EDU (mean reduction is 90%). 
Disease-related signs and symptoms 
Table 4 summarizes the frequencies of the self-reported CRPS-related signs and 
symptoms in the patients. These frequencies were expressed in percents of positive 
reports for CRPS-related signs and symptoms. Surprisingly, in every case, at the end 
of the GEXP all the patients reported a positive change for the better in CRPS-
related signs and symptoms. During FU there was even no report of any of the 
CRPS-related signs and symptoms. Despite the small sample, by using a nonpara-
metric test (Wilcoxon test) the changes from BAS to GEXP (P=0.042) and BAS to FU 
(P=0.039) were also significant. 
 
Table 4 Self-reported signs and symptoms of CRPS (% positive) by the experimental group across study 
periods 
CRPS-I characteristics    
Self-reported symptoms BAS (n=8) GEXP (n=8) FU (n=8) 
 Hyperesthesia 100.0 0.0 0.0 
 Edema 87.5 0.0 0.0 
 Skin color asymmetry 87.5 25.0 0.0 
 Temperature asymmetry 87.5 25.0 0.0 
 Sweating alterations 50.0 0.0 0.0 
BAS, baseline; GEXP, graded exposure in vivo; FU, follow-up. 
Discussion 
This is the first study testing the effects of an exposure-based protocol in the treat-
ment of CRPS-I patients for reducing pain-related fear and pain disability. The aim of 
this study was to experimentally examine whether the validity of the graded expo-
sure in vivo extends to patients with CRPS-I. Eight patients with CRPS-I reporting 
substantial fear of movement/(re)injury, and who were referred for outpatient 
behavioral rehabilitation were included. A replicated single case experimental de-
sign was applied in which chronically disabled patients were assigned to EDU and 
GEXP. 
 
 97 
The randomization tests on the daily measures showed as well individually as in 
group that compared with a no-treatment baseline period and a psycho-educational 
session, a graded exposure in vivo treatment was successful in decreasing levels of 
pain-related fear, pain disability, and pain intensity. This last result is remarkable 
because pain intensity usually is not the target of the GEXP treatment. Similar are 
the results for the assessments at the start of BAS, before and after each interven-
tion and during FU. There was an overall improvement in self-reported disability 
after GEXP, which was also reported during FU. Last but not least, the patients re-
ported that the presence of signs and symptoms consistent with CRPS-I were signifi-
cantly decreased after the GEXP and even disappeared at FU-assessment. This is 
remarkable in the context of the patients’ average pain duration of 3 years without 
resolution. 
 
In contrast to the fast changes in the daily measures during the graded exposure 
treatment of chronic low back pain patients (Vlaeyen et al., 2001; 2002a; 2002b; 
2002c), in which the reduction of pain-related fear and disability was achieved wit-
hin fewer than three exposure sessions, in CRPS-I these changes occurred in an later 
phase of the exposure treatment. An explanation of this delayed effect could be 
that the observed peripheral changes of CRPS-I mediated the effect of information 
on pain. This theory is supported by a study of Arntz and Claassens (2004). They 
tested whether meaning influences the experience of pain. By suggesting that a very 
cold metal bar was either hot or cold, the potentially tissue-damaging property of 
the stimulus was experimentally manipulated. The result of this experiment was 
that harm beliefs are a crucial aspect of meaning that influences the subjective 
intensity of pain. The long-term meaning (i.e. the autonomic consequences) of pain 
might be also play an important role. In low back pain patient’s possible tissue-
damage is not observable. For this reason, it might have been easier to modify the 
meaning attached to their pain as compared to the CRPS patients in whom the 
symptoms are clearly visible. 
 
Additionally, these observable symptoms might be interpreted as tissue damage 
and may direct the attentional focus to the sensation, thereby amplifying the pain 
experience. There is indeed evidence that pain is experienced more strongly when 
the focus of attention is directed towards it (Arntz et al., 1991; 1994; Arntz & de 
Jong, 1993; Janssen et al., 1998; Rode et al., 2001). In line with this is that a tissue-
damage interpretation of pain might include anxiety, which in turn might amplify 
the experience of pain. Recent studies suggest that most of the influence of anxiety 
on pain is mediated by attention (Arntz et al., 1991; 1994; Arntz & de Jong, 1993). 
 
How can we explain the self-reported trophic changes or enhanced efficacy of no-
ciceptive mechanisms or cortical changes by graded exposure in vivo? Disrupted 
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body schema (Schwoebel et al., 2001) and shrinkage of the cortical representation 
of the effected limb in the primary somatosensory cortex (Juottonen et al., 2002) 
have both been observed in CRPS-I patients. Supposedly, common cortical mecha-
nisms are thought to underlie post-stroke and post-trauma CRPS-I (Janig & Baron, 
2003; Riedl et al., 2001). Analogous to these findings it is notable that in phantom 
pain and in stroke patients, a primary goal is to activate cortical areas that subserve 
the affected limb, which leads to symptomatic and functional improvements (Flor et 
al., 2001; Liepert et al., 2000) and which in turn correlate with cortical reorganiza-
tion (Flor et al., 2001; Kopp et al., 1999). It seems that graded exposure in vivo is a 
strategy that aims to activate cortical networks and might be successful for CRPS-I 
rehabilitation. It is not clear however, how the graded exposure in vivo might ad-
dress either of these processes. A possible explanation might be that graded expo-
sure in vivo provide for disruption of the internal body schema. This might raise the 
possibility of a guarding type mechanism that impacts higher order motor processes 
such as motor intent or motor planning. Similar approaches for phantom pain and 
acute CRPS-I are thought to reconcile motor output and sensory input (McCabe et 
al., 2003; Ramachandran, 1995), which implies that a mismatch between motor 
intent and sensory feedback is causative of pain. Galer and Jensen (1999) have 
demonstrated that some patients with CRPS-I have an involuntary neurological 
neglect-like condition. 
 
Another explanation of the effect of graded exposure in vivo for CRPS-I might be 
that this treatment focused on mental and visual attention in order to move the 
affected extremity. Thus, perhaps the graded exposure in vivo requires the CRPS-I 
patient to attend, possibly at an involuntary level, to the affected extremity for a 
certain time. In which case, the graded exposure in vivo may simply serve to reverse 
a learned disuse of the affected extremity (Butler, 2001). 
 
In addition to the exposure in vivo procedure, Moseley (2004) found that a motor 
imagery program (MIP) is also effective for CRPS-I in reducing pain and swelling and 
that this support the involvement of cortical abnormalities in the development of 
this disorder. The MIP is made up of 2 weeks each of hand laterality recognition, 
imagined hand movements with the effected hand and mirror therapy by which the 
unaffected hand is physical active. In contrast to the exposure in vivo procedure, the 
MIP did not involve physical movements and/or activities with the affected extrem-
ity. Although the mechanism of effect of the MIP are not clear and further research 
is needed, Moseley (2004) supposed that success is dependent on sequential activa-
tion of cortical pre-motor (by imaging) and motor (by mirror therapy) networks or 
sustained and focused attention to the affected limb. 
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Finally, several limitations of this study should be mentioned. First, the preliminary 
results reported here are limited in that they are based on a small number of pa-
tients. However, a single-case experimental design was chosen with appropriate 
time series statistical analyses. Second, we did not compare the GEXP with other 
interventions. Replication studies in the form of randomized single-case crossover 
designs or randomized controlled trials using larger samples are warranted. Third, 
the study is impeded by the use of self-report measures only, which are subject to 
response bias. Our study merits replication in which self-report measures are sup-
plemented with objective assessments of touch sensitivity, mechanical allodynia, 
skin temperature asymmetry, swelling and active range of motion. To test how 
CRPS-I patients respond in daily life situations, it would be interesting to use ambu-
latory activity monitors in every day life outside the clinic (Bussmann et al., 2001; 
Schasfoort et al., 2002; 2003). Finally, the follow-up period may not have been suffi-
cient to determine the long-term effect of the treatment or long-term quality of life. 
 
In sum, the current study supports a graded exposure in vivo approach in chronic 
CRPS-I patients reporting substantial levels of pain-related fear The GEXP was suc-
cessful in decreasing levels of self-reported pain-related fear, pain intensity, disabil-
ity, and self-reported peripheral abnormalities. These results underscore the idea 
that the GEXP modifies the meaning people attach to a their pain, and that these 
changes also influences the experienced painfulness. GEXP likely activates cortical 
networks and reconciles motor output and sensory feedback. The results need to be 
verified in a wider chronic CRPS-I population. However, the GEXP offer a promising 
treatment direction for what is a difficult pain disorder to treat. 
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Chapter 5 
Fear of movement/(re) injury in 
chronic low back pain: Education or 
Exposure in Vivo as mediator  
to fear reduction? 
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Herman Mulder. Fear of movement/(re)injury in chronic low back pain: Education or expo-
sure in vivo as mediator to fear reduction. Clin J Pain 2005; 21: 9-17. 
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Abstract 
Clinical research of graded exposure in vivo program (GEXP) in patients with chronic 
low back pain who reported fear of movement/(re)injury shows abrupt changes in 
self-reported pain-related fears and cognitions. The abrupt changes are more char-
acteristics of insight learning rather than the usual gradual progression of trial and 
error learning. The educational session (EDU) at the start of GEXP might have con-
tributed to this insight. The current study examines the contribution of GEXP versus 
an operant graded activity program (OPE) in the reduction of pain-related fear and 
associated disability and physical activity. Six consecutive patients with chronic low 
back pain who reported substantial fear of movement/(re)injury were included in 
the study. After a no-treatment baseline measurement period, all the patients re-
ceived EDU, followed again by a no-treatment period. Patients were then randomly 
assigned to either GEXP or OPE. A diary was used to assess daily changes in pain 
intensity, pain-related fear, pain catastrophizing, and activity goal achievement. 
Standardized questionnaires of pain-related fear, pain vigilance, pain intensity, and 
pain disability were administered before and after each intervention and at the 6-
month follow-up. An activity monitor was carried at baseline, during the interven-
tions, and 1 week at 6-month follow-up. Randomization tests of the daily measures 
showed that improvements in pain-related fear and catastrophizing occurred after 
EDU was introduced. The results also showed a further improvement when GEXP 
followed the no-treatment period after EDU and not during OPE. Performance of 
relevant daily activities, however, were not affected by EDU and improved signifi-
cantly only in the GEXP condition. All improvements remained at half-year follow-up 
only in patients receiving GEXP. These patients also reported a significant decrease 
in pain intensity at follow-up. 
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Introduction 
One of the recent developments in behavioral pain research concerns the mecha-
nisms by which patients with acute pain become chronically disabled. A steadily 
increasing number of studies are showing that observable physical performance and 
self-reported disability levels in patients with sub acute and chronic pain are associ-
ated with cognitive and behavioral, rather than sensory and biomedical, aspects of 
pain (Asmundson et al., 1999; Linton, 2000b; Vlaeyen & Linton, 2000). Fear-
avoidance models have been proposed, and their major assumptions are success-
fully tested (Lethem et al., 1983; Vlaeyen et al., 1995a; 1995b; Vlaeyen & Linton, 
2000; Waddell et al., 1993). A number of studies have reported that pain-related 
fear is one of the strongest predictors of variation in physical performance (Al-
Obaidi et al., 2000; Burns et al., 2000; Crombez et al., 1996; 1999; Vlaeyen et al., 
1995a). Prospective studies have revealed that, in patients with acute back pain, 
pain-related fear is predictive of future disability and work status (Fritz et al., 2001; 
Klenerman et al., 1995; Sieben et al., 2002). If pain-related fear is indeed one of 
important mechanisms responsible for the development and maintenance of 
chronic pain disability, fear reduction should enhance the prevention of further 
pain-related disability and distress. 
 
Current treatments of excessive fears and anxiety are based on the experimental 
psychological work of Wolpe (1958) on desensitization. Later studies revealed that 
the exposure to the feared stimuli appeared to be the most essential component of 
the systematic desensitization. Craske and Rowe (1997) suggested that for fearful 
patients, first-hand evidence of actually experiencing themselves behaving differ-
ently is far more convincing than rational argument, and that the most essential 
step consists of graded exposure to the situations the patient has identified as dan-
gerous or threatening. The bio informational theory of fear put forward by Lang et 
al. (1998) predicts that there are 2 main conditions to reduce fear. First, the fear 
network needs to be activated, and second, new information needs to be available 
that does not confirm the fear expectations that are inherent to the fear memory. 
Following from cognitive models such as the cognitive model of panic and the cogni-
tive model of obsessions (Clark, 1986; Rachman, 1998), which assumes that cogni-
tive errors can be corrected through conscious reasoning, behavioral experiments 
have been developed in which a collaborative empiricism is the bottom line. Expo-
sure (situational and interoceptive) is introduced as a behavioral experiment in 
which catastrophic or irrational thoughts are being challenged. 
 
Clinical support of exposure in vivo with behavioral experiments in chronic low back 
pain patients reporting substantial fear of movement/(re)injury has been reported 
by Vlaeyen et al. (Vlaeyen et al., 2001; 2002a; 2002b). Using a replicated single-case 
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design, they provided preliminary evidence showing that compared with a no-
treatment baseline period and a Graded Activity program (based on operant-
behavioral principles), the individually tailored exposure in vivo was superior in 
decreasing the self-report measures of pain-related cognitions and fears, pain con-
trol, and pain disability. Besides improvements on the self-report measures, an 
increase in physical activity in the home situation was also found with ambulatory 
activity monitors (Vlaeyen et al., 2002a). Although the exposure was provided dur-
ing a period of 3 or 4 weeks, the reduction of pain-related fear was achieved within 
fewer than 3 exposure sessions of 1 hour. Such abrupt changes are more character-
istic of insight learning rather than the usual gradual progression of trial and error 
learning (Rachman & Whittal, 1989). In these studies, the presentation of the ra-
tionale at the start of the exposure might have contributed to this insight. Many 
patients reported that, for the first time, they received a credible rationale for their 
current level of disability. 
 
If it seems that education has indeed a powerful treatment effect at the start of an 
exposure in vivo, there is the possibility of introducing treatment in a stepped care 
approach. To tease out the differential effects of the educational part and the actual 
exposure component found in the studies of Vlaeyen et al. (2001; 2002a; 2002b) we 
decided to: 1) examine whether an educational session alone reduces fear levels; 
and (2) to compare the effectiveness of education followed by graded exposure in 
vivo with behavioral experiments as compared with education with a operant gra-
ded activity program. By means of a replicated single-case experimental design, 
education (EDU) is contrasted with a graded exposure in vivo (GEXP) or operant 
graded activity program (OPE). 
Materials and methods 
Study design 
A replicated single-case experimental design was used with multiple measurements. 
Patients were randomly assigned to treatment group ABC or treatment group ABD. 
After a 3-week no-treatment baseline measurement period (A), all the patients 
received EDU, followed again by a 3-week no-treatment period (B). Then, random 
assignment to either 6-week GEXP (C) or 8-week OPE (D) occurred. Three kinds of 
outcome measures were included. To assess daily changes in pain intensity, pain-
related fear, pain catastrophizing, and activity goal achievement, a diary was used. 
Standardized questionnaires of pain-related fear, pain vigilance, pain intensity, and 
pain disability were administered before and after each treatment, and at 6-month 
follow-up. To measure actual activity levels in the home situation, an activity moni-
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tor was carried at baseline, just after each intervention, and 1 week at 6-month 
follow-up. 
Participants 
Six consecutive patients who were referred for outpatient behavioral rehabilitation, 
and who reported substantial fear of movement/(re)injury (Tampa Scale for Kine-
siophobia [TSK: Kori et al., 1990] score >39), were included in the study. The cut-off 
was based on the median of the TSK distribution of chronic low back pain samples 
reported earlier. Other inclusion criteria were non-specific low back pain for at least 
6 months and age between 18 and 65. Exclusion criteria were illiteracy, pregnancy, 
alcohol or drug abuse, and serious psychopathology based on the Symptom Check-
list of which Dutch norms are available. Due to a major depressive disorder, a post-
traumatic stress disorder, pregnancy, and insufficient fluency in the Dutch language, 
4 of 10 consecutive patients with pain-related fear were excluded. 
Procedure and program overview 
Patients who met the selection criteria received a physical examination and were 
subsequently invited for a semi-structured interview with the psychologist, during 
which a cognitive and behavioral analysis of the pain problem was made. 
The Photograph series of Daily activities (PHODA: Kugler et al., 1999) was used to 
develop a graded hierarchy of feared activities. The patient was requested to place 
each of the 98 photographs along a vertical line with 11 anchor points (ranging from 
0 to 100) printed on a 100 cm × 40 cm hardboard. This fear thermometer was pla-
ced on a table in front of the patient with the following instruction: “Please watch 
each photograph carefully, and try to imagine you performing the same movement. 
Place the photograph on the thermometer according to the extent in which you feel 
that this movement is harmful to your back.” 
After this assessment, all patients started with the baseline period (A), during which 
they completed daily measurements at home. This period was followed by EDU, 
followed again by a 3-week nontreatment period (B). Then, random assignment 
either to 24 hours of GEXP (C) spread over 6 weeks or to 32 hours of OPE (D) spread 
over 8 weeks occurred. 
Education (EDU) 
During the first part of the EDU, diagnostics tests were being reviewed together 
with a physician. The physician explained to the patients that their pain must be 
viewed as a common condition that can be self-managed, rather than as a serious 
disease or a condition that needs careful protection. In cases where the pain-related 
fear was also fuelled by the visual confrontation with diagnostics tests, patients 
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were explained that they probably have overestimated the value of these tests, and 
that in symptom-free people, similar abnormalities can be found (Jensen et al., 
1994). One of the major goals of the second part of the EDU was to increase the 
willingness of the patient to finally engage in activities they have been avoiding for a 
long time. The aim was to correct the misinterpretations and misconceptions that 
have occurred during the development of the pain-related fear. The patient was 
given careful explanation of the fear-avoidance model. By using the patient’s indi-
vidual symptoms, beliefs, and behaviors, it was illustrated how vicious circles (pain-
catastrophic thought-fear-avoidance-disability-pain) maintain the pain problem. 
Graded exposure in vivo (GEXP) 
Based on the graded hierarchy of fear-eliciting situations, individually tailored prac-
tice tasks were developed. There was also one exposure session that actually took 
place in the work or home situation. To challenge the validity of catastrophic as-
sumptions and misinterpretations, behavioural experiments were used during 
GEXP. A detailed description of GEXP can be found in Vlaeyen et al. (2002c). 
Operant graded activity program (OPE) 
This program was based on the operant principles described by Fordyce (1976) and 
Lindström et al. (1992). It was aimed at increasing healthy behaviors and decreasing 
pain behaviors. To avoid contamination between the GEXP and the OPE, activities 
that were placed above 50 on the thermometer of the PHODA were excluded from 
the OPE. The team members monitored this without notifying the patient about this 
rule. The rationale provided to the patients was that inactivity may lead to disuse, 
which often promotes pain, and that increasing of the activity level and muscle 
strength consequently is likely to prevent future disability. 
Outcome measures 
Daily measures 
To check whether the GEXP indeed modified the fear appraisals, pain intensity, and 
activity goal achievement, a short questionnaire was used consisting of 11 visual 
analog scales (VAS; from 0 to 10) with items representing main factors of existing 
questionnaires for pain-related fear and catastrophizing. These items were meant as 
manipulation check. Three main scores of part 1 were derived, consisting of the 
mean scores (range 0-10) of the items from the TSK, the Pain Anxiety Symptoms 
Scale (PASS: McCracken et al., 1992), and the Pain Catastrophizing Scale (PCS: Sulli-
van et al., 1995). Daily pain intensity was measured with an additional VAS anchored 
with “no pain at all” at one extreme and “worst pain experienced” at the other. The 
last 3 VAS referred to the performance of personally relevant activities. Each scale 
consisted of the same question: “How difficult was it to perform this activity to-
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day?” The scale was anchored with “no problem at all” at one extreme and “impos-
sible” at the other. This measure was administered on a daily basis during the whole 
duration of the study and the follow-up period of 1 week. The patients were in-
structed to complete the scales each evening and to send the package the next day 
to the researchers. This measure has been shown to be sensitive to GEXP in previ-
ous studies (Vlaeyen et al., 2001; 2002a; 2002b). 
Questionnaires 
The Dutch version of the TSK was used. Vigilance for pain sensations was measured 
with the Dutch version of the Pain Vigilance and Awareness Questionnaire (PVAQ: 
McCracken, 1997; Roelofs et al., 2002). Patients also completed the Dutch version 
of the Roland Disability Questionnaire (RDQ: Deyo et al., 1998; Roland & Morris, 
1983). 
Activity monitor 
Patients were requested to carry an ambulatory activity monitor (uniaxial acceler-
ometer) attached to a belt dorsally, close to lumbar discs L4 and L5 (Bussman et al., 
1998). Movement counts were registered for an entire week during the moment of 
get up and bedtime, except for activities involving contact with water. The patients 
registered carrying times and the kind of activities performed by the help of a diary. 
At termination of the registration period, the patient returned the device, and the 
data were downloaded to a personal computer. Movement counts were added and 
subsequently divided by the time the accelerometer was carried. The activity moni-
tor was carried 4 times for an entire week. 
Statistical analyses 
For analyzing the resulting data of the daily measures, a randomization test for 
single case experimental designs using the rationale of Edgington (1995) was carried 
out. Because intervention B was expected to be superior to baseline A, and inter-
vention C was expected to be superior to A and intervention B, the null hypothesis 
that there is no differential effect for any of the measurement times was tested 
using a randomization test on the differences between B and A, C, and A, C and B, D, 
and A, D and B. Although the follow-up (F) was expected to be superior to A and 
would not change in relation to C and D, differences between F and A, F and C, F 
and D, were also tested using randomization tests. The analyses were performed 
using the SCRT software (Single-Case Randomization Tests, version 1.1: Onghena & 
Van Damme, 1994). The program also allowed the calculation of a combined P value 
of each design when the cases were considered simultaneously in a meta-analysis 
according to Edgington’s additive method. 
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Preset criteria for non-daily measures 
To conclude whether the treatment could be considered successful, the authors 
decided to formulate preset criteria partly based on existing norms. For the TSK and 
the PVAQ, a reduction of more than 30 percentile points was considered relevant.  
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A = Start BAS (21 days no-treatment period) 
B = EDU (followed by a 21 days no-treatment period) 
C = Start GEXP (12,5 hours over 35 days) 
X = End GEXP (followed by 7 days activity monitor) 
F = FU (6-month follow-up period of 7 days) 
D = Start OPE (35 hours over 49 days) 
Figure 1. Mean daily measures of fear of movement/(re)injury, pain catastrophizing and fear of pain, across
baseline (BAS: 21 days), psycho-education (EDU: 21 days), graded exposure in vivo (GEXP: 12,5 hours over
35 days) in treatment group ABC, operant graded activity program (OPE: 35 hours over 49 days) in treat-
ment group ABD, and 6-month follow-up period (FU: 7 days). 
 
 109 
Treatment group ABC Treatment group ABD 
0
1
2
3
4
5
6
7
8
9
10
A B C X F
cycle
stoop
with a
turning
back
patient 1
                                     
Vas-score
_
+
 
0
1
2
3
4
5
6
7
8
9
10
A B D X F
play tennis
get up
                                     
Vas-score
_
+
patient 2
 
0
1
2
3
4
5
6
7
8
9
10
A B C X F
painting
running
patient 5
                                     
Vas-score_
+
 
0
1
2
3
4
5
6
7
8
9
10
A B D X F
play
tabletennis
lifting a
child
                                     
Vas-score
_
+
patient 3
 
0
1
2
3
4
5
6
7
8
9
10
A B C X F
swimming
make love
patient 6
                                     
Vas-score
_
+
 
0
1
2
3
4
5
6
7
8
9
10
A B D X F
garden
go
shopping
                                     
Vas-score
_
+
patient 4
 
Figure 2. Mean daily measures of self-reported difficulties in performance of activities at home, across 
baseline (BAS: 21 days), psycho-education (EDU: 21 days), graded exposure in vivo (GEXP: 12,5 hours 
over 35 days) in treatment group ABC, operant graded activity program (OPE: 35 hours over 49 days) in 
treatment group ABD, and 6-month follow-up period (FU: 7 days). 
 
In line with Stratford et al. (1998), we decided that a change score of 5 can be clini-
cally relevant for the RDQ. For the PHODA, no norms were available. Therefore, we 
estimated that a 50% decrease would give enough support that the treat value of 
the activities used in both treatment programs had decreased. For the ambulatory 
activity monitor, standardized z-scores were calculated for each patient individually 
by subtracting the mean number of baseline counts and dividing these values by the 
A = Start BAS (21 days no-treatment period) 
B = EDU (followed by a 21 days no-treatment period) 
C = Start GEXP (12,5 hours over 35 days) 
X = End GEXP (followed by 7 days activity monitor) 
F = FU (6-month follow-up period of 7 days) 
D = Start OPE (35 hours over 49 days) 
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baseline standard deviation for that individual. This was done for mean counts in 
the week after EDU and the treatment module. We estimated that an increase of 5 
z-scores could be clinically relevant. 
Results 
Daily measures 
Figure 1 shows the patterns of change of the mean daily VAS ratings for fear of 
movement/(re)injury, pain catastrophizing, and fear of pain for the different treat-
ment groups. Visual inspection of the data suggest that in both treatment groups, 
the EDU produced substantial short-term decreases in fear of movement/(re)injury, 
pain catastrophizing, and fear of pain. Visual inspection also reveals that a further 
decrease of these dependent variables occurred when GEXP followed the no-
treatment period after EDU. On the other hand, when OPE followed B, there was no 
further decrease. The results of the randomization test procedure are displayed in 
table 1 and appear to confirm the conclusions of EDU. Compared with baseline A, 
significant changes are found in fear of movement/(re)injury, pain catastrophizing, 
and fear of pain when EDU takes place. In addition to this, significant changes are 
also found in pain catastrophizing and fear of pain when GEXP (C) is compared with 
B and not when OPE (D) is compared with B. Notable is that particularly in treat-
ment group ABC, all improvements remained during the follow-up period. 
Of interest, and quite unexpectedly, is that in treatment group ABC, a significant 
reduction in pain intensity occurred during follow-up as compared with baseline 
(period A) (table 1). 
Visual inspection of the self-reported difficulties in performance of daily activities at 
home (figure 2) shows that they remained unchanged during EDU (period B) and 
only decreased in the patients who received GEXP (period C). According to the 
graphical display, the randomization test on the raw data showed that the change in 
performance occurred in treatment group ABC for all the patients during GEXP (pe-
riod C), and that the improvements remained during follow-up. Compared with OPE 
(period D) in treatment group ABD, a significant change in performance occurred 
only in patient 2. However, contrary to patient 2, patient 3 and 4 showed a signifi-
cant change in performance during follow-up as compared with baseline (period A). 
Finally, in each treatment group, there was one patient were a significant change 
occurred after EDU (period B). 
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Table 1 P- values for the ABC and ABD treatment group randomization t-tests on the daily measures for 
fear of movement/(re)injury, pain catastrophizing, fear of pain and current pain intensity 
Variables 
Treatment 
sequence† Group ABC 
Treatment 
sequenceb Group ABD 
Fear of movement/ 
(re)injury 
 
 
 
 
Pain catastrophizing 
 
 
 
 
 
Fear of Pain 
 
 
 
 
 
Current pain 
intensity 
BAS-EDU 
BAS-GEXP 
EDU-GEXP 
BAS-FU 
GEXP-FU 
 
BAS-EDU 
BAS-GEXP 
EDU-GEXP 
BAS-FU 
GEXP-FU 
 
BAS-EDU 
BAS-GEXP 
EDU-GEXP 
BAS-FU 
GEXP-FU 
 
BAS-EDU 
BAS-GEXP 
EDU-GEXP 
BAS-FU 
GEXP-FU 
0.024* 
0.016* 
0.097 
0.037* 
0.813 
 
0.024* 
0.016* 
0.016* 
0.037* 
0.292 
 
0.024* 
0.016* 
0.016* 
0.037* 
0.500 
 
0.184 
0.677 
0.667 
0.037* 
0.271 
BAS-EDU 
BAS-OPE 
EDU-OPE 
BAS-FU 
OPE-FU 
 
BAS-EDU 
BAS-OPE 
EDU-OPE 
BAS-FU 
OPE-FU 
 
BAS-EDU 
BAS-OPE 
EDU-OPE 
BAS-FU 
OPE-FU 
 
BAS-EDU 
BAS-OPE 
EDU-OPE 
BAS-FU 
OPE-FU 
0.024* 
0.013* 
0.776 
0.037* 
1.000 
 
0.024* 
0.013* 
0.882 
0.037* 
1.000 
 
0.024* 
0.013* 
0.184 
0.037* 
0.968 
 
0.390 
0.197 
0.803 
0.074 
0.161 
*p < 0.05; † The intervention point was determined randomly with a minimum phase length of 1; Bas, 
baseline; EDU, education; GEXP, graded exposure in vivo; OPE, operant graded activity program; FU, 6-
month-follow-up 
Questionnaires 
Pain-related fear 
Table 2 shows that the mean TSK scores in both treatment groups decreased after 
EDU (period B) and even decreased to a mean score of 21 (<10th percentile) when 
the GEXP (period C) was delivered and not the OPE (period D). For PHODA, a drastic 
reduction was observed at the end of GEXP (period C) as compared with baseline 
(period A) and EDU (period B) and remained at follow-up. 
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Table 2 Mean scores of fear of movement/(re)injury (TSK), pain vigilance (PVAQ), self-reported disability 
(RDQ), and fearfulness of movements (PHODA), taken at baseline, before and after each first treatment 
module, and at the 6 month follow-up for treatment groups ABC (N=3) and ABD (N=3) 
Questionnaires Treatment Group ABC Treatment Group ABD 
Tampa Scale for Kinesiophobia 
[TSK] 
 
 
 
 
Pain Vigilance and Awareness 
Questionnaire [PVAQ] 
 
 
 
 
Roland Disability Questionnaire 
[RDQ] 
 
 
 
 
The Photograph series of Daily 
activities [PHODA] 
Baseline 
Education 
Start GEXP 
End GEXP 
Follow-up 
 
Baseline 
Education 
Start GEXP 
End GEXP 
Follow-up 
 
Baseline 
Education 
Start GEXP 
End GEXP 
Follow-up 
 
Baseline 
Education 
Start GEXP 
End GEXP 
Follow-up 
41 
29,33 
33,33 
21,33 
20,33 
 
49,33 
44,67 
41 
18,33 
19,67 
 
15 
12,67 
14,67 
2,67 
2 
 
68,33 
66 
68,67 
11,67 
12 
Baseline 
Education 
Start OPE 
End OPE 
Follow-up 
 
Baseline 
Education 
Start OPE 
End OPE 
Follow-up 
 
Baseline 
Education 
Start OPE 
End OPE 
Follow-up 
 
Baseline 
Education 
Start OPE 
End OPE 
Follow-up 
46 
30 
31,3 
31,3 
33 
 
50,3 
45 
44,67 
35,67 
37,33 
 
16,33 
11,67 
15,67 
15 
15,67 
 
71,33 
72,33 
72 
59 
58,67 
 
Pain vigilance 
As compared with baseline (period A), table 2 shows that the decrease of the mean 
score of the PVAQ at the end of EDU (period B) was not relevant in both treatment 
groups. However, under the influence of both GEXP (period C) and OPE (period D), 
the decrease of the mean score in both treatment groups was clinical relevant. 
Hereby, it is notable that in treatment group ABD, the reduction of 30% was, com-
pared to baseline (period A) and EDU (period B), just managed by OPE (period D) 
and that in group ABC, a reduction of 70% was observed after GEXP (period C). 
Pain disability 
For the RDQ, table 2 shows that relevant changes are observed when both GEXP 
(period C) and OPE (period D) were introduced. Overall, RDQ scores decreased from 
a mean of 15 to a mean of 2 in group ABC and from 16 to 6 in group ABD. These 
differences largely exceed the preset criterion of 5. 
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Activity monitor 
In accordance with the self-reported difficulties in performance of personal relevant 
daily activities at home, figure 3 shows that the mean standardized scores of the 
activity monitor data did not change after EDU (period B) and only increased clini-
cally relevant in group ABC during GEXP (period C). 
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Figure 3. Activity monitor data. Mean standardized z-scores (and standard error bars) for patients who 
received intervention ABC (baseline-education-exposure) and intervention ABD (baseline-education-
operant graded activity program); *z-score is based on intra-person baseline mean and SD. 
Discussion 
The aim of this study was to examine the effects of a single educational session 
followed by actual exposure in vivo or operant graded activity. Six consecutive pa-
tients with low back pain who were referred for outpatient behavioral rehabilitation 
and reported substantial fear of movement/(re)injury were included. A single-case 
experimental design was applied in which chronically disabled patients were ran-
domized over two cognitive-behavioral treatments. Both the randomization tests on 
the daily measures and pre-post assessments showed that after education and the 
following no-treatment period, subjective ratings of pain-related fear and cata-
strophizing decreased substantially in all patients. This suggests that a highly indivi-
dualized and tailored response to a personal formulation of a patient’s problem 
within a substantive model has good empirical support in changing patient’s percep-
tions about the harmfulness of physical activity and threat value of pain and is sup-
posed to be part of CBT. Another point to make here is that our educational session 
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does not appear to be a simple reassurance approach. On the whole, reassurance 
seems to have a transient impact with an immediate reduction of worry and con-
cern followed by a rebound to pre-intervention levels within 24 hours or so. In re-
ducing pain-related fear, the results of the current study suggest that our education 
works in 1 session. This implicates that it would be a really effective intervention to 
use in primary care if one could identify at-risk patients. 
 
However, despite the effect of education on pain-related fear, the self-reported 
difficulties in performance of daily activities at home and the subjective ratings of 
the PHODA remained unchanged during that period. These variables only decreased 
in the patients who received the graded exposure in vivo. This suggests that educa-
tion is not powerful enough to change actual escape and avoidance behavior. Why 
education only influences beliefs about pain and is not actual escape and avoidance 
behavior is an intriguing question, which merits further examination. There is gro-
wing evidence that attitudes toward physical activity, and the role of implicit versus 
explicit affective evaluations, play an important role in the treatment outcomes of 
chronic low back pain. Studies have shown that especially highly accessible attitudes 
such as the deeply ingrained fear of movement/(re)injury will evoke automatic acti-
vation from memory when the object is encountered (Fazio, 1986; Sanbonmatsu & 
Fazio, 1990; Sarafino, 1998). If patients have labeled attitude objects as positive, 
approach behavior will occur. Conversely, avoidance behavior is elicited when atti-
tude objects have acquired a negative valence. Furthermore, it is possible that indi-
viduals can hold “dual attitudes” which result from different evaluations of the sa-
me attitude object, one of which is an automatic, implicit attitude and the other 
being an explicit one (Ajzen, 2001; Bohner & Wänke, 2002; De Jong et al., 2003; 
Hermans et al., 2002a; Wilson et al., 2000). The following citation from one patient 
in the current study is a nice illustration: “After the educational session, I realized 
that my concerns about (re)injury were irrational, and that I had avoided a lot of 
activities the last few years for no reason. However, when my wife asked me to go 
out for a ride on the bike yesterday, I immediately said no.” Consequently, it might 
be expected that the dimensionality and thus the complexity in attitudes have an 
impact on (speed of) the change of avoidance and escape behavior. 
 
Another possible reason for the lack of association between beliefs and behavior is 
the use of self-report questionnaires. It has been suggested that self-reports, as 
explicit measures, assess what are called “self-attributed motives” and that they 
may be clouded with demand characteristics, self-presentational bias, or attributio-
nal a priori theories (De Jong, 2002; Fazio, 1986; Fazio et al., 1995; Nisbett & Wilson, 
1977; Sherman et al., 2004). As a consequence, it could be that self-attributed moti-
ves are akin to explicit attitudes that are expressed when people are asked directly 
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how they feel, and that implicit motives, assessed by the activity monitor, are simi-
lar to habitual implicit attitudes, in that they automatically influence behavior. 
 
The finding that the activity monitor data follow the same picture as the daily self-
report measures on activity achievement supports the assumption that actual expo-
sure to fear-eliciting activities and/or movements is necessary to modify escape and 
avoidance behavior due to pain-related fear. It also suggests that the confrontation 
of fear-eliciting activities in the treatment setting is analogue for how patients res-
pond in daily life situations. Moreover, treatment gains produced during EXP seem 
to generalize to the home setting and in the absence of therapists. 
 
Although the results show that exposure in vivo with behavioral tests are superior 
to an operant-behavioral graded activity treatment in this subgroup of patients 
expressing substantial fear of movement/(re)injury, there are a number of caveats 
to be considered. First, this study is limited in that it included only 6 patients. On the 
other hand, a single-case experimental design was chosen with appropriate rando-
mization tests. Second, during the exposure in vivo, behavioral tests have been 
developed. Theoretically, it is possible that the effects of the exposure in vivo 
treatment are due to this component. However, in practice, behavioral tests are 
difficult to separate from mere exposure, and they can best be used simultaneously. 
In any case, the findings of this study contribute to the idea that interventions for 
patients with chronic low back pain with substantial pain-related fear have to be 
tailored to the specific attitudes of the patient in question. 
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Abstract 
Using a randomized replicated single case experimental design, this study examined 
whether extinction of pain-related fear during graded exposure in vivo (GEXP) in 
fearful patients with Complex Regional Pain Syndrome type I (CRPS-I) of the upper 
extremities, generalized better to a new movement when subjects were exposed to 
multiple stimuli during the treatment as compared to an exposure treatment in 
which patients were repeatedly exposed to a smaller number of activities. In the 
Multiple Stimuli condition (MSTI, N = 4), GEXP consisted of at least 15 activities to 
which patients were exposed once, and in the Multiple Exposure condition (MEXP, 
N = 4), patients were exposed to 3 activities to which patients were exposed five 
times each. In both conditions generalization of GEXP was tested by exposing pa-
tients to a new fearful activity. It was hypothesized that generalization of extinction 
is facilitated in MSTI. In contrast to the expectations, patients of both conditions 
performed equally well in the test exposure, showing generalization to a new stimu-
lus both immediately after GEXP and during 6-month follow-up. Overall, it seems 
that, irrespective of the kind of exposure, extinction generalized to new threatening 
activities. Possible mechanisms of GEXP in relation to generalization are discussed. 
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Introduction 
Pain-related fear has been identified as one of the most potent predictors of long-
term pain-related disability (Leeuw et al., 2007a; Vlaeyen & Linton, 2000). Pain is an 
evolutionary hard-wired experience that interrupts ongoing activities and captures 
attention to protect the individual from further injury. In the short term, defensive 
behaviors such as escape and avoidance from painful activities after injury are adap-
tive and allow the injury to heal and pain to subside. However, prolongation of the-
se behaviors may have the paradoxical effect that fear and associated disability 
sustains. The unnecessary fear of engaging in rehabilitative efforts, leading to pre-
occupation with bodily symptoms, is often associated with catastrophic 
(mis)interpretation of persistent pain, in terms of most extreme negative conse-
quences, such as the belief that activity might aggravate the initial injury and thus 
must be harmful (Asmundson et al., 1999; Turk & Okifuji, 2002, Leeuw et al., 2007a; 
Sullivan et al., 2005). Pain catastrophizing is associated with increased reporting of 
pain, higher levels of disability, and higher levels of health care use, longer hospitali-
zations, increased pain medication usage, and higher levels of motor pain behaviors 
(Keefe et al., 2004). Furthermore, catastrophic thinking inevitably results in pain-
related fear, which may cluster around interoceptive (e.g. pain itself), propriocepti-
ve (e.g. specific activities/movements) or exteroceptive (e.g. work environment) 
stimuli. Pain-related fear often causes a cascade of psychological and physical 
events which in turn can perpetuate pain problems (Leeuw et al., 2007a; Vlaeyen & 
Linton, 2000). 
 
Exposure therapy is the preferred treatment of various kinds of anxiety disorders 
(Cox et al., 1992). Recent clinical experimental studies and clinical trials have shown 
that graded exposure in vivo is also a successful treatment for chronic pain patients 
presenting a pain-related fear (Boersma et al., 2004; De Jong et al., 2005a, 2005b; 
Leeuw et al., 2008; Linton et al., 2007; Vlaeyen et al., 2001, 2002a, 2002b; Woods & 
Asmundson, 2008). During exposure, a former conditioned stimulus (CS: specific 
activity) is presented several times during which the representation of the uncondi-
tioned stimulus (UCS: pain) changes. The individual learns that a specific activity no 
longer predicts the catastrophic consequences, for example, pain is no longer a sign 
of injury. During exposure the meaning of pain changes to a less threatening UCS. 
Despite the success of exposure in chronic pain it is still the question if extinction 
generalizes to new threatening activities. Return of fear is a problem frequently 
encountered after successful exposure treatment (Hermans et al., 2005). The evi-
dence so far (Baeyens et al., 2005; Bouton & Swartzentruber, 1991; Craske et al., 
2008; Hermans et al., 2005; Rachman, 1989; Vansteenwegen et al., 2007) suggests 
that extinction cannot be equated with ‘unlearning’ but rather the learning of ex-
ceptions to the rule that physical activity is dangerous. The fear response can spon-
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taneously arise after a while (spontaneous recovery), when confronted with a new 
CS-US event (rapid reacquisition), or with an unpredicted UCS (reinstatement). A 
study by Rescorla (1996) shows that exposure does not alter the acquired CS-US 
association, suggesting that extinction is context dependent (Bouton & King, 1983; 
Craske et al., 2008; Hermans et al., 2005; Vansteenwegen et al., 2007). 
 
A number of studies have shed light on the generalization of extinction in chronic 
pain patients. First, Goubert et al. (2002) investigated whether the effects of expo-
sure to one movement generalize towards another dissimilar movement. Patients 
were requested to perform two movements twice. Analyses revealed that patients 
initially over-predicted pain, but after exposure the over-prediction was readily 
corrected. However, this exposure effect did not generalize from the first to the 
second movement. Additionally, the lack of generalization was only characteristic 
for patients reporting a high level of catastrophic thinking about pain. In a subse-
quent study where ratings for perceived harm were also obtained, similar results 
were reported (Crombez et al. 2002). Secondly, Goubert et al. (2005) investigated 
the benefits of exposure to a variety of movements versus exposure to the same 
movements on the correction of over-prediction of pain and behavioral performan-
ce on a final behavioral test which was the same for all the patients. The results 
showed that patients over-predicted pain during a threatening behavioral test. No 
support was found for the hypothesis that varied exposure facilitates generalization 
of exposure effects. Contrary to these studies, Trost et al. (2008) showed successful 
generalization of pain expectancy corrections across four adaptations of a reaching 
task, each introducing an element of increased intensity, in chronic low back pain 
patients reporting high levels of pain-related fear. 
 
The results of the above-described studies in back pain patients showed that extinc-
tion of pain-related fear is a laborious process that poorly generalizes to other 
movements or contexts. Extinction is not ‘unlearning’, but learning something new. 
Patients learn conceptual exceptions to their general rule: ‘This movement is harm-
ful’. From this point of view it seems important to expose fearful individuals to 
stimuli that were encountered during the acquisition of fear, and to provide ade-
quate exceptions so that these exceptions will form the general rule. However, in 
rehabilitation medicine the question is how many exceptions should be offered 
during exposure therapy to be able to function in normal life? If generalization of 
extinction is so hard to accomplish, will pain patients reporting high levels of pain-
related fear only learn that they do not have to be fearful for the activities that are 
performed during the exposure sessions? 
 
The primary objective of this study was to replicate the finding that exposure to 
multiple movements promotes generalization of extinction to new stimuli. Using a 
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replicated single case experimental design, we decided to experimentally examine 
whether extinction of pain-related fear during a graded exposure in vivo program 
(GEXP) in patients with Complex Regional Pain Syndrome type I (CRPS-I) reporting 
high levels of pain-related fear generalized to threatening activities to which they 
were not exposed during GEXP. In a previous study of De Jong et al. (2005a), results 
showed that GEXP seems to be a successful treatment in CRPS-I patients. Two GEXP 
conditions of 15 sessions were tested: a Multiple Stimuli condition (MSTI) in which 
the exposure therapy consisted of 15 activities to which the patients were exposed 
once, and a Multiple Exposure condition (MEXP) of 3 activities to which the patients 
were exposed five times. Our expectation was that as compared to patients in 
MEXP, the patients in the MSTI condition experienced more ‘exceptions to the rule’, 
as a result of which they would show less fear when exposed to a new movement. 
Materials and methods 
Study design 
A randomized replicated sequential single-case experimental ABC-design was used 
(Onghena & Edgington, 2005). Patients were randomly assigned to one of the two 
exposure conditions (period B). Randomisation occurred after the baseline (BAS; 
period A) and was done by a computer system providing allocations in a locked, 
unreadable file that could be assessed only by an independent research administra-
tor. In MSTI, GEXP consisted of 15 activities to which the patients were exposed 
once and in MEXP of 3 activities to which the patients were exposed five times. Also 
the length of the baseline was randomized and varied between 12-16 days. Finally, 
at 6-months there was a follow-up period of two weeks (FU; period C). 
Participants 
Eight consecutive patients with CRPS-I to the upper extremities were included in the 
study. CRPS-I is a painful disabling disorder that is poorly understood. Symptoms of 
CRPS-I include continuing pain, allodynia, or hyperalgesia with which the pain is 
disproportionate to any inciting event, abnormal swelling, hair or nail growth, skin 
colour or temperature changes, sweating, and limited range of motion and move-
ment disorders. The diagnosis of CRPS-I was made according to the criteria formu-
lated by the International Association for the Study of Pain (IASP: Merskey & Bog-
duk, 1994; Stanton-Hicks et al., 1995), and based on physician evaluation of objec-
tive symptoms. The patients were referred for outpatient behavioral rehabilitation 
at the department of rehabilitation of the University Hospital Maastricht, and they 
reported pain for at least 6 months and substantial fear of movement/(re)injury 
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(Tampa Scale for Kinesiophobia [TSK: Miller, Kori, & Todd, 1991] score > 39). The 
cut-off was based on the median of the TSK distribution of chronic low back pain 
samples reported earlier (Crombez, Vlaeyen, Heuts & Lysens, 1999; Vlaeyen & Lin-
ton, 2000). Given the findings of Goubert et al. (2002), which indicated that lack of 
generalization was only characteristic for patients reporting a high level of catastro-
phic thinking, it was hypothesized that differences in pain catastrophizing should be 
avoided. Therefore, patients were included if they also were characterized by high 
levels of pain catastrophizing (The Pain Catastrophizing Scale [PCS: Sullivan & 
Bishop, 1995] score > 21). This cut-off was based on the median of the PCS distribu-
tion of chronic low back pain samples (Van Damme et al., 2000). The ages of the 
patients were between 18 and 65 years. 
 
Further, exclusion criteria were illiteracy, pregnancy, impairment of contra lateral 
extremity (e.g. because of rheumatoid arthritis, prior sympathectomy of the af-
fected extremity), alcohol or drug abuse, and serious psychopathology based on the 
Symptom Checklist (SCL-90: Arrindell & Ettema, 1986) of which Dutch norms were 
available. With regard to psychopathology none of the potential participants were 
excluded. During the study ten patients dropped out due to various reasons. Of 
these, four patients were excluded after the psychological intake of the GEXP be-
cause they still specified pain-reduction as their only treatment goal. GEXP was not 
focused on pain reduction, but to improve overall functioning despite the pain. Two 
patients declined participation to the study, because they refused to terminate 
ongoing treatment. Two patients dropped out during the exposure in vivo sessions, 
of which one had to keep rest after heart problems were diagnosed and the other 
because of family conflicts. Finally, two patients were excluded at the end of GEXP. 
Both patients had concealed the fact of an ongoing lawsuit and due to this situation 
not completed the questionnaires appropriately. They were afraid that their re-
search data would be passed on the court. Patients who dropped out from the stu-
dy were replaced by new consecutive patients. Finally, eight patients were included 
in the study. The patients randomized to MSTI (N = 4) were all female with a mean 
age of 49 ± 4.8 (SD) of which three patients suffer from CRPS-I in the dominant hand 
and one in the non-dominant hand. In two patients there was a clear limitation of 
active movements, visible by a deviating position at rest of the upper extremity 
(claw-shaped fingers or hyper extension of the MCP’s). One patient randomized to 
MEXP (N = 4) was male and the other three were female. Their mean age was 39 ± 
11.0 (SD). Also in MEXP, three patients suffered from CRPS-I in the dominant hand 
and one in the non-dominant hand. In one patient there was a clear limitation of 
active movements. At inclusion, the mean duration of the complaints was 3.5 years 
(range: 1.5 years – 8 years). 
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Procedure and program overview 
The Medical Ethics Committee of the University Hospital Maastricht approved the 
research protocol. Patients were first evaluated by the rehabilitation physician who 
conducted a full physical examination, evaluated previous diagnostic tests, and 
informed participants about the study. When patients agreed to participate, the 
researcher sent additional written information, along with an informed consent 
form, TSK, PCS and SCL-90. If patients fulfilled the pre-set inclusion criteria, they 
started with the baseline measurement period (BAS). 
To test whether the effects of GEXP generalized to other not presented threatening 
activities, patients performed a behavioral test under supervision of an independent 
occupational therapist. This was done just after GEXP as well as during FU. In addi-
tion, at the start of BAS and after the above-mentioned behavioral tests, the same 
independent occupational therapist observed and evaluated, to what extent the 
affected arm/hand was involved in a series of standardized daily activities using the 
Radboud Skills Test (RST: Cup, van de Ven-Stevens & Corstens-Mignot, 1999). These 
activities were not performed during GEXP. Besides the RST also standardized ques-
tionnaires were completed. Further, during BAS, GEXP and two weeks after GEXP 
and FU patients completed daily measures at home. 
Graded exposure in vivo (GEXP) 
The same outpatient therapist team provided GEXP in both conditions. The team 
consisted of a behavioral therapist and an occupational therapist both experienced 
in the cognitive-behavioral rehabilitation of patients with chronic pain. In both con-
ditions, GEXP was highly structured, protocolized, individually tailored, and aimed to 
restore a normal pattern of daily function, including complete return to work. Pain 
reduction and decrease of the observed and reported physiological signs was not a 
direct goal. 
 
The GEXP started with a psychological intake by the behavioral therapist aimed to 
complete a behavioral analysis of the pain problem with special attention to pa-
tient’s catastrophic interpretations of the pain problem. After the psychological 
intake (one session) an educational session was provided by the therapist team 
explaining the treatment rationale to each patient individually. Patients were given 
a careful explanation of the fear-avoidance model using their own individual symp-
toms, beliefs and behaviors in relation to their pain complaints. The therapist team 
illustrated the paradoxical and dysfunctional effects of various safety behaviors, and 
offered the patient a new view on pain as a common condition that can be self-
managed, rather than as a serious disease or a condition that needs careful protec-
tion. One of the major goals of the educational component was to help the patient 
understand that the consequences of pain are catastrophically overestimated, and 
that various safety behaviors are not adaptive anymore. Directly after the explana-
 124 
tion of the treatment rationale, a hierarchy of fear-eliciting movements and activi-
ties was made using the Photograph series of Daily Activities for the upper extremi-
ties (PHODA-UE: Dubbers, Vikström & de Jong, 2003). Patients were requested to 
judge the harmfulness of 125 physical movements from daily life activities repre-
sented by photographs. Using a (fear) thermometer, each picture was given a rating 
between zero (representing the situation which was not harmful for the upper ex-
tremity) to 100 (representing the situation which was absolutely damaging the up-
per extremity). Based on the graded hierarchy of the PHODA-UE individually tailored 
behavioral experiments were developed. For MSTI these were at least fifteen activi-
ties and for MEXP only three activities. To be sure that all activities were quite thre-
atening in both conditions, only activities rated > 50 on the thermometer were in-
cluded. Subsequently, during the next sessions patients were gradually and system-
atically exposed to these tailored and fear-provoking activities. To enhance gener-
alization and maintenance exposure was provided to the maximum spectrum of 
contexts and natural settings that can be achieved in and around the hospital set-
ting. A more detailed description of GEXP can be found in Vlaeyen, De Jong, Leeuw 
& Crombez (2004). 
Measures 
Fear of movement/(re)injury 
The Dutch language version of the Tampa Scale for Kinesiophobia (TSK-DV: Goubert 
et al., 2000) was used to quantify fear of movement/(re)injury. The TSK-DV consists 
of 17 statements that have to be rated on a four-point scale (1 = strongly agree, 4 = 
strongly disagree). The total score was calculated after inversion of items 4, 8, 12, 
and 16 which are phrased in reversed key. The total score varied between 17 and 
68. The Dutch version of the TSK has been shown to be sufficiently reliable and valid 
(Goubert et al., 2004, Roelofs et al., 2007). 
The perceived harmfulness of daily activities 
To measure the threat-value of daily activities the Photograph Series of Daily Activi-
ties of the upper extremities was used (PHODA: Dubbers et al., 2003) The PHODA 
included 125 photographs of various daily activities. Patients had to indicate to 
what extent they perceived these daily activities to be harmful and/or threatening. 
The PHODA focussed on patient’s judgment about the consequences of certain 
movements. A thermometer consisted of a vertical line anchored at the bottom 
with 0 which means ‘not harmful’ and at the top with 100 which means ‘very harm-
ful’ was used. Each photograph was given a rating according to its position on the 
thermometer. A mean total score ranging from 0 to 100 was calculated as the sum 
of each rating divided by 125. The PHODA has been used as a measurement instru-
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ment in several studies that examined the effectiveness of graded exposure in vivo 
(e.g. De Jong et al., 2005a, 2005b; Leeuw et al., 2008). 
Pain catastrophizing 
The degree of pain catastrophizing was measured by the Pain Catastrophizing Scale 
(PCS: Sullivan, Bishop & Pivik, 1995). In this study, the Dutch version of the PCS was 
used (PCS-DV: Van Damme, Crombez, Bijttebier, Goubert & Van Houdenhove, 
2002). The PCS instruction asked the participants to reflect on past painful experi-
ences and to indicate the degree to which they experienced each of the thirteen 
thoughts or feelings when they were experiencing pain on a 5-point Likert scale (0 = 
not at all, 4 = all the time). The PCS-DV has been shown an highly reliable and valid 
measure of thinking in catastrophes (Van Damme et al., 2002). 
Behavioral test 
In order to test generalization each patient performed a behavioral test after GEXP 
(post-test) and during FU, consisting of two activities. The first activity consisted of a 
fall forward, which should be absorbed by the hands. This activity was standardized 
for all patients and was done at post-treatment as well as at FU. The second activity 
was a random selection of one of four ‘not-likely to happen in daily-life’ activities 
(box against a punching bag, do push-ups, give a Chinese burn [it involves gripping 
the top of somebody’s forearm with both hands then rotating the hands in opposite 
directions, thus stretching the skin], hang on a climbing rack). These activities were 
drawn from intake information of a previous study in CRPS-I patients (de Jong et al., 
2005a). The activity selected at FU was always different from the one selected at 
post-treatment. The tests were performed under supervision of an independent 
occupational therapist. The perceived harmfulness of these activities was rated at 
baseline and just before and immediately after the performance at post-treatment 
and at FU. 
Functional disability 
Functional disability was measured with the Radboud Skills Test (RST: Cup et al., 
1999) and the Radboud Skills Questionnaire (RASQ: Oerlemans et al., 2000b). The 
aim of the RST is to observe and evaluate to what extent CRPS-I patients involve 
their affected arm/hand during activities which normally are done two-handed: 
walk, put a letter in an envelope, put a pillow in a pillow-cover, put on a dress shirt, 
close a button, put on a sock, dry up the dishes, fold up a towel. The tasks were 
scored on a five point Likert scale (0 = the task is normally executed two-handed, 4 = 
the task can not be executed without help). Also the way patients experienced diffi-
culty with the task was measured. This was scored on a three point Likert scale (0 = 
no problem, 2 = a great problem). The RST provides a measure of functioning as 
judged by an independent occupational therapist (performing score) and the pa-
 126 
tient himself (difficulty score). The RST has shown good psychometric properties (de 
Boer et al., 2001). 
The RASQ, a self-report questionnaire, measures skills in which both hands were 
notably active. The skills, or daily activities, were described in forty-five items and 
divided into six domains: 1) performing abilities; 2) household activities; 3) recrea-
tional activities; 4) social activities; 5) remaining; and 6) work. A total score was 
computed, along with the six domain scores. Each of the items was scored on a five-
point Likert scale (1 = normal, 5 = ‘I do not perform the activity anymore as a result 
of CRPS-I’, and there was an extra score of ’9’ for ‘not applicable’). The patient indi-
cated the effort of the activity by choosing a number. Different scores were com-
puted by summing up relevant items (minus the number of items in which the cate-
gory ‘not applicable’ was chosen), divided over the number of items of the relevant 
scale. The questionnaire has been found reliable in CRPS-patients, with good 
agreement between the outcomes for test-retest and inter observer reliability stud-
ies as established with the method of Bland and Altman (1986) (Oerlemans et al., 
2000b). 
Internal validity checks 
Daily measures 
To check whether the GEXP indeed modified activity goal achievement, fear of mo-
vement/(re)injury and pain catastrophizing and also possibly pain intensity, a brief 
diary was used consisting of 11 items with visual analog scales. The first 7 items 
(table 1) represented the main factors of existing questionnaires for fear of move-
ment/(re)injury (Tampa Scale for Kinesiophobia [TSK]: Goubert et al., 2000, 2004; 
Miller et al., 1991; Roelofs et al., 2004, 2007) and pain catastrophizing (Pain Catas-
trophizing Scale [PCS]: Sullivan, Bishop & Pivik, 1995; Van Damme, Crombez, Bijtte-
bier, Goubert & Van Houdenhove, 2002). All items were scored on 10 cm visual 
analogue scales (VAS), anchored ‘totally disagree’ - ‘totally agree’. Two main scores 
were derived, consisting of the mean scores (range 0 to 10) of the items from the 
TSK and PCS. Pain intensity was measured with an additional VAS anchored with ‘no 
pain at all’ at one extreme and ‘worst pain experienced’ at the other. The last three 
VAS referred to the performance of personally relevant activities that represented 
three main functional goals. Each scale was preceded by the same question: “How 
difficult was it to perform this activity today?” The scale was anchored with ‘no 
problem at all’ at one extreme and ‘impossible’ at the other. The diary was com-
pleted during the whole duration of the study, and the follow-up period. The diary 
has been shown to be sensitive to GEXP in previous studies (e.g. De Jong et al., 
2005b). 
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Table 1 Items of the shortened and adapted versions of the TSK and PCS that are completed on a daily 
basis. 
Fear of movement/(re)injury (adapted and modified from TSK) 
1. If I exercise I might be in danger of reinjuring myself. (Harm) 
2. My body is telling me I have something dangerously wrong. (Fear) 
3. My pain complaints would decrease if I were to exercise. (Exercise) 
4. I can’t do everything because it’s too easy for me to get injured. (Avoidance) 
 
Pain catastrophizing (adapted and modified from PCS) 
1. When I am in pain I keep thinking about how badly I want the pain to stop. (Rumination) 
2. When I am in pain I wonder whether something serious may happen. (Magnification) 
3. When I am in pain I feel I can’t go on with my daily activities. (Helplessness) 
TSK, Tampa Scale for Kinesiophobia; PCS, Pain Catastrophizing Scale 
Treatment expectancy and credibility 
When the rationale of GEXP was explained and at the end of GEXP patients com-
pleted one expectancy and one credibility item on 10cm VAS, with ‘not at all’ and 
‘very much’ on the extremes: ‘Do you expect that GEXP will help you to cope better 
with your pain complaints?’ (Expectancy) and ‘Do you believe that GEXP offered to 
you is a meaningful treatment for patients with CRPS-I?’ (Credibility) (Borkovec & 
Nau, 1972). This measurement was carried out by an independent occupational 
therapist. 
Statistical analyses 
For analyzing the resulting data of the diary, a randomization test based on the 
random determination of the moments of phase change or intervention points to 
test a null hypothesis about treatment effects in single case experimental designs 
and using the rationale of Edgington was carried out (Onghena & Edgington, 1994). 
With respect to Student t tests, analysis of variance F tests, or other inferential pro-
cedures from within the general linear model framework, randomization tests were 
used because they had the advantage of being valid for single-case experiments 
without making distributional assumptions (Edgington & Onghena, 2007), of being 
easy to apply (Edgington, 1980; Onghena & Edgington, 2005) and of being extremely 
versatile for even the most complex single-case designs (Onghena & Van Damme, 
1994; Persons & Silberschatz, 1998). The randomization tests in this study made use 
of the difference between means as (directional) test statistic. Replicated single-
case experiments may be considered as multiple studies that can be combined using 
meta-analytical procedures. Because the replicated single-case experiments in this 
study provided independent tests of the same null hypothesis, the directional P-
values of these tests were combined by calculating the sum of the P-values and 
comparing this sum with all other sums that were arised under the general null 
hypothesis (if the null hypothesis is true, than the P-value is just a random draw 
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from a uniform [0,1] distribution). A more detailed description of the randomization 
tests for single-case experimental designs can be found in Onghena and Edgington 
(2005). 
 
Because GEXP was expected to be superior to BAS the null hypothesis that there is 
no differential effect for any of the measurement times was tested using a randomi-
zation test on the differences between GEXP and BAS. While FU was expected to be 
superior to BAS and would not change in relation to GEXP, differences between FU 
and BAS and FU and GEXP were also tested using randomization tests. The analysis 
was performed using the SCRT software (Single-Case Randomization Tests, version 
1.1: Onghena & Van Damme, 1994). 
Preset criteria for non-daily measures 
For the non-daily measures (TSK, PHODA, PCS, RST and RASQ) the limited number of 
data made it impossible to use randomization tests. Therefore, we decided to for-
mulate pre-set criteria to detect a clinically important change as the result of GEXP. 
Based on the results of previous single case studies on the efficacy of GEXP (e.g. De 
Jong et al., 2005a, 2005b), for the TSK and PCS, a reduction of more than 30 percen-
tile points, and for the RASQ, a mean improvement of 50%, was considered rele-
vant. Because a number of items from the RASQ were used as activity to observe 
the involvement of the affected hand during the RST, by which it seemed that both 
instruments were strongly linked, we estimated that also a mean improvement of 
50% on the RST could be supposed as clinically relevant. To detect actual changes of 
the PHODA it was considered that the change should exceed a variation of 20 points 
on the 0-100 scale (Leeuw, Goossens, van Breukelen, Boersma & Vlaeyen, 2007b). 
Results 
Internal validity checks 
Expectancy and credibility check 
Mean expectancy ratings (7.83 ± 0.36 SD and 7.10 ± 2.14 SD) and credibility ratings 
(6.63 ± 1.17 SD and 7.73 ± 2.24 SD) were relative high in both conditions, and higher 
as compared to a previous GEXP study in CRPS-I patients (De Jong et al. 2005). Mea-
surements after GEXP showed a further increase of the expectancy ratings (8.23 ± 
1.47 SD and 9.43 ± 0.48 SD) and the credibility ratings (7.98 ± 1.66 SD and 9.15 ± 
0.51 SD). The results imply that the differential effectiveness of GEXP in both condi-
tions was not substantially influenced by differences in treatment credibility and 
expectancy. 
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Daily measures 
The P-values of the randomization tests on the raw data of the daily measures for 
each patient in both conditions are displayed in table 2. Compared with BAS, after 
GEXP significant changes were found in fear of movement/(re)injury for each pa-
tient in MSTI and patient 5 and 6 in MEXP. Although patient 7 and 8 in MEXP re-
ported a high score on the whole TSK during the inclusion of the study, the VAS-
scores of the diary for the relevant variables were already low at BAS. Due to this, 
no significant difference between BAS and GEXP was observed. Notable is that all 
improvements remained during FU. The same tendency was observed for the vari-
able pain catastrophizing with the exception of patient 8 who showed also a signifi-
cant change between BAS and GEXP. With regard to personally relevant activities, 
the results showed a significant change in each activity after GEXP for patient 2, 3 
and 4 in MSTI and patient 6 and 7 in MEXP. Also at FU these improvements re-
mained stable. Although visual inspection of the daily measures of patient 1 in MSTI 
and patient 5 and 6 in MEXP suggested that GEXP had a positive impact on person-
ally relevant activities, both at BAS, GEXP and FU the raw data were characterized 
by outliers, which seemed to be a possible explanation that no significant differ-
ences were found in these patients. Of interest, and quite unexpectedly, was that at 
FU in MSTI for each patient and in MEXP for patient 5 and 7 a significant difference 
could be observed for pain experience. Patient 6 showed much fluctuation in pain 
experience and patient 8 experienced throughout the study a lot of pain. In conclu-
sion, based on the overall results and in accordance with its purpose, GEXP indeed 
modified the fear appraisals and promoted the achievement of functional goals. 
Outcome measures 
Behavioral Test 
Table 3 and 4 provides an overview regarding the performance of the standard 
(headlong fall) and the pre-randomized specific activity, both considered as very 
threatening, during the behavioral tests observed for each patient in MSTI and 
MEXP. Both in behavioral test 1 (after GEXP) and 2 (at FU) all patients performed 
the specific activity without any safety behavior. During the behavioral test after 
GEXP, the independent occupational therapist observed safety behavior in one 
patient from MSTI during the performance of the standard activity. Conversely, 
during follow-up no safety behaviors were observed. On the basis of these observa-
tions it could be stated that all patients after GEXP, irrespective of the exposure 
condition, were able to perform threatening activities and that learning effects of 
GEXP generalized to threatening activities not performed during GEXP. 
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Table 2 P Values for each patient in MSTI (GEXP: ≥ 15 activities) and MEXP (GEXP: 3 activities) of the 
Randomization t Test on the diary data between BAS-GEXP and BAS-FU for the dependent variables fear 
of movement/(re)injury (FOM), pain catastrophizing (CAT), pain experience (PE) and personally relevant 
activities 
  Variables 
 
Condition 
Treatment 
Sequencea 
 
FOM 
 
CAT 
 
PE 
 
Activity 1 
 
Activity 2 
 
Activity 3 
MSTI 
Patient 1 
 
Patient 2 
 
Patient3 
 
Patient 4 
 
BAS-GEXP 
BAS-FU 
BAS-GEXP 
BAS-FU 
BAS-GEXP 
BAS-FU 
BAS-GEXP 
BAS-FU 
 
0.04* 
0.04* 
0.04* 
0.04* 
0.04* 
0.04* 
0.04* 
0.04* 
 
0.04* 
0.04* 
0.04* 
0.04* 
0.04* 
0.04* 
0.04* 
0.04* 
 
0.08 
0.07 
0.04* 
0.04* 
0.08 
0.04* 
0.19 
0.04* 
 
0.73 (write) 
0.36 
0.04* (drive) 
0.04* 
0.04* (cycle) 
0.04* 
0.04* (sew) 
0.04* 
 
0.68 (peel) 
0.09 
0.04* (cycle) 
0.04* 
0.04* (swim) 
0.04* 
0.04* (cycle) 
0.04* 
 
0.05* (cycle) 
0.06 
0.04* (type) 
0.04* 
0.04* (iron) 
0.04* 
0.04* (type) 
0.04* 
MEXP 
Pat. 5 
 
Pat. 6 
 
Pat. 7 
 
Pat. 8 
 
BAS-GEXP 
BAS-FU 
BAS-GEXP 
BAS-FU 
BAS-GEXP 
BAS-FU 
BAS-GEXP 
BAS-FU 
 
0.04* 
0.04* 
0.04* 
0.04* 
1.00 
0.39 
1.00 
1.00 
 
0.07 
0.04* 
0.04* 
0.04* 
1.00 
0.18 
0.04* 
1.00 
 
0.43 
0.04* 
0.15 
0.15 
1.00 
0.04* 
0.50 
0.39 
 
0.04* (row) 
0.04* 
0.05* (shopping) 
0.05* 
0.07 (clean) 
0.04* 
0.22 (shopping) 
0.11 
 
0.11 (climb) 
0.12 
0.05* (tinker) 
0.05* 
0.04* (tinker) 
0.04* 
0.25 (walk) 
0.11 
 
0.11 (type) 
0.04* 
0.05* (clean) 
0.05* 
0.04* (cook) 
0.04* 
0.22 (build) 
0.11 
* P < 0.05 
a The intervention point was determined randomly 
BAS, baseline; GEXP, graded exposure in vivo; FU, 6-month follow-up 
 
Tables 3 and 4 also display the perceived harmfulness of the standard and specific 
activity at BAS and during the behavioral tests after GEXP and at FU. In line with the 
previous GEXP study in CRPS-I patients of De Jong et al. (2005a) these ratings were 
quite elevated. At the start of behavioral test 1, the mean harmfulness ratings were 
lower than during BAS, suggesting that extinction during GEXP indeed generalized 
towards new activities. During behavioral test 1 the experienced harmfulness of the 
standard and specific activity was significantly lower in MEXP as compared to MSTI. 
Despite the observation that the activity was carried out without safety behaviors, 
particularly patient 3 (table 3) still experienced the fall forward as very threatening. 
The mean-score of the baseline-threat during behavioral test 2 in MEXP was for the 
standard activity almost and for the specific activity already decreased to zero. For 
these patients the 6-month period after behavioral test 1 was not followed by a 
(partial) return of perceived harmfulness. On top of that, activities that were rated 
as harmful during BAS and not used during the GEXP, were also rated as less harm-
ful. By contrast, there was a larger reduction of perceived harmfulness in MSTI as 
compared to MEXP. 
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Table 3 Overview of the performing of the standard activity (fall forward absorbed by the hands) during 
the behavioral tests after GEXP (behavioral test 1) and at FU (behavioral test 2) and the threat-score of 
the standard activity determined at BAS and during the behavioral tests for each patient in MSTI (GEXP: ≥ 
15 activities) and MEXP (GEXP: 3 activities) 
 Fall forward 
  Behavioral Test 1 Behavioral Test 2 
 
Condition 
 
BAS 
Baseline 
threat 
Experienced 
threat 
 
Perform 
Baseline 
threat 
Experienced
threat 
 
Perform 
MSTI 
Pat. 1 
Pat. 2 
Pat. 3 
Pat. 4 
 
100 
80 
100 
100 
 
50 
10 
70 
1 
 
25 
10 
70 
0 
 
+/- 
+ 
+ 
+ 
 
50 
20 
50 
3 
 
30 
0 
40 
0 
 
+ 
+ 
+ 
+ 
Mean 
SD 
95 
10.0 
33 
32.7 
26 
30.9 
 31 
23.3 
18 
20.6 
 
MEXP 
Pat. 5 
Pat. 6 
Pat. 7 
Pat. 8 
 
100 
100 
100 
100 
 
30 
10 
50 
30 
 
0 
0 
0 
10 
 
+ 
+ 
+ 
+ 
 
20 
0 
0 
0 
 
0 
0 
0 
0 
 
+ 
+ 
+ 
+ 
Mean 
SD 
100 
.0 
30 
16.3 
3 
5.0 
 5 
10.0 
0 
.0 
 
+ = performing activity without safety behavior, +/- = performing activity with safety behavior 
Range: 0-100 (the lower the score the better) 
Bas, baseline of the study; GEXP, graded exposure in vivo; FU, 6-month follow-up 
Fear of movement/(re)injury 
Table 5 displays the mean TSK-score at BAS, after GEXP, and at FU for patients in 
MSTI and MEXP. The patients in MSTI (mean TSK-score: 42, SD = .8) and MEXP (me-
an TSK-score: 45, SD = 6.7) reported almost the same degree of pain-related fear at 
BAS. Both in MSTI (mean TSK-score: 26, SD = 4.4) and MEXP (mean TSK-score: 22, SD 
= 5.1) pain-related fear decreased after GEXP. Based on the pre-set criteria, these 
results could be interpreted as clinically relevant. Despite the overall positive results 
of the TSK-score, MEXP (decrease of 23 points) showed a greater decrease than 
MSTI (decrease of 16 points). During FU the mean TSK-scores remained unchanged. 
The perceived harmfulness of daily activities 
The results of the PHODA are summarized in table 5. At BAS the mean total scores 
of the PHODA in Condition I (mean PHODA-score: 62) were higher than in Condition 
II (mean PHODA-score: 54). Both in Condition I (mean PHODA-score: 10) and Condi-
tion II (mean PHODA-score: 0.5) a relevant reduction in PHODA-scores was observed 
after GEXP. During FU the mean total score of the PHODA in Condition I (mean 
PHODA-score: 7) further decreased and remained almost at the same level in Condi-
tion II (mean PHODA-score: 0.3). Given that the PHODA consisted of 125 photo-
graphs and in both GEXP conditions patients were not exposed to all these activi-
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ties, it might be concluded that in both conditions extinction during GEXP general-
ized well to other activities. 
 
Table 4 Overview of the performing of the specific activities during the behavioral tests after GEXP (be-
havioral test 1) and at FU (behavioral test 2) and the threat-score of the specific activities determined at 
BAS and during the behavioral tests for each patient in MSTI (GEXP: ≥ 15 activities) and MEXP (GEXP: 3 
activities) 
 Specific Actvity 
  Behavioral Test 1  Behavioral Test 2 
 
Condition 
 
BAS 
Baseline 
threat 
Experienced
threat 
 
Perform
 
BAS 
Baseline 
threat 
Experienced 
threat 
 
Perform 
MSTI 
Pat. 1 
Pat. 2 
Pat. 3 
Pat. 4 
 
100a 
100b 
100d 
100d 
 
50a 
10b 
10d 
1d 
 
30a 
0b 
10d 
0d 
 
+ 
+ 
+ 
+ 
 
100d 
100c 
80b 
100b 
 
65d 
20c 
50b 
0b 
 
30d 
0c 
40b 
0b 
 
+ 
+ 
+ 
+ 
Mean 
SD 
100 
.0 
18 
21.9 
10 
14.1 
 95 
10.0 
34 
29.3 
25 
28.9 
 
MEXP 
Pat. 5 
Pat. 6 
Pat. 7 
Pat. 8 
 
90c 
100d 
100d 
100a 
 
20c 
10d 
10d 
30a 
 
0c 
5d 
0d 
10a 
 
+ 
+ 
+ 
+ 
 
90a 
100a 
100c 
100d 
 
0a 
0a 
0c 
0d 
 
0a 
0a 
0c 
0d 
 
+ 
+ 
+ 
+ 
Mean 
SD 
98 
5.0 
18 
9.6 
4 
4.8 
 98 
5.0 
0 
.0 
0 
.0 
 
a = Boxing, b = Chinese burn, c = Push-ups, d = Hanging; + = performing activity without safety behavior, +/- 
= performing activity with safety behavior; Range: 0-100 (the lower the score the better); Bas, baseline; 
GEXP, graded exposure in vivo; FU, 6-month follow-up 
 
Pain catastrophizing 
Regarding pain catastrophizing (table 5) the mean PSC-score at BAS in MSTI (mean 
PCS-score: 24.25, SD = 1.5) was the same as in MEXP (mean PCS-score: 24.50, SD = 
1.3). Both in MSTI (mean PCS-score: 6.5, SD = 5.1) and MEXP (mean PCS-score: 3.8, 
SD = 3.9) pain catastrophizing decreased after GEXP. Again, the decrease in MEXP 
(decrease of 19.2 points) was greater than in MSTI (decrease of 10.3 points). During 
FU the mean PCS-score in MSTI decreased still a little (mean PCS-score: 6.3, SD = 
4.2). However, MEXP (mean PCS-score: 9.8, SD = 11.4) showed an increase of pain 
catastrophizing during FU. 
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Table 5 The mean total score of fear of movement/(re)injury (TSK), the perceived harmfulness of daily 
activities (PHODA), and pain catastrophizing (PCS), of MSTI (GEXP: ≥ 15 activities) and MEXP (GEXP: 3 
activities), determined at BAS, after GEXP and FU 
  Mean total score 
 Condition BAS GEXP FU 
TSK1 MSTI 
 
MEXP 
 
42 
(SD = .8) 
45 
(SD = 6.7) 
26 
(SD = 4.4) 
22 
(SD = 5.1) 
26 
(SD = 4.4) 
22 
(SD = 5.1) 
PHODA2 MSTI 
 
MEXP 
 
62 
(SD = 2.6) 
54 
(SD = 16.4) 
10 
(SD = 9.4) 
0.5 
(SD = 1.0) 
7 
(SD = 6.8) 
0.3 
(SD = .5) 
PCS3 MSTI 
 
MEXP 
 
24.25 
(SD = 1.5) 
24.50 
(SD = 1.3) 
6.5 
(SD = 5.1) 
3.8 
(SD = 3.9) 
6.3 
(SD = 4.2) 
9.8 
(SD = 11.4) 
1Range: 17-68 (the lower the better); 2Range: 0-100 (the lower the better); 3Range: 0-52 (the lower the 
better) ; Bas, baseline; GEXP, graded exposure in vivo; FU, 6-month follow-up 
 
Functional disability 
Table 6 displays the results of the RST and RASQ. The mean total score of the ob-
served quality of the standardized activities of the RST determined at baseline were 
higher in Condition I. This means that patients in MSTI showed more objectively 
restrictions in the performance of ten daily life activities than the patients in MEXP. 
After GEXP, the mean total score decreased in both conditions. This was of the same 
size and clinically relevant. After GEXP no problems were observed by the assessor 
in MEXP. Despite a slight decline, this effect remained for all patients at FU. Accord-
ing to the results of the observed quality, patients in MSTI evaluated the standard-
ized activities at BAS as more difficult than patients in MEXP. After GEXP the pa-
tients in MSTI evaluated the standardized activities of the RST as less difficult. In 
MEXP there were no difficulties reported. In both conditions the difference of the 
mean-scores was the same size. At FU there was no appreciable change in both 
conditions. 
 
On the basis of the mean item scores of the RASQ it can be concluded that at BAS 
patients in MSTI indicated somewhat more disabilities than in MEXP. After GEXP, 
the mean item score in both conditions showed a clear and clinically important 
reduction of the reported disabilities. Compared to BAS the mean improvement in 
MSTI, calculated on the total number of items, was 53.3% (range: 43% - 67%) and in 
MEXP 61.5% (range: 48% - 75%). During FU the mean item score of the RASQ was 
still significantly lower than at BAS. However, in both conditions these scores were 
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higher than post treatment. In MSTI the mean relapse, once again calculated on the 
total number of items, was 5%, and MEXP 21%. 
 
Table 6 The mean total score for the observed quality (observation) and subjective difficulties (evalua-
tion) of the standardized activities of the Radboud Skills Test (RST), and the mean item score of the 
Radboud Skills Questionnaire (RASQ), of MSTI (GEXP: ≥ 15 activities) and MEXP (GEXP: 3 activities), 
determined at BAS, after GEXP and FU  
  Mean score 
 Condition BAS GEXP FU 
RST observation1 MSTI 
 
MEXP 
 
17.3 
(SD = 12.1) 
11.3 
(SD = 12.4) 
5.5 
(SD = 4.8) 
0.3 
(SD = .5) 
6.3 
(SD = 8.0) 
2.0 
(SD = 3.4) 
RST evaluation2 MSTI 
 
MEXP 
 
8.5 
(SD = 2.1) 
6.0 
(SD = 5.1) 
2.8 
(SD = 1.9) 
0.3 
(SD = .5) 
2.3 
(SD = 1.7) 
0 
(SD = 0) 
RASQ3 MSTI 
 
MEXP 
 
3.46 
(SD = .33) 
3.06 
(SD = .79) 
1.64 
(SD = 0.51) 
1.28 
(SD = .42) 
1.67 
(SD = .43) 
1.34 
(SD = .53) 
1The mean total score (sum of score for each single activity), Range: 0-40 (the lower the better); 2The 
mean total score (sum of score for each single activity), Range: 0-18 (the lower the better); 3The mean 
item score, Range: 0-5 (the lower the better); Bas, baseline; GEXP, graded exposure in vivo; FU, 6-month 
follow-up 
Discussion 
This study was designed to test the hypothesis that exposure to multiple stimuli 
promotes better generalization to new stimuli as compared to exposure to a limited 
number of stimuli. Using a randomized replicated single case experimental design, 
we decided to experimentally examine whether extinction of pain-related fear in 
patients with CRPS-I to the upper extremities generalized to threatening activities to 
which the patients were not exposed during GEXP. Two exposure conditions were 
compared, a condition during which patients were exposed once to 15 different 
activities (MSTI), and a condition during which patients were exposed five consecu-
tive times to only 3 activities (MEXP). We hypothesized that generalization of extinc-
tion is facilitated in MSTI. 
 
In contrast with our hypothesis, extinction of pain-related fear generalized equally 
well in both conditions. First, both forms of exposure resulted in a significant reduc-
tion in fear of movement, pain catastrophizing and functional disability. Second, 
despite pain reduction was not a direct goal, with the experience of less fear and 
the possibility to perform threatening activities even pain experience decreased in 
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most patients. Third, behavioral tests after GEXP and at FU showed low perceived 
harmfulness for new activities that were rated as harmful during baseline, and to 
which patients were not exposed during exposure. Finally, the threat-value of daily 
activities presented by photographs (PHODA) decreased in all patients after GEXP 
and at FU patients still reported that these activities were not harmful. 
 
In line with a previous exposure study in CRPS-I patients (De Jong et al., 2005a) the 
results of this study support GEXP as a successful treatment for CRPS-I patients 
reporting high levels of pain-related fear. After GEXP and during FU independent 
observations of daily activities showed that patients involved the affected hand to a 
full extent, whereas these were avoided at BAS. The success of GEXP is remarkable 
because pain is obviously central to the diagnosis of CRPS-I and pain reduction is not 
a direct goal of GEXP. Therefore, it seems that the catastrophic representation of 
pain is more important than the experienced pain intensity as it is. According to the 
theory of exposure patients learned during GEXP that the pain is less threatening 
than supposed, or were able to inhibit their fear responses. Using a motor imaginary 
task in CRPS-I patients Moseley et al. (2008) showed that pain catastrophizing and 
pain-related fear are not only related to change in pain but also to swelling which is 
an criteria of CRPS-I. The authors suggested that pain and swelling seems to be 
modulated by autonomic arousal and beliefs about pain. 
 
Further, it is interesting to conclude that both exposure conditions facilitated gen-
eralization and overall somewhat better results are observed for MEXP. One possi-
ble explanation might be that during each exposure session all patients were ex-
posed to a threatening activity which consists of several threatening movements. 
Recently, Rescorla (2006) suggested that greater extinction derives from the ab-
sence of the aversive stimulus in the presence of multiple compared to single origi-
nal predictors of the aversive stimulus. Combined conditioned stimuli’s (CS) for 
additional exposure sessions are superior to separate CS’s, resulting in less sponta-
neous recovery, less re-instatement and slower re-acquisition (Rescorla, 2006). 
Based on findings on non-primate learning (e.g. Bouton & Swartzentruber, 1991) 
and phobias (Rowe & Craske, 1998a; 1998b), studies in chronic low back pain pa-
tients (Crombez et al.,1996; 1998; 2002; Goubert et al., 2002; 2005) already investi-
gated whether exposure to different movements may enhance the generalization of 
the knowledge that ‘many movements are not painful and hazardous’. However, no 
support was found for the hypothesis that varied exposure facilitates generalization 
of exposure effects. In contrast to the current study, generalization of exposure was 
tested whether the effects of one movement (e.g., bending forward, straight leg 
rising) generalized towards another dissimilar movement, whereas in this study 
patients were exposed to functional activities (e.g., garden, wash, vacuum, golf) 
which exist of several movements. Moreover, these activities were individually 
 136 
tailored based on a fear hierarchy. In the generalization studies of Crombez et al. 
(2002) and Goubert et al. (2002, 2005) the movements to which patients are ex-
posed were selected by the researcher in question. The results of our study are 
more in line with the study by Trost et al. (2008) who showed successful generaliza-
tion of pain expectancy corrections across movements in low back pain patients. 
These authors suggested that the increased intensity of performing tasks during the 
behavioral test is the reason that a gradual extinction of the over-predictive re-
sponse was observed. In MEXP the increased intensity of the performing task mainly 
existed of duration and the number of repetitions of the three identified threaten-
ing activities, whereas in MSTI this was more the graded fear hierarchy of the activi-
ties. On the basis of this it can be assumed that not the variety of activities but the 
repeated exposure to some few individually identified threatening activities might 
be of importance. 
 
Another different factor with regard to the above mentioned generalization studies 
is that, irrespective of the treatment condition, GEXP was provided to the maximum 
spectrum of patients’ contexts and natural settings that can be achieved in and 
around the hospital setting. As Rescorla and Heth (1975) already suggested, to facili-
tate generalization it could be important that the UCS is the same as the UCS in-
volved in the acquisition of the fear responses. In our study we used a behavioral 
test context that was different from the GEXP context and daily life situations. We 
defined the context in the behavioral tests in terms of activities (not addressed 
during GEXP and not presented in daily life), room (not used during GEXP) and time 
(after GEXP and during FU). The results showed clearly that the patients had a com-
plete contextual control which caused overall generalization. Although patients 
were exposed to several movements, it seems that variation of the exposure con-
text also help explain why both exposures are successful in the generalization of 
extinction. 
 
Also, in direct contrast to the above-mentioned generalization studies we did not 
expect and strive for a fear reduction of 100% from baseline during one exposure 
session. Certainly during the first eight exposure sessions a fear-reduction of 50% 
was experienced as successful. This is in line with results of research on experimen-
tal manipulations which indicate that lower fear at completion of exposure does not 
predict better outcomes overall (Farchione, 2002; Rachman, Robinson & Lopatha, 
1987). Thus, whereas reported fear and dysfunctional beliefs generally declined 
within an exposure session (although not always), there is good evidence to indicate 
that this decline was indicative of learning or of long-lasting improvement. 
 
A number of limitations to the present study must be considered. First, the prelimi-
nary results reported here are limited in that they are based on a small number of 
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CRPS-I patients. Second, at BAS patients in Condition II had lower functional disabil-
ity scores than those in Condition I. Despite randomization it appeared that patients 
in Condition II may have been less impaired. Further, the fact that both conditions 
differ in gender is an important shortcoming of the current study. Third, the effects 
of GEXP regarding generalization are examined in CRPS-I patients who reported high 
levels of fear of movement/(re)injury. However, pain-related fear is a general, over-
arching construct, encompassing various specific fears. For example, ‘fear of intero-
ceptive stimuli’ like pain, skin color and temperature changes, and edema or ‘fear of 
movement/(re)injury’ which signifies the fear that certain movements may be 
harmful by causing (re)injury. Therefore, one should be cautious in generalizing to 
other patients until the effects of GEXP and the nature of pain-related fear are ex-
amined more extensively and their clinical implications are more fully considered. 
Fourth, despite some patients reported almost no pain after GEXP and during FU, 
overall the results showed and clinical experience has learned that performing some 
of the activities and/or movements still hurts. However, this not necessarily restricts 
daily life functioning. Nevertheless, it seems to be unlikely that a permanent extinc-
tion of anticipatory responses can be accomplished. Fifth, by use of a behavioral 
test, generalization was observed in a clinical setting and not in the home or work 
situation. Finally, the follow-up period may not have been sufficient to determine 
the long-term effect of GEXP in relation to generalization. 
 
In sum, the current study supports that, irrespective of the kind of exposure, GEXP 
generalized to new threatening activities. Generalization was also found for ob-
served quality of performance from standardized activities, self-reported functional 
disability, pain-related fear and pain catastrophizing, and the experienced pain and 
threat of daily activities. It seems that generalization of extinction is best facilitated 
if graded exposure exists of individually identified threatening activities existing of 
multiple movements to which the patient should be exposed several times. The 
mentioned results are of clinical importance as they suggest that under the influ-
ence of GEXP CRPS-I patients learn that pain is a common condition that can be self-
managed, rather than as a serious disease or condition that needs careful protec-
tion. However, the results need to be verified in a wider (chronic) pain population. 
Besides, further research into the role of inhibitory processes during extinction and 
evocation of such processes at the time of re-exposure to a previously feared stimu-
lus, and examination of the influence of context and time and fear tolerance is war-
ranted. 
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Chapter 7 
Summary and general discussion 
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When traditional and biomedical treatments fail and pain-related disability grows, 
pain patients are often referred to rehabilitation centers. Generally, the treatment 
in these centers is interdisciplinary and based on bio-psychosocial or behavioral 
rehabilitation models which assume that pain disability is not only determined by 
the underlying pathology, but also, by cognitive, behavioral, emotional and social 
factors. Treatment methods from operant conditioning principles and psycho-
physiological and cognitive psychology concepts are applied to the treatment of 
chronic pain. Research shows variable results of cognitive-behavioral treatment 
programs. As a result, it is argued to match treatments to patient characteristics to 
increase the effectiveness of treatments (Turk, 1990). To develop effective custom-
ized treatments, in recent years behavioral pain research is focused on the mecha-
nisms by which patients with acute pain become chronically disabled. A number of 
studies have reported that pain-related fear is one of the strongest predictors of 
variation in physical performance (Vlaeyen & Linton, 2000). 
 
Because of its substantial contribution of in the maintenance of chronic pain, pain-
related fear is an important target for intervention. Indeed, several studies revealed 
that exposure in vivo (GEXP) is an effective treatment in chronic low back pain pa-
tients who report high levels of pain-related fear. However, on the basis of the re-
sults of these studies and the overall complexity of exposure there are still several 
questions that need to be addressed. For example, which treatment characteristics 
make the GEXP successful or unsuccessful in pain-related fear? What is actually 
learned during GEXP? Does the extinction of pain-related fear generalize to other 
movements and activities that were not included in the treatment? Is GEXP applica-
ble in patients with pain disorders with observable tissue pathology such as neuro-
pathic pain? In short, enough questions to answer in the process of optimizing GEXP 
in pain-related fear. By examining whether the effects of GEXP generalized from 
chronic low back pain to other pain problems such as complex regional pain syn-
drome and posttraumatic neck pain, the contribution of specific treatment compo-
nents to outcome, and the question whether exposure to multiple stimuli enhances 
generalization after treatment, the goal of this dissertation was to further explore 
the utility of GEXP. 
 
Before discussing the results, the main findings can be summarized as follows. The 
first study (chapter 2) focused on the role of pain-related fear in Complex Regional 
Pain Syndrome type I (CRPS-I). The results showed that pain-related fears, if meas-
ured with the PHODA, as well as pain severity were important predictors of pain 
disability. Although replications are necessary, the conclusion that pain-related fear 
in CRPS-I patients is a promising research direction in the understanding of pain 
disability in CRPS appeared justified. Chapters 3 and 4 described a number of single-
case experiments in which the effectiveness of GEXP in patients with posttraumatic 
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neck pain (PTNP) and CRPS-I reporting substantial pain-related fear was tested. Both 
studies supported the effectiveness of a GEXP approach in these patients. GEXP was 
successful in decreasing not only pain-related fear, but also pain intensity, disability 
levels, and in increasing the daily physical activity level. Striking was also that physi-
ological signs and symptoms related to CRPS-I were positively influenced by GEXP. 
 
The reduction of pain-related fear occurred rather quickly after the initiation of the 
exposure treatment. As the exposure protocol used in the aforementioned studies 
always started with an educational part, the results might have been the result of 
the new information provided by the therapist during this initial session. Therefore, 
a study was carried out (Chapter 5) in which we examined the contribution of the 
educational part of GEXP in the reduction of pain-related fears and cognitions, and 
the associated disability and physical activity. The results showed that pain-related 
fears and cognitions were indeed positively influenced by the education. Contrary, 
performance measures of daily activities were not affected by the educational ses-
sions and improved only during the exposure sessions. Finally, in chapter 6 it was 
examined whether the effects of GEXP in fearful CRPS-I patients generalized to th-
reatening activities which were not addressed during GEXP. Overall, it seems that, 
irrespective of the kind of exposure, GEXP generalized to new threatening activities. 
Testing the role of pain-related fear in complex regional pain syndrome 
In recent years the investigation into potential pathophysiological mechanisms in-
volved in Complex Regional Pain Syndrome type I (CRPS-I) has intensified. The gen-
eral consensus is that the pathophysiology of CRPS-I is still not known (Wilson et al., 
2005), and the contribution of psycho-physiological interactions to the development 
of CRPS-I is largely speculative. Although it has repeatedly been shown that in chro-
nic musculoskeletal pain pain-related fear is associated with escape-avoidance be-
haviors and associated functional disability, the role of pain-related fear in CRPS-I 
was never tested systematically. Recently, Moseley et al. (2008) demonstrated that 
motor imagery increased pain and swelling in CRPS-I patients and that this effect 
seems to be modulated by pain catastrophizing and pain-related fear. According to 
the authors, these results corroborate the findings from recent studies that high-
light the contribution of cortical mechanisms to pain on movement in CRPS-I which 
was suggested earlier (Andersen & Buneo, 2003; Gieteling et al., 2008; Krause et al., 
2006; Maihöfner et al., 2005, 2007; Schwenkreis et al., 2003). During movement, 
patients with chronic pain show more activation of the right insular cortex (Maihof-
ner et al., 2007) thought to hold representations of the sympathetic nervous system 
(Hilz et al., 2006). The increase in swelling related to pain-related fear and pain 
 142 
catastrophizing suggests that cognitive variables may modulate the link between 
motor and sympathetic activities. 
Is pain-related fear an important predictor of general physical health and 
functional disability in CRPS-I? 
Pain-related fear is one of the strongest predictors of disability in chronic muscu-
loskeletal pain and pain-related fear appears relevant CRPS-I as well. Therefore, we 
investigated the role of pain-related fear in CRPS-I using data of two cross-sectional 
studies (chapter 2). Study I included CRPS-I patients visiting an outpatient pain cli-
nic. In study II, members of the Dutch association for CRPS-I patients were invited to 
complete a number of questionnaires. Overall, both studies showed that pain sever-
ity was an important predictor of general physical health and a higher level of func-
tional disability respectively. Additionally, study I revealed a significant relationship 
between depression and general physical health. An interesting, and somewhat 
unexpected finding was that pain-related fear was an important predictor of func-
tional disability in CRPS-I, but only when measured with a pictorial fear of activity 
scale (PHODA; Dubbers et al., 2003; Jelinek et al., 2003) -as was the case in study II- 
and not when measured with a more commonly used questionnaire tapping fear of 
movement/(re)injury (TSK, Miller et al., 1991). There are at least two explanations 
for this unexpected finding. One possible explanation for this could be that the 
PHODA, as opposed to the TSK, is more sensitive and better capable to capture 
inter-individual variation. The results show that the standard deviation of the mean 
TSK score is much smaller than that of the mean PHODA score. This means that it 
would be possible to infer that the patients have indicated that they believe pain 
due to movement is a sign of impending harm (TSK), but there is more individual 
variation in the kind of activities that are considered harmful (PHODA). Indeed, the 
PHODA was developed as a specific measure of pain-related fear, including pictorial 
presentations of concrete movements that are relevant for patients with upper and 
lower extremity pain. Conversely, the TSK is made up of statements reflecting the 
idea that painful movement in general is harmful. Since the PHODA requires pa-
tients to respond to specific pictorial stimuli reflecting movements of the upper or 
lower extremities, it has also the potential to activate fear schemata more directly 
and elicit emotional reactions. The importance of the immediate and specificity of 
fear provoking stimuli has been noted by several studies. For example, Lang (1995) 
showed reliable affective psychophysiologic responses, defined by the judged va-
lence (appetitive/pleasant or aversive/unpleasant) and arousal elicited by a threat-
ening pictures. Picture-evoked affective responses are also associated with potenti-
ated startle reflexes during unpleasant pictures and inhibited startle reflexes during 
the presentation of pleasant pictures. In addition, both effects were augmented by 
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high picture arousal. Also Wessa et al. (2005) showed in a group of motor vehicle 
accident survivors with subclinical posttraumatic stress disorder (PTSD) that acci-
dent-related pictures enhanced startle responses and neutral pictures had a signifi-
cantly lower response. The authors suggest that traumatized persons with PTSD 
show exaggerated emotional responses to trauma-related stimuli and reduced cog-
nitive responses to several types of stimuli that may interfere with the extinction of 
the emotional trauma memory. It would be interesting to study psychophysiological 
responses of CRPS patients when exposed to the PHODA pictures. Another explana-
tion is that PHODA measures expected pain level fear of pain in certain contexts. 
Contrary to the findings in patients with low back and cervical pain (e.g. Vlaeyen & 
Linton, 2000; Nederhand et al., 2006), clinical experience suggests that CRPS-I pa-
tients describe their fear not in terms of movement and injury, as tapped with the 
TSK, but in terms of uncontrollable interoceptive stimuli (e.g. pain). Previous re-
search (e.g. Asmundson & Nicholas-Carleton, 2005; Keogh et al., 2001; Carleton et 
al., 2006) has shown that fear of pain, as measured with PASS, increases vulnerabil-
ity to pain disability. However, as far as known, it is never examined whether fear of 
pain is related to CRPS-I. An intriguing question is whether pain-related fear in neu-
ropathic pain has different features than in musculoskeletal pain, or more specifi-
cally what the exact conditioned stimulus is. It might well be that in CRPS patients 
aversive interoceptive stimuli are more important than proprioceptive ones which 
may be more relevant to chronic back pain patients. 
Exposure in patients with Posttraumatic Neck Pain and Complex Regional 
Pain Syndrome type I reporting substantial pain-related fear 
Overall, the general understanding is that Posttraumatic Neck Pain (PTNP) and 
Complex Regional Pain Syndrome type I (CRPS-I) are complex in nature and that the 
number of empirically supported treatments for these pain disorders remains lim-
ited. Nevertheless, in chronic pain management there is increasing consensus re-
garding the importance of a behavioral medicine approach to symptoms and disabil-
ity. For patients with PTNP, cognitive behavior therapy (CBT) programs have been 
developed as well, of which those promoting physical activity and are focussed on 
regaining function have proven to be relatively more effective (Hurwitz et al., 2008). 
Although these studies suggest that activity increase is associated with faster return 
to work and a decrease in pain and disability levels, there is evidence showing that 
these changes are mediated by the reduction of the catastrophic (mis)inter-
pretations of pain (Smeets et al., 2006, Leeuw et al., 2008, Spinhoven et al., 2004). 
In CRPS-I functional restoration and reactivation via interdisciplinary approach have 
been thought to be required for optimal outcome (Harden, 2005). However, the 
specifics as to what the components of an effective, efficient functional restoration 
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program should be, what modalities are to be delivered, when, and for how long 
were all open questions. 
 
Given the beneficial results of GEXP in CLBP patients who report high levels of pain-
related fear, and because pain-related fear has shown to be associated with PTNP 
and CRPS-I, there are good reasons to believe that a GEXP treatment would be be-
neficial for fearful PTNP and CRPS-I patients as well. For the majority of these pa-
tients explanations grounded in physical pathology are inadequate and conventional 
approaches to pain have failed, which suggest that alternative explanations need to 
be explored. Patterns of pain-related avoidance behaviour seen among these pa-
tients can be individually analyzed using an associative fear learning framework and 
subsequently targeted with exposure-based treatments. From this perspective, the 
mechanism of action for successful treatments in fearful PTNP and CRPS-I patients is 
based on a frequent and gradual increase of pain-eliciting stimuli without trying to 
reduce or alter the experience. Indeed, the exposure to movements might correct 
the sustained mismatch between motor activity en sensory feedback in PTNP and 
CRPS-I patients (e.g. Harden, 2005, Nijs et al., 2009), which may serve as ongoing 
source of nociception. The incorporation of GEXP as therapeutic approach for func-
tional restoration is then axiomatic, but should be confirmed. 
Does GEXP extend to PTNP and CRPS-I patients? 
To answer this question, two intervention studies were conducted. The current 
studies supported a GEXP approach to chronic PTNP (study I) and CRPS-I (study II) 
patients reporting elevated levels of pain-related fear. The GEXP was successful, and 
as shown in study I, superior to GA in decreasing levels of pain-related fear, pain 
catastrophizing, pain disability, and pain intensity. In the same study also improve-
ments were found in the performance of physical activity in the home situation as 
measured with ambulatory activity monitors. A remarkable finding was that the 
participants of Study II reported that they did not experience any physiological signs 
and symptoms anymore after GEXP and even at 6 month. However, it is not clear 
how GEXP might address either of these processes. One possible explanation is that 
GEXP is a strategy mechanism that impacts higher order motor processes such as 
motor intent or motor planning. Another explanation might be that GEXP focused 
on mental and visual attention in order to move the affected extremity. Thus, per-
haps GEXP requires the patient to attend to the affected extremity, which may ser-
ve to reverse a learned disuse of the affected extremity (Butler, 2001). 
 
Despite the success of GEXP several limitations of these replicated single case ex-
perimental studies should be mentioned. First, the preliminary results reported are 
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limited in that they are based on a small number of patients. However, in both stud-
ies an experimental design was chosen with appropriate statistical analyses (ran-
domization tests). Randomization tests have the advantage of being valid for single-
case experiments without making distributional assumptions, of being easy to ap-
ply, and of being extremely versatile for even the most complex single-case designs 
(e.g. Onghena & Edgington, 2005). Conversely, the results of the non-daily meas-
ures, with limited number of data points, were not subjected to randomization tests 
and for the most part based on arbitrarily chosen preset-criteria. Second, only in 
study I GEXP was compared to another intervention. Because the experimental 
design did not include washout periods between the different treatment compo-
nents – for evident reasons-, it is possible that carry-over effects occurred. Indeed, 
when GA followed GEXP the improvements remained stable, which is also consis-
tent with the favourable FU results. As already noted, GA showed to be helpful for 
chronic neck pain disability across a number of studies. However, in study I, change 
during GA was marginal at best, when GA preceded GEXP. Both GA and GEXP were 
performed according to a specific protocol. In addition, GA and GEXP were delivered 
by different therapists. Because patients’ attitudes and beliefs, and thereby pa-
tients’ disability levels, may be derived from the projected attitudes and beliefs of 
health care providers (e.g. Rainville, 1990), the two teams were comparable in 
terms of experience and therapists’ preferences. Efforts were made to achieve the 
same level of enthusiasm in each therapist who participated in either GA or GEXP. 
Nevertheless, therapists may consider GEXP as a more credible treatment than GA 
which may have influenced their treatment behaviour in favour of GEXP (e.g. Leeuw 
et al., 2008). Third, study II was impeded by the use of self-report measures only, 
which may have been subject to response bias. Finally, the 6-month FU may not 
have been sufficient to determine the long-term effect of GEXP or long-term quality 
of life. To increase generalization of GEXP across patients more simultaneous or 
sequential replications of single-case experiments with future measurement occa-
sions are needed. Replication strategies also allow one to design small clinical trials, 
detect patterns of response or subgroup of patients or design Randomized Clinical 
Trials (RCT) as a collection of replicated single-case experiments. Further, physio-
logical measures (e.g. pain thresholds, oedema and thermal detection) or objective 
measures of behavior seem most promising as target measures in single-case ex-
periments for pain research. 
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How many exposure sessions are needed to demonstrate trend changes 
and significant effects? 
GEXP has already successfully been applied in chronic low back pain (CLBP) patients. 
Not only a number of single-case experimental studies have been carried out suc-
cessfully, also randomized controlled clinical trials have shown positive results with 
regard to pain disability and pain-related fear (Leeuw et al., 2008; Linton et al., 
2008; Woods & Asmundson, 2008). However, in comparison with the single-case 
experimental exposure studies in patients with low back pain of Vlaeyen et al. 
(2001; 2002a; 2002b) the current studies showed that more exposure sessions were 
needed to demonstrate trend changes and significant effects in PTNP and CRPS-I 
patients. A possible explanation is that PTNP and CRPS-I patients experience multi-
ple complaints and fears, not just fear of movement. Not only neck pain but also 
symptoms such as headache, visual disturbances, dizziness, weakness, paraesthesia, 
nausea, both upper and lower limb numbness and tingling, tinnitus, and cognitive 
problems (concentration and memory disturbances) are common in PTNP patients 
in the acute stage after a traumatic event (Barnsley et al., 1994; Ferrari et al., 2005). 
Symptoms of CRPS-I can also include abnormal swelling, abnormal hair or nail 
growth, abnormal skin color or temperature changes, abnormal sweating, limited 
range of motion and movement disorders (Wilson et al., 2005). Although pain is 
normally a leading symptom in CRPS-I, the autonomic, motor, and trophic signs and 
symptoms of CRPS-I are not necessarily coupled with pain (Eisenberg & Melamed, 
2003). In many patients with CLBP, the main concern is the experienced pain inter-
fering with daily life activities signals injury. These concerns can relatively easily be 
challenged as injury will never follow increased physical activity, given the non-
specificity of their pain complaints. In contrast, the concerns of PTNP patients (e.g. 
“If I would lift heavy weights, then I do not have full control of my neck, which will 
worsen the pain complaints, with the result that I will not be able to do my job in 
the future”) and CRPS-I patients (e.g. “If I would walk without crutches, the pain will 
worsen and the foot becomes thick and intensely hot, by which I will loss control of 
my leg, which increased the likelihood of uncontrolled movements, which will ag-
gravate the CRPS”) may be much more difficult to challenge. Another explanation of 
the delayed effect could be that, contrary to GEXP in CLBP, the sessions mainly con-
sisted of exposure to personally relevant activities that represented the main func-
tional goals that were chosen by the patients themselves occurred in a later phase. 
Because of the multiple fears in PTNP and CRPS-I patients, the progress in the fear 
hierarchy occurred more slowly than during GEXP in CLBP. 
 
In CRPS-I patients it is possible that the observed peripheral changes of CRPS-I me-
diated the effect of information on pain. This assumption is supported by a study of 
Arntz and Claassens (2004) who tested whether the meaning attached to pain influ-
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ences the pain intensity. By suggesting that a very cold metal bar which was briefly 
placed in the neck was either hot or cold, the potentially harmful property of the 
stimulus was experimentally manipulated. Participants who were given the informa-
tion that the metal bar was hot reported more pain than those who were told that a 
cold bar was applied to their neck. The authors found that harm beliefs are a crucial 
aspect of meaning that mediated the association between the information and 
provided report of pain. Based on these findings it seems interesting to investigate 
whether there is a difference between CRPS-I patients who experience there vaso-
motor abnormalities in the affected extremity as warm or those who experience 
them as cold. In CLBP patients, possible tissue-damage is not observable, by which it 
might be easier to modify their meaning attached to their pain as compared to 
CRPS-I patients in whom symptoms are clearly visible. Additionally, these observ-
able symptoms might be interpreted catastrophically and may direct hypervigilance 
to sensations of the body, thereby amplifying the pain experience. Indeed, there is 
evidence that the intensity of pain is related to this vigilance (e.g. Crombez et al., 
2004). In line with this the catastrophic interpretation of pain might include anxiety, 
which in turn might amplify pain intensity (Arntz et al., 1991; 1994; Arntz & de Jong, 
1993). 
Mediating effect of GEXP 
According to the single-case studies of Vlaeyen et al. (2001; 2002a; 2002b) it is of 
interest that not only pain-related fear, pain catastrophizing and pain disability but 
also pain experience is positively affected by GEXP. Moreover, the results suggest 
that the decrease in pain experience temporarily follows an associated decrease in 
pain-related fear. This is in line with the Fear-Avoidance model. However, such 
strong reduction in pain is not common in usual cognitive-behavioral treatments for 
chronic pain (Kole-Snijders et al., 1999; Morley et al., 1999). Furthermore, it is re-
markable that in study II self-reported trophic changes or enhanced efficacy of no-
ciceptive mechanism or cortical changes are influenced by GEXP. We offer five pos-
sible explanations for these findings. 
 
First, one explanation is that change in pain and autonomic, motor, and trophic 
signs and symptoms of CRPS-I are related to pain catastrophizing and pain-related 
fear which are the primary focus of GEXP. Indeed, Moseley et al. (2008) found in 
patients with CRPS-I and also in a group of non-CRPS pain that the higher patients 
report pain-related fear or pain catastrophizing, the larger the increase in pain and 
swelling with imagined hand movements. Sympathetic arousal is positively related 
to an increase of swelling. Maihöfner et al. (2007) showed that during movement 
chronic pain patients have more activation of the primary insular cortex, thought to 
hold representations of the sympathetic nervous system, than healthy controls. The 
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findings that increase in swelling are related to pain-related fear and pain catastro-
phizing suggests that cognitive variables may modulate the link between motor and 
sympathetic activities. The results of Moseley et al. (2008) suggest that pain-related 
fear affects motor processes and pain even in the absence of actual performance of 
physical movement, also demonstrating that cognitions may modulate pain process-
ing in the absence of nociception. 
 
Second, it is demonstrated that some chronic pain patients have an involuntary 
neurological neglect-like condition (Galer & Jensen, 1999; Förderreuther et al., 
2004; Frettlöh et al., 2006). This finding suggest that PTNP and CRPS-I patients may 
experience a change in their body perception which can be very unsettling, frighten-
ing and/or repulsive, and ensures avoidance behavior. Therefore, for the patients it 
could be difficult to maintain conscious attention to the affected limb and its ade-
quate use, which will consequently worsen the disordered sensorimotor function. 
Thus, the success of GEXP may be due to requiring to attend to the affected extrem-
ity for a certain time. In which case, GEXP may simply serve to reverse a learned 
experiential avoidance response of the affected extremity or limb. 
 
Third, the reduction of pain-related fear levels may be due to a reduction of selec-
tive attention towards the affected body extremity. Experimental studies on the 
role of attention and pain-related fear have shown that chronic pain patients with 
elevated levels of pain-related fear habitually attend to somatic sensations (As-
mundson et al., 1997; Peters et al., 2002). These findings suggest the decrease in 
pain experience during GEXP was mediated by a process in which the reduction of 
the threat value of previously fear-eliciting stimuli also produced a redirection of 
the attention away from pain and bodily sensations. 
 
Fourth, the effects of GEXP could also be mediated by an increase in acceptance of 
pain. For example, Wicksell et al. (2008) tested an intervention consisted of values-
based exposure and acceptance strategies to improve functioning and life satisfac-
tion by increasing the participants’ abilities to behave in accordance with values in 
the presence of interfering pain and distress (psychological flexibility). In this study, 
the functional relationship between chronic pain and disability was explained by a 
learning theory model emphasizing avoidance of unpleasant experiences (e.g. pain, 
fatigue, fear; Fordyce, 1976). For chronic pain patients activities that reduce pain 
and distress but are less active and stimulating will likely produce a reinforcing 
short-term relief. Over time, this behavior may gradually compromise functioning 
and life quality without a corresponding decrease in symptoms. Exposure to previ-
ously avoided situations is considered to be the core intervention, emphasizing 
acceptance of what cannot be directly changed (thoughts, emotions, bodily sensa-
tions) as a way of engaging in activities that are meaningful but possibly painful or 
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fear-provoking. Behavioral activation was not carried out during sessions but rather 
by the patients between sessions. The goal of acceptance and commitment therapy 
(ACT), is to increase psychological flexibility, defined as the ability to act effectively 
in accordance with personal values in the presence of negative private experiences 
such as pain or distress (Hayes et al., 2006). Compared to a wait-list control condi-
tion Wicksell et al. (2008) showed that after the exposure-ACT condition for pain 
disability, life satisfaction, fear of movements, depression and psychological inflexi-
bility significant differences in favour of the treatment group were seen. For both 
groups no change was seen in pain intensity, which implies that reported increase in 
functional ability and life quality was not due to a corresponding decrease in pain. 
Based on these results and because GEXP differs from the exposure strategies as 
applied by Wicksell et al. (2008), future GEXP studies may test the validity of the 
idea that the results are mediated by increased acceptance. 
 
Fifth, in the literature on catastrophizing’s influence on pain in the context of rheu-
matic disease (RA) it is suggested that pain catastrophizing might be directly or indi-
rectly associated with inflammatory processes (Edwards et al., 2006). For example, 
Schoenfeld-Smith et al. (1996) have reported positive relationships between catas-
trophizing (or helplessness, one component of catastrophizing) and elevated indices 
of disease activity and inflammation. Because studies in RA have shown that high 
levels of catastrophizing prospectively predicted worsening erythrocyte sedimenta-
tion rates (e.g. Evers et al., 2003), these authors suggest directional relationships 
between pain catastrophizing and inflammation. Catastrophizing may also contrib-
ute to interactions between pain and the immune system (Watkins & Maier, 2002). 
In sum, although no blood samples were taken from our patients, one could specu-
late that effects of GEXP might be mediated by a reduction of pro-inflammatory 
cytokines associated with a reduction of pain catastrophizing. 
GEXP initially increases pain levels 
Despite the overall positive influence of GEXP on pain experience both in study I and 
II there appears to be an increase in pain experience at the onset of GEXP. In the 
PTNP-study a possible explanation may have to do with the natural history of the 
participants. They could be characterized as not-at-fault drivers who experience 
feelings of are anger at the other driver who caused the injury and keeping him/her 
from attaining an important life goals (Ferrari et al., 2005; Mayou, 1994; Berkowitz 
& Harmon-Jones, 2004). High levels of anger might be associated with more intense 
pain experience and more severe disability (Bruehl et al., 2003; Burns & Bruehl, 
2005). It has been suggested that perceptions of injustice and anger are related. 
Sullivan et al. (2008) found that individuals who perceived injustice and had sus-
tained injuries in motor vehicle accidents, as a result of someone else’s fault, also 
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reported more severe pain, more pain sites, and greater depression. In addition, 
DeGood and Kierman (1996) found that chronic pain patients who blamed others 
for their pain reported more pain and more emotional distress than patients who 
did not ascribe fault for their pain condition. It is interesting to note that research 
suggested that blaming others for one’s situation appears to be sufficient to engen-
der negative outcomes (Turk & Okifuji, 1996; Blyth et al., 2003) and that perceptions 
of injustice might allow individuals to remain stuck in their current pain situation. 
Also subjectively aversive conditions which are the result of the injury can generate 
anger (Berkowitz & Harmon-Jones, 2004). An example of such aversive conditions 
could be exposure to activities and/or movements in which physical discomfort or 
pain will be experienced (Anderson et al., 1998; Berkowitz & Harmon-Jones, 2004). 
The induction of anger and pain-evoked cardiac responses that are elicited by anger 
produces increased pain intensity and pain unpleasantness (Rainville et al., 1995). 
However, there are also studies that have shown the opposite, namely that anger 
just inhibits pain (e.g. Bruehl et al., 2009). Despite the negative role of anger and 
perceived injustice on pain experience at the start of GEXP, data from the GEXP 
study in PTNP (see this thesis) indicate that exposure therapy finally helps reduce 
the hallmark features of chronic PTNP (e.g. pain experience, disability and fear). 
Moderation 
Besides the specific effects of exposure it is important to consider the influence of 
non-specific effects as well. (e.g. Mahomed et al., 2002; Vase et al., 2005; Goffaux et 
al., 2007). Overall, positive or negative expectations may result in the reduction or 
amplification of pain along with inhibition or activation of several brain regions 
(Sawamoto et al., 2000; Porro et al., 2003; Lorenz et al., 2005; Keltner et al., 2006). 
According to these observations it seems that expectation of either low- or high-
intensity painful stimuli has a strong influence on the perceived pain. Clinical studies 
on the effectiveness of cognitive-behavioral rehabilitation programs for chronic low 
back pain and fibromyalgia showed that patients’ initial beliefs about the success of 
a given pain treatment have an important influence on the final treatment out-
come, and that patients with higher treatment expectancies significantly received 
less disability compensation, were less fearful and more satisfied (Goossens et al., 
2005; Smeets et al., 2008). 
 
A criticism of study I is a lack of consideration for the influence of non-specific ef-
fects such as expectation. On the other hand, in study II patients were asked for 
expectancy and credibility of GEXP. This was done after the educational part of the 
GEXP, and before the actual exposure. Participants not only received the rationale 
of the exposure therapy and a positive approach of the diagnosis CRPS-I, a verbal 
suggestion that clinical improvement should be expected was given as well. Inde-
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pendently, both the rehabilitation physician and the other team members told the 
patients that they may expect a positive influence of GEXP on their pain complaints. 
The mean expectancy and credibility ratings were relative low for the GEXP in study 
II. This implied that the patients did not expect that GEXP will help to cope better 
with their pain complaints, and that they did not believe that GEXP was a meaning-
ful treatment for patients with CRPS-I. However, given the medical history of the 
CRPS-I patients who have participated in this study, this negative expectancy is 
hardly surprising. Overall, chronic CRPS-I patients are usually confronted with re-
peated failures finding a solution for their pain problem. Contrary to be expected, 
the low expectancy about GEXP did not had any negative effect on the experienced 
clinical benefits immediately after GEXP and at 6-month FU. All patients did not only 
report a large decrease in pain disability but also in pain experience and CRPS-I 
related physiological signs and symptoms. 
 
Finally, effectiveness is not a feature of exposure alone. In the first place, the inter-
actions between patient, therapist and/or therapist team and the exposure sessions 
and/or therapy program are important for the success of GEXP. For example thera-
peutic alliance, motivation of the patient, therapist/team prognoses, therapist ap-
praisal of patients behavior, attitude of the therapist (self-confidence, no con-
cern/anxiety when patient bellow with pain) or planning of the sessions are just a 
few examples which could define the course of the GEXP. As an addition to the 
ongoing discussion concerning the magnitude of therapist effect in GEXP, therapist 
variables appear to influence treatment alliance more than outcome (Wampold, 
2001). 
Contribution of specific treatment components to outcome and 
generalization of GEXP 
Education versus GEXP 
The results of the first single-case experimental studies examining the effectiveness 
of GEXP in patients with chronic low back pain (CLBP) showed abrupt changes in 
self-reported pain-related fears and cognitions (Vlaeyen et al. 2001, 2002a, 2002b). 
These changes seem to be more characteristics of insight learning rather than the 
usual gradual progression of trial and error learning. The educational session at the 
start of GEXP might have contributed to this insight. To test this hypothesis it was 
examined in six consecutive CLBP patients, whether a single educational session 
followed by GEXP or operant graded activity (GA) had indeed a powerful treatment 
effect. Both daily measures and pre-post assessments showed that after education 
and the following no-treatment period, subjective ratings of pain-related fears and 
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catastrophizing decreased substantially. Based on these results it seems that a tai-
lor-made formulation of a patient’s pain problem, within a substantive fear-
avoidance model, has good empirical support in patient’s perceptions about the 
harmfulness of physical activity and threat value of pain. Moreover, in reducing 
pain-related fear the results suggest that the education of the current study works 
in one session which implicates that it would be a really effective intervention to 
use in primary care if one could identify at-risk patients. Except providing personal-
ized information the aim of the education was also that patients should indicate 
their adherence to participate in major behavioral change in order to regulate 
themselves in the period ahead. Adherence implied the patient’s active choice in 
the process, rather than passive co-operation or obedience to the recommenda-
tions of the therapist team. Further, it was a process that therapists and patient 
undertook in order to reach an agreed plan of disability management. Finally, by 
inviting family or close friends of patients during the educational session the thera-
pist team tried to realize social and emotional support which also appeared to lead 
to lower levels of anxiety (Edwards & Clarke, 2004). 
 
In addition, the current study has shown that education, although essential, is not 
sufficient to guarantee that patients actually perform fearful activities and/or mo-
vements. Educating the patient that being active leads to functional possibilities 
alone, and perhaps even a better quality of life, is not enough to make him/her 
more active. Self-reported performance in daily life, subjective ratings of the PHODA 
and even activity monitor data support the assumption that GEXP is necessary to 
modify escape and avoidance behavior due to pain-related fear and not GA. It 
seems that fearful chronic pain patients can change their behavior by means of 
exposure therapy. However, motivation to change behavior requires active partici-
pation on their part. 
 
A possible reason for the lack of association between beliefs and behavior is that 
the willingness to perform health-related behaviors involves a complex tangle of 
attitudes to physical activity, implicit versus explicit affective evaluation, expecta-
tions, previous experiences of physical activity, and social pressure. Despite decision 
alternatives available in memory, decisions often rely on an “attitude-based” strat-
egy, thereby ignoring available and contradictory information (Sanbonmatsu & 
Fazio, 1990). This means that attitudes such as the deeply ingrained pain-related 
fear may evoke automatic activation from memory when the patient encounters 
threatening situations. Explicit attitudes are distinguished from implicit or automatic 
attitudes and both may guide one’s behavior (Fazio, 1990). Explicit attitudes may 
guide one’s behavior by a deliberate and conscious analysis of the costs and bene-
fits of that behavior, whereas implicit attitudes may guide in a more spontaneous 
and affective manner, without actively considering the positive and negative as-
 153 
pects. This means that patients may have different evaluations of the same activity. 
For example, the patient realizes that his concerns about harm are irrational; how-
ever, when suddenly confronted with a threatening movement avoidance of move-
ment will occur all the same. The results of the current study suggest that education 
did not have a strong effect on patients’ implicit attitudes toward pain-related ac-
tivities or movements but did change their explicit attitudes. It seems that explicit 
attitudes toward pain-related activities or movements are readily changed when 
faced with the fear-avoidance model that is inconsistent with the existing proposi-
tions about pain. On the other hand, implicit attitudes may change only when new 
associations are formed through evaluative conditioning or when new propositions 
ingrain in into new associations (Gawronski & Bodenhausen, 2006). Based on the 
results it can be assumed that GEXP offers sufficient possibilities for evaluative con-
ditioning processes to change implicit attitudes toward pain-related activities or 
movements. In addition, because changes of implicit attitudes toward pain-related 
activities or movements, which are mediated by changes in cognitive strategies (i.e. 
more positive propositions about pain), may become apparent if there is enough 
time to ingrain these propositions, it seems that GEXP allows for this possibility. 
Generalization 
Despite the success of GEXP in chronic pain patients who report high levels of pain-
related fear, it is still a question whether fear extinction generalizes to new threat-
ening activities. The results of the activity monitor data of the PTNP-study and the 
education-study suggests that the confrontation of fear-eliciting activities in the 
treatment setting is analogue for how patients respond in daily life situations. Mo-
reover, treatment gains produced during GEXP seems to generalize to the home 
setting and in the absence of therapists. Contrary, some recent experimental stud-
ies raise doubt about the generalization of the exposure effects (e.g. Vansteen-
wegen et al., 2007; Goubert et al., 2005). Research into the return of fear has re-
vealed that extinction does not mean unlearning (e.g. Craske et al., 2008). It appears 
that the extinguished fear response can arise spontaneously after a while (sponta-
neous recovery), or reoccur when confronted with a new CS-US event (rapid reac-
quisition) or an unpredicted US (reinstatement). In addition, it also appears that 
extinction is context-sensitive (e.g. Craske et al., 2008). It has been established that 
what has been learned during the process of extinction not necessarily generalizes 
towards other situations; not even when the extinction process takes place during 
the original process of acquisition. 
 
Whenever context changes can result in return of fear, the subsequent question is 
how this return can be prevented and on top of that which typical feature of GEXP is 
responsible for the supposed generalization. Animal research showed that when-
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ever extinction is received in different contexts it leads to less return of conditioned 
suppression in yet a new context when compared extinction in only one context 
(Chelonis et al., 1999; Gunther et al., 1998). In human demonstration of multiple 
context methods as prevention for return of fear is still scarce. By the use of com-
puter-conditioned suppression tasks Neumann (2006) demonstrated that extinction 
in multiple contexts can reduce renewal of fear. Further, using retrieval cue meth-
ods Vansteenwegen et al. (2006) and Collins and Brandon (2002) showed larger 
return of fear when cues were given that were also present during acquisition than 
when retrieval cues were also present during extinction. Furthermore, Rowe and 
Craske (1998) showed that return of fear towards a new spider exemplar was re-
duced when multiple stimulus examples were used during exposure instead of one 
and the same spider. Finally, Vansteenwegen et al. 2007 showed that spider-anxious 
students that were exposed to videotapes with the spider presented in different 
locations of a house showed less return of fear when confronted with the spider in a 
new context than students that were exposed to repeated presentations of a video-
taped spider in one specific location of the house. 
 
In this thesis a clinical study is described in which the primary objective was to repli-
cate the finding that exposure to multiple conditioned stimuli can enhance the gen-
eralization process of extinction. By the use of a randomized replicated single case 
experimental design it was examined whether GEXP generalized better to a new 
movement when fearful CRPS-I patients were exposed to 15 activities once as com-
pared to an GEXP program in which fearful CRPS-I patients were exposed to 3 activi-
ties to which patients were five time each. In contrast to the expectations, both 
conditions generalized to new threatening activities. Based on these results it seems 
that multiple stimuli exposure is not a sine qua non to prevent relapse. 
 
Independent of the context in which certain activities and/or movements will be 
performed it seems that the experienced pain and even more the catastrophic rep-
resentation of pain is important in CRPS-I patients. According to the theory of ex-
tinction CRPS-I patients learned during GEXP that the US (pain) is less threatening 
than supposed. The US was, as it were, biased by the representation. In addition, it 
seems reasonable that the supplemented cognitive techniques during GEXP were 
necessary to directly challenge negative valence and also the validity of catastrophic 
assumptions and misinterpretations by which generalization can be realized. 
 
Further, a possible explanation of the success of generalization might be that in 
both GEXP conditions during each exposure session all patients were exposed to a 
certain threatening activity which consists of several threatening movements. Mo-
reover, these activities were individually tailored based on a fear hierarchy. It can be 
assumed that not the variety activities but the repeated exposure to some few indi-
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vidually identified threatening activities might be of importance. Another explana-
tion could be that the CS was not the movement or activity, but the painful sensa-
tion itself. This may mean that it does not matter which movements or activities are 
identified, but that exposure to pain and related physiological sensations is suffi-
cient to ensure generalization. In this case, GEXP seems to be a form of interocep-
tive exposure (e.g. Flink et al., 2009). 
 
Finally, to facilitate generalization it could be important that during GEXP the CS is 
the same as the CS involved in the acquisition of the fear responses. GEXP was pro-
vided to the maximum spectrum of patients’ contexts and natural settings that can 
be achieved in and around the hospital setting. Although patients were exposed to 
several movements, it seems that variation of the exposure context also help ex-
plain why both exposures are successful in the generalization of extinction. Finally, 
based on results of research on experimental manipulations which indicate that 
lower fear at completion of exposure does not predict better outcomes overall (e.g. 
Farchione, 2002), the protocol of GEXP does not strive for a fear reduction of 100% 
from baseline during one exposure session. Certainly during the first eight exposure 
sessions a fear-reduction of 50% was experienced as successful. Thus, whereas 
reported fear and dysfunctional beliefs generally declined within an exposure ses-
sion (although not always), there is good evidence to indicate that this decline was 
indicative of learning or of long-lasting improvement. 
Where do we go from here? 
Despite the success of GEXP in chronic pain patients who report high levels of pain-
related fear there is still uncertainty about the basic principles that underlie it. The-
refore, there is a need for more theory-based research. Studies focusing on expec-
tancies, context, and neurocognitive processes might shed more light on the me-
chanisms underlying associations between pain-related fear and chronic pain. 
Expectancies 
Expectancies for the likelihood of aversive events are central to human fear condi-
tion (e.g. Craske et al., 2008). In chronic pain for example, propositional knowledge 
about the association between two stimuli, such as a specific activity and/or move-
ment (CS) and subsequent pain or pain increase (US), as a potential sign of injury, 
(e.g. Lovibond & Shanks, 2002; Ohman & Mineka, 2001), is considered a strong 
correlate of conditioned responding. As already suggested, expected occurrence of 
the US (pain) is violated during GEXP. During GEXP, a mismatch between the expec-
tancy of negative consequences of a certain activity and/or movement and the 
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absence of these consequences occurs. There probably are a number of ways of 
violating expectancies for pain (US). In the view of the studies in this thesis it seems 
that this may extend to the role of cognitive techniques applied within GEXP, which 
aim to shift expectancies for aversive events through logical empiricism. Future 
research should explicitly examine the role of cognitive techniques and which mis-
conceptions are corrected during GEXP in order to fully understand what has been 
learned or has not been learned. Furthermore, research to durations or frequencies 
of unreinforced exposure to certain activities and/or movements that surpass the 
rate at which aversive events are expected to occur is warranted. It might be 
worthwhile to manipulate the duration of the GEXP trials relative to violation of 
fear-based expectancies. 
Safety behavior 
Should we wean safety signals and safety behaviors during GEXP? A number of stud-
ies have supported the hypothesis that safety behaviours are interfering with the 
benefits of exposure therapy (e.g., Sloan & Telch, 2002). Hence, by relying on safety 
behavior, anxious pain patients might be unable to obtain disconfirmatory evidence 
related to their unrealistic beliefs about certain pain stimuli. Indeed, they might 
conclude that their own actions (i.e., the safety behavior itself) prevent feared out-
comes. In the context of GEXP, such strategies might thus inhibit the process of 
adaptive cognitive change about pain and related physiological signals. Tang and 
colleagues (2007) were the first who examined the use of safety-seeking behaviors 
(SSBs) in chronic low back pain patients. By exposing participants to pain-provoking 
situations (such as lifting) these authors identified a wide range of SSBs, particularly 
in patients with high health anxiety, which continued throughout the time the pa-
tient remained in a feared situation. Based on their findings Tang et al. (2007) sug-
gested that SSB is distinct from overt pain behavior and may be a defining charac-
teristic of chronic pain patients reporting high levels of health anxiety. Further, the 
study of Tang et al. (2007) also showed that the use of SSB was more strongly corre-
lated with the presence of catastrophic thoughts during pain-provoking tasks, whe-
reas the display of overt pain behavior was more strongly correlated with the level 
of pain experienced during these tasks. It is hypothesized that pain patients who 
catastrophize about physical activity, in that it will cause pain/(re)injury, will form 
SSBs, thereby prevent the pain patients from disconfirming their beliefs about dan-
ger from physical activities. Clinically, this may have important implications to the 
treatment of chronic pain patients in whom health anxiety is an important factor of 
their behavior. There is a need to look beyond communicative pain behavior and 
total avoidance of activities and movements as target for interventions (Tang et al., 
2007). The use of behavioral experiments to challenge maladaptive thoughts and 
beliefs is emphasized by cognitive-behavioral theories of anxiety disorders (e.g. 
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Salkovskis et al., 2003). Well, as described behavioral experiments form part of 
GEXP. It seems therefore interesting to examine whether GEXP has the same results 
without the addition of behavioral experiments. 
 
In addition to research on the role of safety behavior in exposure, a recent discus-
sion dealt with the distinction between safety behavior and adaptive coping strate-
gies (Thwaites & Freeston, 2005). Both strategies are aimed at reducing fear but are 
not intended to avoid catastrophic outcomes. Despite the theoretical distinction of 
safety behavior and coping, in clinical practice it is often difficult to differentiate 
between them. Differences can only be determined after evaluating a patient’s 
intention for their use, their perceived function in a specific context, and the impact 
on catastrophizing. Depending on the feared consequences it seems possible that 
the same behavior functions both as safety mechanism and a coping strategy. For 
instance, a component of GEXP, the hierarchy of feared activities, may be perceived 
by some pain patients as a form of controlling pain and related physiological symp-
toms, leading them to fear situations in which they fail at control pain and related 
symptoms. On the other hand, it can also lead to greater perceived control, less fear 
during GEXP, and might increase patients’ motivation at the start of GEXP to expose 
themselves to feared activities and/or movements. Furthermore, related research 
suggests that safety behavior promotes adaptive cognitive change (Rachman, 1993). 
 
Based on the above mentioned findings there is a strong need for greater under-
standing of possible positive and negative consequences of safety behavior and the 
role of behavioral experiments in fearful pain patients. Is it only the perceived avail-
ability of safety behaviors that has a negative effect on fear reduction or is their use 
necessary? Is moving toward safety behavior during GEXP, rather than away from it, 
more effective in reducing avoidance behaviors? Do safety behaviors aid to modify 
catastrophic beliefs because of the fact that pain patients do not misattribute their 
success to external factors? What is the role of behavioral experiments rather than 
exposure to challenge catastrophic thoughts and beliefs? Does this allow patients to 
engage with the process of change behavior? Is there influence of duration to per-
form a pain-provoking task required to avoid ceiling effects? Most research to safety 
behavior is done in a laboratory setting by the use of a carefully standardized pro-
cedure: how is it in the “real world” (e.g. in patient’s home/work situation)? In sum, 
there still are many questions about the use of safety behaviors of which the an-
swers have important implications for GEXP. 
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Random GEXP 
The generalization study in this thesis showed that exposure to multiple as well as 
‘only’ single activities leads to generalization. Despite variability also random expo-
sure is assumed to result in generalization (Schmidt & Bjork, 1992). In a random 
condition, patients practiced exposure to feared activities and/or movements in 
random order, which means that GEXP occurs with disregard of the fear hierarchy. 
Examining the effects of GEXP based on random GEXP compared to a so-called 
blocked GEXP in which the pain patient will be exposed to a certain feared activity 
repeatedly before moving to the next more feared activity might shed new light on 
this issue. 
Spacing of GEXP sessions 
Research has shown that temporally spaced exposure trials often result in a stron-
ger acquisition-type of learning than temporally massed trials (e.g. Scharf et al., 
2002). It seems that greater storage strength of memory is gained by partial forget-
ting between learning episodes, which in turn is presumed to slow the loss of the 
retrievable memory over time (Bjork & Bjork, 2003). Currently, the use of GEXP is 
outlined by a protocol which prescribed two exposure sessions in a week spread 
over 8 to 9 weeks. Because this schedule is not theoretically driven and GEXP with 
the protocol as it stands seems to be a successful treatment, both in the short and 
long run, one could wonder whether an expanding spaced schedule of progressively 
longer intervals between GEXP sessions or consecutive sessions might have any 
influence on the outcome of GEXP. In addition, it is important to study this topic in 
different varieties of pain complaints. 
Offsetting context effects 
Despite no return of fear was found in the generalization study as well as in the 
follow-up period in the other GEXP studies of this thesis and also in the early studies 
(Vlaeyen et al. 2001, 2002a, 2002b) there are still some questions that have to be 
answered. Is more return of fear found if re-testing occurred in the original fear 
acquisition context? For example, the environment of the hospital or proximity of 
medical facility may be a particularly meaningful context during GEXP. It remains to 
be determined which contexts play an important role in pain-related fear learning 
and extinction. Another question to investigate is whether pain-alone exposures 
also offset context-based renewal effects.  
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Neurobiological research 
The majority of neurobiological research on fear learning and exposure has focussed 
on the amygdala, the prefrontal cortex (PFC) and the hippocampus (see Sotres-
Bayon et al., 2006 for a review). The precise function of the amygdala is still unclear. 
Nevertheless it seems that this area plays a role in fear learning and is involved in 
extinction learning as well. The hippocampal formation seems to play a critical role 
in encoding contextual information, which is necessary to form an integrated mem-
ory of features of the context before conditioning can take place. Finally, the PFC 
seems responsible for executive control and decision making, and certain parts of 
the PFC (i.e., ventral medial) are responsible for emotional regulation, and, in par-
ticular, the ability to interpret emotional stimuli and change behavior accordingly 
(e.g. Craske et al., 2008). 
 
Research to understand the neural mechanisms of GEXP, and emotional regulation 
during GEXP in particular, is hardly implemented. It seems interesting to understand 
how the PFC, amygdala and hippocampus interact to fully encode the extinction 
memory in fearful pain patients and which exact nature role the PFC and amygdala 
play in fear extinction. Given the role of the PFC, behavioral methods for enhancing 
PFC throughout GEXP may also prove to be a useful direction for research. If cogni-
tive restructuring enhances the benefits of GEXP alone, it is quite conceivable that 
this may be done by activation of the PFC. Further, it would be of interest to estab-
lish the role of PFC activation in linguistic processing and typical cognitive restruc-
turing and the connection of such activation to the development of new, inhibitory 
associations and expectancies. 
Conclusions 
This dissertation presented some studies to further explore the utility of GEXP. It 
has been shown that the application of GEXP has considerable promise in the 
treatment of pain patients who have a clearly articulated pain-related fear. The 
effects of GEXP generalized from chronic low back pain to other pain problems such 
as complex regional pain syndrome and posttraumatic neck pain. Significant ad-
vances have been made in understanding the behavioral and cognitive mechanisms 
involved in GEXP and how these mechanisms enhances generalization. Hopefully 
this work will contribute to better care for patients with chronic pain for who rela-
tively few evidence-based treatment options exist. 
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Wanneer traditionele en biomedische behandelingen niet het beoogde resultaat 
opleveren, worden pijnpatiënten vaak doorverwezen naar revalidatiecentra. De 
behandelingen binnen deze centra zijn in het algemeen interdisciplinair en geba-
seerd op bio-psycho-sociale en gedragsmatige revalidatie modellen. Deze modellen 
gaan ervan uit dat de ervaren beperkingen niet alleen bepaald worden door de 
onderliggende pathologie, maar ook door cognitieve factoren (b.v. het denken in 
catastrofes), gedragsmatige (b.v. het vermijden van bepaalde activiteiten), emotio-
nele (b.v. sombere stemming) en sociale (b.v. algemene opvattingen over ziekte en 
gezondheid). Methoden die tijdens de behandeling aan bod komen zijn afkomstig 
uit de beginselen van de operante conditionering (observeerbaar pijngedrag zoals 
inactiviteit dient de focus van behandeling te zijn) en de cognitieve psychologie 
(focus ligt op de rol van attributies en verwachtingen, gevoel van controle en pro-
bleemoplossingvaardigheden). Onderzoek naar cognitief-gedragsmatige behande-
lingen laat wisselende resultaten zien. Dientengevolge wordt gesuggereerd om 
behandelingen nog beter af te stemmen op specifieke kenmerken van de patiënt. In 
de afgelopen jaren heeft cognitief-gedragsmatig pijnonderzoek zich dan ook gericht 
op mechanismen die een rol spelen bij de ontwikkeling van een acuut naar een 
chronisch pijnprobleem. Een aantal studies hebben laten zien dat aan pijn gerela-
teerde angst een van de sterkste voorspellers is voor de waargenomen variatie in 
fysieke prestaties bij pijnpatiënten. 
Omdat pijngerelateerde angst een substantiële bijdrage levert aan het in stand 
houden van chronische pijn, is het een belangrijk doelwit binnen de behandeling. 
Sterker nog, verschillende studies hebben laten zien dat een exposure in vivo be-
handeling (GEXP) een effectieve behandeling is bij chronische lage rugpijn patiënten 
die een hoge mate van aan pijn gerelateerde angst rapporteren. Echter, de resulta-
ten van deze studies en de complexiteit van GEXP hebben ook extra vragen opge-
roepen. Bijvoorbeeld, welke behandelcomponenten maken GEXP al dan niet suc-
cesvol? Wat wordt eigenlijk geleerd tijdens GEXP? Is het uitdoven van pijngerela-
teerde angst te generaliseren naar andere bewegingen en activiteiten die niet zijn 
opgenomen in de GEXP? Is GEXP ook toe te passen bij pijnpatiënten met waar-
neembare weefselpathologie zoals neuropathische pijn? Kortom, antwoorden op 
deze vragen kunnen bijdragen aan het optimaliseren van GEXP bij pijngerelateerde 
angst. Het doel van dit proefschrift is om de toepassing van GEXP verder te onder-
zoeken door na te gaan 1) of GEXP, naast chronische rugpijn, ook positieve effecten 
oplevert bij andere pijnproblemen, zoals Complex Regionaal Pijn Syndroom en post-
traumatische nekpijn, 2) wat de bijdrage is van specifieke behandelcomponenten in 
het resultaat van GEXP, en 3) of blootstelling aan meerdere stimuli generalisatie 
verbetert na afloop van GEXP. 
 
In hoofdstuk 1, de inleiding van dit proefschrift, wordt allereerst stilgestaan bij het 
concept pijn. Pijn is een multidimensionele ervaring, die zowel een sensorische-
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discriminatieve dimensie (b.v. de locatie, duur en intensiteit van de pijn) als  affec-
tief-motivationele dimensie heeft (b.v. de onaangenaamheden van pijn en angst 
voor pijn) bevat, en geen één-op-één relatie heeft met de mate van weefselbescha-
diging. Er bestaat grote variabiliteit met betrekking tot de  intensiteit van de ervaren 
pijn  tussen individuen. Maar één individu kan pijn varieren afhankelijk van de con-
text waarin het individu zich bevindt. Bovendien, wanneer de pijn aanhoudt en 
chronisch wordt lijken affectief-motivationele aspecten meer op de voorgrond te 
treden, terwijl de sensorische een geringere rol spelen bij de pijnervaring. Vervol-
gens wordt ingegaan op de rol van pijngerelateerde angst als verklaring waarom 
acute pijnpatiënten een chronisch pijnprobleem met de daarbij horende beperkin-
gen kunnen ontwikkelen. Klassieke of Pavloviaanse conditionering wordt van ouds-
her beschouwd als model voor de acquisitie van angst. Dit betekent dat een van 
oorsprong neutrale stimulus wordt gekoppeld met een biologisch relevante en be-
dreigende stimulus of situatie. Helaas is er weinig onderzoek gedaan naar de rol van 
klassieke conditionering in de ontwikkeling van pijn-gerelateerde angst. Het is ech-
ter waarschijnlijk dat een acute episode van ernstige pijn of andere lichamelijke 
sensaties wordt gezien als een teken van schade (ongeconditioneerde stimulus: US) 
en een onschuldige activiteit of beweging (geconditioneerde stimulus: CS) hieraan 
wordt gerelateerd. Het resultaat van dit leerproces is dat propositionele kennis over 
de relatie tussen de twee stimuli (de beweging met de toegenomen pijn als teken 
voor schade) wordt opgeslagen in het geheugen. Wanneer het subject wordt bloot-
gesteld aan dezelfde soort van beweging, zal deze beweging de associatie met de 
toename van pijn activeren, wat resulteert in het uitlokken van een geconditioneer-
de respons (CR). Zelfs meer dan het oproepen van een herinnering, zorgt dit leer-
proces ervoor dat de betreffende beweging resulteert in het activeren van een ac-
tieve verwachting, namelijk die van een bedreigende gebeurtenis. Herhaling van het 
leerproces zorgt er ook voor dat de beweging een goede voorspeller wordt van 
toenemende pijn als teken van schade: ‘Wanneer ik mijn vierjarig kind optil, dan 
ervaar ik onmiddellijk meer pijn in mijn rug wat duidelijk aangeeft dat mijn wervels 
versleten zijn’ en ‘Als ik mijn kind niet optil, dan zal de pijn in mijn rug niet toene-
men, hetgeen betekent dat ik mijn wervels niet nog meer ga beschadigen’. Het 
subject legt niet alleen een verband tussen twee gebeurtenissen (associatief leren), 
maar leert ook dat de ene gebeurtenis de andere voorspelt (verwachtingsleren). 
Verwachtingsleren resulteert uiteindelijk in generalisatie van angst voor activiteiten, 
bewegingen en/of situaties vergelijkbaar met de onschadelijke beweging die de pijn 
heeft uitgelokt. De nieuwe en bedreigende betekenis van een oorspronkelijk neu-
trale beweging zorgt ervoor dat het subject zijn gedrag zal veranderen. Meer en 
meer activiteiten, bewegingen en/of activiteiten zullen worden vermeden. Pijn-
gerelateerde angst kan zich ontwikkelen op minstens drie verschillende manieren: 
directe ervaringen (bijvoorbeeld een specifieke beweging verhoogt de pijn of de 
zwelling van de gebruikte arm); verbale informatie (bijvoorbeeld een arts die aan-
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geeft dat er spraken is van artrose); of het observeren van anderen (bijvoorbeeld 
een vriend zittend in een rolstoel vanwege dezelfde pijnklachten of niet in staat is 
om te werken). Naast vermijding en ontsnappingsgedrag en verhoogde pijnervaring 
is pijngerelateerde angst gerelateerd aan denken in catastrofes over pijn, hypervigi-
lantie, functionele beperkingen, veranderingen op centraal niveau, motorische ab-
normaliteiten, en depressiviteit. Exposure lijkt een geschikte behandeling. Het 
wordt gezien als een proces waarbij de patiënt tijdens een bepaalde periode her-
haaldelijk wordt blootgesteld aan bedreigende situaties terwijl aversieve  conse-
quenties uitblijven. Dit proces wordt ook wel extinctie genoemd. Extinctie verwijst 
naar een zich herhalende presentatie van een geconditioneerde stimulus (CS: bij-
voorbeeld een onschuldige activiteit) in de afwezigheid van de ongeconditioneerde 
stimulus (US: bijvoorbeeld een pijnproducerende of angstopwekkende stimulus) 
waarmee de CS voorheen was gekoppeld. Onderzoek heeft laten zien dat extinctie 
niet leidt tot het uitdoven van de angst en dat het veranderen van de context waar-
in extinctie heeft plaatsgevonden en het aanbieden van een onverwachte US erva-
ring na afloop van extinctie kan leiden tot een gedeeltelijk herstel van de ogen-
schijnlijk gedoofde angstreacties. Extinctie in wisselende contexten en herhaling lijkt 
in dit opzicht belangrijk te zijn. Bovendien blijkt dat cognitieve processen die dis-
functionele overtuigingen beïnvloeden onderdeel uitmaken van de exposure thera-
pie. 
Voor pijnpatiënten die een hoge mate van pijngerelateerde vrees rapporteren is 
een ‘graded exposure in vivo’ (GEXP) ontwikkeld om extinctie van aan pijn gerela-
teerde angst te bewerkstelligen. Tijdens GEXP wordt de patiënt tijdens een bepaal-
de periode herhaaldelijk wordt blootgesteld aan bedreigende situaties.  GEXP is zeer 
gestructureerd, geprotocolleerd, op maat gesneden, en streeft naar een normaal 
patroon van het dagelijks functioneren, met inbegrip van volledige terugkeer naar 
het werk. Zowel experimentele single-case studies als gerandomiseerde gecontro-
leerde studies (RCT) hebben aangetoond dat GEXP effectief is in het verminderen 
van functionele beperkingen bij patiënten met chronische lage rugpijn. Echter, bij 
twee RCT’s was deze vermindering niet statistisch significant ten opzichte van een 
controle groep die op een wachtlijst stonden, gebruikelijke therapie (contact met 
een huisarts, medicatie, fysiotherapie) aangeboden kregen, of deelnamen aan een 
programma waarin stapsgewijs activiteiten werden opgebouwd. Over het geheel 
genomen is een van de meest opvallende kenmerken in deze studies het genoemde 
belang van de educatieve component van de exposure behandeling. Tijdens de 
educatie wordt het vrees-vermijdings-model geïllustreerd en uitgelegd. Ook wordt 
beschreven dat het belangrijk is om tijdens de exposure verschillende angstopwek-
kende activiteiten aan te bieden en dat therapeuten over de benodigde competen-
ties beschikken. Tot slot, de resultaten van de single-case studies, alsook die van de 
RCT’s, zijn hoopvol met betrekking tot generalisatie van extinctie.  
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Hoofdstuk 2 van dit proefschrift is gericht op de rol van pijngerelateerde angst bij 
patiënten met een Complex Regionaal Pijn Syndroom type I (CRPS-I), ook wel post-
traumatische dystrofie genoemd. Twee studies worden gepresenteerd. Studie I 
omvat een steekproef van patiënten met een (sub)acute CRPS-I die zijn verwezen 
naar een poliklinische pijnpoli. In Studie II zijn patiënten met chronische CRPS-I en 
die lid zijn van de Nederlandse patiëntenvereniging uitgenodigd om deel te nemen 
aan een onderzoek. De resultaten van Studie I laten zien dat de hevigheid van de 
pijn, maar niet pijngerelateerde angst zoals gemeten met de Tampa Schaal voor 
Kinesiofobie (TSK), gerelateerd is aan de mate van functionele beperkingen bij een 
(sub)acute CRPS-I. Deze resultaten zijn niet consistent met eerder onderzoek bij 
patiënten met pijn aan het bewegingsapparaat waarbij een hoge TSK-score wel 
gerelateerd was aan de mate van functionele beperkingen, en zelfs meer nog dan 
de pijn zelf. Hoewel er een gebrek is aan consensus tussen onderzoekers, wordt 
CRPS-I gezien als een neuropathisch pijnsyndroom. Daarom is verondersteld dat de 
TSK niet gevoelig genoeg is om de mate van pijngerelateerde angst te meten, en is 
in Studie II ook een instrument gebruikt die bestaat uit foto’s van dagelijkse activi-
teiten (PHODA) om pijngerelateerde angst te meten. De resultaten van Studie II 
laten zien dat bij patiënten met een chronische CRPS-I, naast de hevigheid van de 
pijn, ook de aan pijn gerelateerde angst, gemeten met de PHODA, een significante 
voorspeller is voor de mate van functionele beperkingen. Hoewel replicatie studies 
noodzakelijk zijn, lijkt het gerechtvaardigd om te concluderen dat de rol van pijnge-
relateerde angst een veelbelovende onderzoeksrichting is naar het begrijpen van de 
ervaren functionele beperkingen bij CRPS-I. 
 
Hoofdstuk 3 en 4 beschrijven een tweetal studies waarin door middel van single-
case experimenten met herhaalde metingen de effectiviteit van GEXP is onderzocht 
bij patiënten met posttraumatische nekpijn (PTNP) en CRPS-I. Patiënten die deel-
namen aan de studie rapporteerden een hoge mate van pijngerelateerde angst. In 
de PTNP studie hebben patiënten zowel een GEXP alsook een operant ‘graded actvi-
ty’ (OPE) programma doorlopen. Het doel van OPE is gezond gedrag bevorderen en 
pijngedrag te verminderen. Er wordt vanuit gegaan dat inactiviteit (pijngedrag) leidt 
tot een verminderde belastbaarheid, welke pijn bevorderd, en dat het verhogen van 
het activiteitenniveau en de spiersterkte in de toekomst waarschijnlijk zal leiden tot 
minder beperkingen. De volgorde waarin GEXP en OPE werd aangeboden gebeurde 
op basis van toeval. Door gebruik te maken van dagboekjes hebben beide studies 
laten zien dat tijdens GEXP er niet alleen een significatie vermindering plaatsvindt 
van pijngerelateerde angst en het denken in catastrofes over pijn, maar ook voor 
wat betreft pijnintensiteit. Tevens rapporteren alle patiënten tijdens GEXP doelen te 
kunnen bereiken die betrekking hebben op de uitvoering van activiteiten die bij 
aanvang van de studies als onmogelijk werden verondersteld. Gestandaardiseerde 
vragenlijsten over pijngerelateerde angst, pijnintensiteit en functionele beperkin-
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gen, die voorafgaande en na afloop van iedere interventie werden afgenomen laten 
alleen na afloop van GEXP een significante afname zien. Om het niveau van dagelijk-
se fysieke activiteit te kwantificeren werd door PTNP patiënten tijdens deze perio-
den ook een ambulante bewegingsmeter gedragen. Een significante toename van 
de dagelijkse fysieke activiteit was wederom alleen te zien na afloop van GEXP. 
Tenslotte, het meest opvallende resultaat was dat fysiologische verschijnselen en 
symptomen, zoals abnormale gevoeligheid voor prikkeling van de zintuigen, oe-
deem, veranderde lichaamskleur en temperatuur, en een verstoorde zweetsecretie, 
die verband houden met CRPS positief werden beïnvloed door GEXP. Tijdens een 
follow-up meting van 6 maanden bleken alle hierboven beschreven positieve resul-
taten, als gevolg van GEXP, nog steeds aanwezig te zijn. Beide studies ondersteunen 
de effectiviteit van GEXP bij patiënten met PTNP en CRPS-I die een hoge mate van 
pijngerelateerde angst rapporteren. 
 
Klinisch onderzoek, dat mede heeft geleid tot de vraagstellingen binnen dit proef-
schrift, heeft laten zien dat bij chronische lage rugpijn patiënten vrij snel na de start 
van het GEXP programma een abrupte afname van pijngerelateerde angsten en 
cognities plaatsvindt. Deze abrupte veranderingen zijn meer een kenmerk van in-
zichtelijk leren in plaats van de gebruikelijke leermethode van vallen en opstaan. Als 
het GEXP protocol is gevolgd, zou het dus zo kunnen zijn dat het educatieve deel 
aan het begin van GEXP heeft bijgedragen tot dit inzicht. Hoofdstuk 5 van dit proef-
schrift beschrijft een studie waarin de bijdrage van de educatie aan het verminderen 
van pijngerelateerde angst, en de daaraan verbonden beperkingen in fysiek functio-
neren, bij chronische lage rugpijn patiënten is onderzocht. Na een periode waarin 
geen enkele behandeling is gevolgd, kregen alle patiënten het educatieve deel van 
de GEXP aangeboden, gevolgd door wederom een behandelvrije periode. Patiënten 
werden vervolgens willekeurig toegewezen aan hetzij GEXP of een gedragsmatige 
oefentherapie (OPE). Ook nu weer werd een dagboekje gebruikt om dagelijkse ver-
anderingen van pijnintensiteit, pijngerelateerde angst, het denken in catastrofes 
over pijn en de moeilijkheid om een bepaalde activiteit uit te voeren te meten. 
Tevens werd voorafgaand en na afloop van iedere interventie en tijdens een 6-
maanden follow-up gestandaardiseerde vragenlijsten afgenomen om pijngerela-
teerde angst, gevoeligheid voor pijn, pijnintensiteit en ervaren beperkingen als 
gevolg van de pijn te meten, en droegen de patiënten gedurende één week een 
ambulante bewegingsmeter. De resultaten van de dagelijkse metingen laten zien 
dat pijngerelateerde angst inderdaad positief werd beïnvloed door de educatie. 
Echter, het uitvoeren van relevante dagelijkse activiteiten werd niet beïnvloed door 
de educatie, maar verbeterde alleen onder invloed van GEXP. Ook tijdens de 6-
maanden follow-up werden deze verbeteringen alleen gevonden bij patiënten die 
een GEXP hadden gevolgd, en rapporteerde deze groep zelfs een significante afna-
me in pijnintensiteit.  
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Ondanks het succes van GEXP bij chronische pijn is het nog de vraag of extinctie 
generaliseert naar nieuwe bedreigende activiteiten. Uit dierexperimenteel onder-
zoek naar de terugkeer van angst is gebleken dat extinctie niet betekent afleren 
betekent. Het lijkt erop dat de gedoofde angstreactie na een tijdje weer spontaan 
kan ontstaan, of opnieuw kan optreden bij confrontatie met een nieuwe CS-US 
gebeurtenis of een onverwachte US. Tevens lijkt extinctie ook context gevoelig. 
Exposure onderzoek bij lage rugpijn patiënten heeft laten zien dat wat is geleerd 
tijdens extinctie niet noodzakelijkerwijs generaliseert naar andere situaties, zelfs 
niet wanneer extinctie plaatsvindt in een situatie waarin de oorspronkelijke angst is 
ontstaan. Hoofdstuk 6 van dit proefschrift beschrijft een studie met als primaire 
doel een eerdere studie te repliceren waarin gevonden werd dat exposure aan 
meerdere stimuli en/of contexten generalisatie bevordert. Door gebruik te maken 
van een single-case experimenteel design werd onderzocht of de effecten van GEXP 
bij angstige CRPS-I patiënten generaliseren naar bedreigende activiteiten waaraan 
de patiënten tijdens GEXP niet zijn blootgesteld. Twee GEXP condities bestaande uit 
15 sessies van één uur werden met elkaar vergeleken. Conditie I bestond uit een 
GEXP programma van minimaal 15 activiteiten waaraan patiënten slechts één keer 
werden blootgesteld en Conditie II uit 3 activiteiten waaraan patiënten vijf maal 
werden blootgesteld. In beide condities werd generalisatie van extinctie getest door 
patiënten na een succesvolle GEXP bloot te stellen aan een nieuwe activiteit. De 
veronderstelling was dat generalisatie van extinctie wordt bevorderd door de condi-
tie waarin de meerdere activiteiten werden aangeboden. In tegenstelling tot wat 
werd verwacht presteerden de patiënten uit beide condities even goed tijdens de 
test exposure. Bij alle patiënten was sprake van generalisatie naar een nieuwe acti-
viteit direct na afloop van GEXP en tijdens een 6-maanden follow-up. Over het ge-
heel genomen lijkt het erop dat, ongeacht de aard van GEXP, extinctie generaliseert 
naar nieuwe bedreigende activiteiten. 
 
Tenslotte worden in hoofdstuk 7 allereerst de bevindingen van dit proefschrift sa-
mengevat en vervolgens ter discussie gesteld. De studies in dit proefschrift hebben 
aangetoond dat GEXP een veelbelovende behandeling is voor chronische pijnpatiën-
ten die een hoge mate van pijngerelateerde angst rapporteren. De effecten van 
GEXP generaliseren van chronische lage rugpijn naar andere pijnproblemen zoals 
CRPS-I en PTNP. Aanzienlijke vooruitgang is geboekt in het begrijpen van de ge-
dragsmatige en cognitieve mechanismen die betrokken zijn bij GEXP en hoe deze 
mechanismen generalisatie van extinctie versterken. Desondanks blijven er nog 
steeds onduidelijkheden bestaan over de cognitieve processen die ten grondslag 
liggen aan het succes van GEXP. Er is daarom behoefte aan meer theoretisch gericht 
onderzoek. Studies gericht op verwachtingen (bijvoorbeeld, voorgenomen kennis 
over het verband tussen een specifieke activiteit en de daaropvolgende pijn als 
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potentieel teken van schade), het wel of niet toepassen van veiligheidsgedrag tij-
dens GEXP, willekeurige exposure (GEXP wordt aangeboden zonder acht te slaan op 
de angsthiërarchie), het leereffect van tijdelijk gespreide en opeenvolgende exposu-
re sessies, het neutraliseren van de context (bijvoorbeeld, het gegeven dat GEXP 
plaatsvindt in het ziekenhuis kan een belangrijke rol spelen), en neuro-cognitieve 
processen werpen misschien meer licht op de mechanismen die ten grondslag lig-
gen aan de associaties tussen pijngerelateerde angst en chronische pijn.  
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Het schrijven van een proefschrift was naast een klinische taak en het vaderschap 
een zware exercitie. Zonder de steun en hulp van vele lieve mensen was dit nooit 
gelukt. Het is dan ook fijn om iedereen die direct of indirect heeft bijgedragen aan 
dit proefschrift hieronder te kunnen bedanken. 
 
Ik kan niet anders concluderen dat ik bevoorrecht ben geweest om onder de vleu-
gels van Johan Vlaeyen te hebben mogen werken aan dit proefschrift. Johan, een 
betere promotor en inspirator was niet voor te stellen. Je passie en inzet voor het 
onderzoek dat we samen hebben uitgevoerd, en nog steeds uitvoeren, is bewonde-
renswaardig. Ondanks je overvolle agenda, maakte je tijd voor mij vrij, en werd ik 
iedere keer weer verrast door de snelheid waarmee ik teksten voorzien van com-
mentaar terugkreeg. De ruimte die ik kreeg voor mijn eigen inbreng en de waarde-
ring voor mij als persoon heeft me veel zelfvertrouwen gegeven. Dankzij jou heb ik 
niet alleen veel geleerd over pijn, wetenschappelijk onderzoek en de gedragsthera-
pie, maar ook over mezelf. Prioriteiten stellen! Johan, hopelijk is dit proefschrift 
slechts een tussenstation en zullen we op velerlei levensgebieden nog samen genie-
ten. 
 
De leden van de beoordelingscommissie: Madelon Peters (voorzitter), Rob Smeets, 
Maarten van Kleef, Steven Linton en Deborah Vansteenwegen dank ik voor het 
beoordelen van mijn proefschrift. Rob, ook bedankt voor het kritisch nakijken van 
mijn proefschrift op (taalkundige) foutjes!  
 
Dank gaat uit naar de fantastische inzet en medewerking van de behandelteams en 
de patiënten tijdens de studies van dit proefschrift. Mede dankzij Adelante afdeling 
‘Reuma en Pijn’ zijn de eerste exposure behandelingen opgezet en bestudeerd. 
Vooral Peter Heuts, als toenmalig hoofd, ben ik hier zeer dankbaar voor. Het klinisch 
deel van de exposure therapie werd bij Adelante mede uitgevoerd door Mario Gei-
len en Herman Mulder. Mario en Herman, bedankt voor de samenwerking en het 
feit dat jullie jezelf ook hebben blootgesteld aan het geven van een behandeling die 
niet overeenstemde met de reguliere zorg.  
 
De samenwerking met mijn huidige collega’s van de afdeling Revalidatie 
MUMC/azM is van grote waarde. Niet alleen voor de totstandkoming van dit proef-
schrift, maar ook voor het met heel veel plezier initiëren en uitvoeren van pijnreva-
lidatie en pijnonderzoek. Joop Ruijgrok, revalidatiearts en ad interim-hoofd, bedankt 
voor je inzet bij het creëren van mijn positie binnen de afdeling Revalidatie. Dankzij 
jou heeft de exposure behandeling een belangrijke plek binnen de klinische zorg 
gekregen. Rob Smeets, huidig hoofd, dank ik voor het geven van de ruimte om mijn 
onderzoeksactiviteiten te kunnen blijven uitvoeren binnen de nieuwe vakgroep 
Revalidatiegeneeskunde van de UM. Ook Jeanine Verbunt, revalidatiearts, wil ik 
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bedanken voor haar steun hierbij. Rob, Joop en Jeanine en de revalidatieartsen 
Marjon van Eijsden, Erik de Klerk, Joep Cluitmans en Antal Sanders, bedankt voor 
jullie inzet bij het exposure onderzoek. En nu de paramedici: enthousiast en vol met 
energie! Corine Cuypers, op de eerste plaats wil ik jou bedanken voor je inzet. Je rol 
binnen de exposure behandeling en je hulp bij organisatorische zaken rondom ex-
posure verdienen veel lof. Maria Kerkhofs, als eerste paramedicus binnen het 
MUMC/azM heb jij je ‘gewaagd’ aan het geven van exposure. Hiermee heb je je 
collega’s laten inzien dat het mogelijk is om je eigen angst als behandelaar te over-
winnen; bedankt! Anita Stevens, Christoph Loo, Marianne Maas, Margot van Melick, 
Tanja Hermans en Corien Rebel, ook jullie bedankt voor je inzet. 
 
Naast de hierboven genoemde collega’s van het MUMC/azM wil ik in het bijzonder 
Marlies den Hollander en Els Oostveen bedanken. Marlies, zowel binnen het onder-
zoek als de patiëntenzorg heb je me altijd op een positieve wijze bijgestaan en van 
suggesties voorzien. Door jouw enthousiasme en inzet heeft de exposure behande-
ling aan kwaliteit gewonnen. Ik geef nu het promotiestokje door aan jou! Els, jij hebt 
voor mij op de afdeling revalidatie van het MUMC/azM de randvoorwaarden gecre-
eerd waardoor ik mijn werk als gedragstherapeut/onderzoeker met zoveel plezier 
kan uitvoeren. Altijd kan ik een beroep op je doen en sta je voor mij klaar. Bedankt 
voor al deze goede zorgen! Marlies en Els, ik ben in mijn nopjes dat jullie als para-
nimfen tijdens de promotieplechtigheid aan mijn zijde staan! 
 
Sjors Roox, hoofd van de afdeling fysiotherapie MUMC/azM, en Phil Geerlings, 
hoofd van de afdeling ergotherapie MUMC/azM, dank ik dat zij behandelaars van 
hun afdeling de kans hebben gegeven mee te werken aan het exposure onderzoek.  
 
De samenwerking met de poli pijnbestrijding MUMC/azM is van groot belang ge-
weest voor het exposure onderzoek. Maarten van Kleef, afdelingshoofd, en Jaap 
Patijn, coördinator pijnbestrijding, bedankt voor jullie inzet. 
 
Het promotieonderzoek was ondergebracht bij het departement Clinical Psychologi-
cal Science (CPS) van de Faculty of Psychology and Neuroscience UM, voorheen 
Departement Medische Klinische en Experimentele Psychologie (DMKEP) van de 
Faculty of Health, Medicine and Life Sciences UM, en de Nederlands-Vlaamse on-
derzoekschool Experimentele Psychologie (EPP). Angela Verweij, dankzij jouw inzet 
voor prima werkfaciliteiten en aandacht voor sociale aspecten heb ik mijn verblijf bij 
DMKEP/CPS als zeer prettig ervaren. Bedankt hiervoor! Arnoud Arntz en Rense 
Hoekstra, bedankt voor jullie inzet om mij te ontlasten van patiëntenzorg zodat ik 
een aaneengesloten periode heb kunnen werken aan mijn proefschrift. Erik Schou-
ten, bedankt voor je statistische ondersteuning en Rosanne Janssen, bedankt voor 
je hulp bij het opslaan en verwerken van de onderzoeksdata. Leve EMIUM! Tot slot 
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wil ik de collega’s Mariëlle Goossens, Madelon Peters en Sita van Riet, en de voor-
malig DMKEP/CPS collega’s Jantha de Gelder, Maaike Leeuw, Karolien Vangrons-
veld, Anja van den Hout en Peter de Jong bedanken voor hun hulp en/of advies bij 
de verschillende studies die zijn uitgevoerd. 
 
Peter Boon, Ruud Severeijns, Gerdy Konings en Lidwine Bruinen, alle werkzaam bij 
de afdeling Medische Psychologie MUMC/azM ten tijde van mijn aanstelling daar, 
bedankt voor jullie inzet en hulp. Peter Boon heeft me de mogelijkheid gegeven om 
de opleiding tot gedragstherapeut te volgen en onderzoek te verrichten. Ruud en 
Gerdy, jullie intervisie heeft aan de basis gestaan van mijn ontwikkeling tot gedrags-
therapeut.  
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